0001079973-16-001283.txt : 20161114 0001079973-16-001283.hdr.sgml : 20161111 20161114143041 ACCESSION NUMBER: 0001079973-16-001283 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BION ENVIRONMENTAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000875729 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 841176672 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-19333 FILM NUMBER: 161993735 BUSINESS ADDRESS: STREET 1: C/O BOX 566 STREET 2: 1774 SUMMITVIEW WAY CITY: CRESTONE STATE: CO ZIP: 81131 BUSINESS PHONE: (212) 758-6622 MAIL ADDRESS: STREET 1: C/O BOX 566 STREET 2: 1774 SUMMITVIEW WAY CITY: CRESTONE STATE: CO ZIP: 81131 FORMER COMPANY: FORMER CONFORMED NAME: RSTS CORP DATE OF NAME CHANGE: 19930328 10-Q 1 bion_10q-093016.htm FORM 10-Q FOR THE PERIOD ENDED 9/30/2016

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2016

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _________

Commission File No. 000-19333

Bion Environmental Technologies, Inc.

(Name of registrant in its charter)

Colorado		84-1176672
(State or other jurisdiction of incorporation or formation)		(I.R.S. employer identification number)

Box 566 / 1774 Summitview Way

Crestone, Colorado 81131

(Address of principal executive offices)

(212) 758-6622

(Registrant's telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

		Large accelerated filer ☐		Accelerated filer ☐
		Non-accelerated filer ☐ (Do not check if a smaller reporting company)		Smaller reporting company ☒

SEC 1296 (03-10) Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS: Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Not applicable.

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. On November 3, 2016, there were 23,763,305 Common Shares issued and 23,058,996 Common Shares outstanding.

BION ENVIRONMENTAL TECHNOLOGIES, INC.

FORM 10-Q

TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION		Page

Item 1.	Financial Statements	5
	Consolidated financial statements (unaudited):
	Balance sheets	5
	Statements of operations	6
	Statement of changes in equity (deficit)	7
	Statements of cash flows	8
	Notes to unaudited consolidated financial statements	9-23

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	24

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	37

Item 4.	Controls and Procedures	37

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	38

Item 1A.	Risk Factors	38

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	38

Item 3.	Defaults Upon Senior Securities	38

Item 4.	Mine Safety Disclosures	38

Item 5.	Other Information	38

Item 6.	Exhibits	39

	Signatures	40

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that involve substantial risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will," "expect," "intend," "estimate," "anticipate," "project," "predict," "plan," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. The expectations reflected in forward-looking statements may prove to be incorrect.

PART I – FINANCIAL INFORMATION

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS


	September 30,			June 30,
	2016			2016
	(unaudited)
ASSETS
Current assets:
Cash	$	64,418		$	170,194
Prepaid expenses		15,901			15,240
Subscription receivable		-			7,500
Deposits and other receivables		1,000			1,000

Total current assets		81,319			193,934

Property and equipment, net (Note 3)		3,757			4,259

Total assets	$	85,076		$	198,193

LIABILITIES AND EQUITY (DEFICIT)

Current liabilities:
Accounts payable and accrued expenses	$	818,133		$	768,272
Series B Redeemable Convertible Preferred stock, $0.01 par value,
50,000 shares authorized; 200 shares issued and outstanding,
liquidation preference of $30,500 and $30,000, respectively (Note 7)		27,900			27,400
Deferred compensation (Note 4)		1,657,541			1,436,595
Loan payable and accrued interest (Note 5)		8,621,827			8,563,662
Total current liabilities		11,125,401			10,795,929

Convertible notes payable - affiliates (Note 6)		3,311,988			3,280,647
Total liabilities		14,437,389			14,076,576

Deficit:
Bion's stockholders' equity (deficit):
Series A Preferred stock, $0.01 par value, 10,000 shares authorized, no shares issued and outstanding		-			-
Series C Convertible Preferred stock, $0.01 par value,
60,000 shares authorized; no shares issued and outstanding		-			-
Common stock, no par value, 100,000,000 shares authorized, 23,761,168
and 23,573,057 shares issued, respectively; 23,056,859
and 22,868,748 shares outstanding, respectively		-			-
Additional paid-in capital		102,434,634			102,278,364
Accumulated deficit		(116,846,159	)		(116,216,493	)
Total Bion's stockholders' deficit		(14,411,525	)		(13,938,129	)

Noncontrolling interest		59,212			59,746
Total deficit		(14,352,313	)		(13,878,383	)
Total liabilities and deficit	$	85,076		$	198,193

See notes to consolidated financial statements.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

THREE MONTHS ENDED SEPTEMBER 30, 2016 AND 2015
(UNAUDITED)
	2016			2015

Revenue	$	-		$	-


Operating expenses:
General and administrative (including stock-based
compensation (Note 7))		424,691			507,905
Depreciation		502			75,879
Research and development (including stock-based
compensation (Note 7))		112,243			134,489


Total operating expenses		537,436			718,273

Loss from operations		(537,436	)		(718,273	)

Other expense:
Interest expense, net		92,764			114,756

		92,764			114,756

Net loss		(630,200	)		(833,029	)

Net loss attributable to the noncontrolling interest		534			1,295

Net loss applicable to Bion's common stockholders	$	(629,666	)	$	(831,734	)

Net loss applicable to Bion's common stockholders
per basic and diluted common share	$	(0.03	)	$	(0.04	)

Weighted-average number of common shares outstanding:
Basic and diluted		23,544,122			22,289,077

See notes to consolidated financial statements.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

THREE MONTHS ENDEDSEPTEMBER 30, 2016

(UNAUDITED)

	Bion's Shareholders'
	Series C Preferred Stock				Common Stock				Additional		Accumulated			Noncontrolling			Total
	Shares		Amount		Shares		Amount		paid-in capital		deficit			interest			equity/(deficit)

Balances, July 1, 2016		-	$	-		23,573,057	$	-	$	102,278,364	$	(116,216,493	)	$	59,746		$	(13,878,383	)

Issuance of common stock for services		-		-		20,492		-		16,556		-			-			16,556
Vesting of options for services		-		-		-		-		20,856		-			-			20,856
Sale of common stock		-		-		30,467		-		22,850		-			-			22,850
Sale of units		-		-		120,000		-		90,000		-			-			90,000
Warrants exercised for common stock		-		-		10,000		-		-		-			-			-
Conversion of debt		-		-		7,152		-		6,008		-			-			6,008
Net loss		-		-		-		-		-		(629,666	)		(534	)		(630,200	)
Balances, September 30, 2016		-	$	-		23,761,168	$	-	$	102,434,634	$	(116,846,159	)	$	59,212		$	(14,352,313	)

See notes to consolidated financial statements.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

THREE MONTHS ENDED SEPTEMBER 30, 2016 AND 2015

(UNAUDITED)


	2016			2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(630,200	)	$	(833,029	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		502			75,879
Accrued interest on loan payable, deferred compensation and other		101,560			114,969
Stock-based compensation		37,412			41,272
Increase in prepaid expenses		(661	)		(3,914	)
Increase in accounts payable and accrued expenses		49,861			34,429
Increase in deferred compensation and convertible notes		215,400			227,400

Net cash used in operating activities		(226,126	)		(342,994	)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		-			(3,260	)
Net cash used by investing activities		-			(3,260	)

CASH FLOWS FROM FINANCING ACTIVITIES
Decrease in subscription receivable		7,500			13,125
Proceeds from sale of common stock		22,850			-
Proceeds from sale of units		90,000			-
Proceeds from exercise of warrants		-			174,189

Net cash provided by financing activities		120,350			187,314

Net decrease in cash		(105,776	)		(158,940	)

Cash at beginning of period		170,194			339,286

Cash at end of period	$	64,418		$	180,346

Supplemental disclosure of cash flow information:
Cash paid for interest	$	-		$	-

Non-cash investing and financing transactions:
Issuance of common stock to satisfy deferred compensation	$	6,008		$	171,717
Exercise of warrants for promissory note receivable for shares	$	-		$	105,000

See notes to consolidated financial statements.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

1. ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENT'S PLANS:

Organization and nature of business:

Bion Environmental Technologies, Inc. ("Bion" or "We" or the "Company") was incorporated in 1987 in the State of Colorado and has developed and continues to develop patented and proprietary technology and business models that provide comprehensive environmental solutions to a significant source of pollution in United States agriculture, large scale livestock facilities known as Confined Animal Feeding Operations ("CAFO's"). Bion's technologies (and applications related thereto) produce substantial reductions of nutrient releases (primarily nitrogen and phosphorus) to both water and air (including ammonia, which is subsequently re-deposited to the ground) from livestock waste streams based upon our operations and research to date (and third party peer review thereof). We are continually involved in research and development to upgrade and improve our technology and technology applications, including integration with third party technology. Bion provides comprehensive and cost-effective treatment of livestock waste onsite (and/or at nearby locations), while it is still concentrated and before it contaminates air, soil, groundwater aquifers and/or downstream waters, and, in certain configurations, can be optimized to maximize recovery of marketable nutrients for potential use as fertilizer (organic and/or inorganic) and/or feed additives plus renewable energy (and related environmental credits).

During the 2014 to 2016 fiscal years, the Company increased its research and development focus on augmenting the basic 'separate and aggregate' approach of its technology platform to provide additional flexibility and to increase recovery of marketable nutrient by-products (in organic and non-organic forms) and renewable energy production (either/both biogas and/or renewable electricity), thereby increasing potential related revenue streams and reducing dependence of its future projects on the monetization of nutrient reductions (which still remain a very important part of project revenue streams). This research and development effort also involves ongoing review of potential "add-ons" and applications to our technology platform for use in different regulatory and/or climate environments. These research and development activities have targeted completion of development of the next generation of Bion's technology and technology platform. We believe such activities will continue at least through the 2017 fiscal year, subject to availability of adequate financing for the Company's operations, of which there is no assurance.

Currently, Bion is focused on using applications of its patented and proprietary waste management technologies and technology platform to pursue three main business opportunities: 1) installation of Bion systems ( some of which may generate verified nutrient credits and revenues from the production of renewable energy and byproducts) to retrofit and environmentally remediate existing CAFOs ("Retrofits") in selected markets where: a) government policy supports such efforts (such as the Chesapeake Bay watershed, some Great Lakes Basin states, and/or other states and watersheds facing EPA 'total maximum daily load' ("TMDL") issues, and/or b) where CAFO's need our technology to obtain permits to expand or develop without negative environmental consequences; 2) development of new state-of-the-art large scale waste treatment facilities in strategic locations ("Projects") ( some of these may be Integrated Projects as described below) with multiple revenue streams, and 3) licensing and/or joint venturing of Bion's technology and applications (primarily) outside North America. The opportunities described at 1) and 2) above each require substantial political and regulatory (federal, state and local) efforts on the part of the Company and a substantial part of Bion's efforts are focused on such political and regulatory matters. Bion is currently pursuing the international opportunities primarily through the use of consultants with existing relationships in target locations. The most intense focus is currently on the requirements for the clean-up of the Chesapeake Bay faced by the Commonwealth of Pennsylvania and the potential use of Bion's technology and technology platform on CAFOs as an alternative to what the Company believes is far more expensive nutrient removal downstream in storm water projects.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

Management believes that Bion's technology platform (including utilization of various third party technologies to supplement the Company's proprietary technologies), through the combination of remediation of the waste streams of large scale existing CAFOs with recovery of valuable marketable nutrients and renewable energy, can enable the integration of large-scale CAFO's and their end-product users, renewable energy production from the CAFO waste stream, on site utilization of the renewable energy generated and biofuel/ethanol production in an environmentally and economically sustainable manner while reducing the aggregate capital expense, operating costs and environmental footprint for the entire integrated complex ("Integrated Projects"). In the context of Integrated Projects, Bion's waste treatment process, in addition to mitigating polluting releases, enables generation of renewable energy from the CAFO waste stream, which renewable energy can be sold into renewable energy markets (with material economic incentives) and/or utilized by integrated facilities including ethanol plants, CAFO end-product processors (including cheese, ice cream and/or bottling plants in the case of dairy CAFO's and/or slaughter and/or processing facilities in the context of beef and/or swine CAFO's) and/or other users as a fossil fuel replacement. The nutrients (primarily nitrogen and phosphorus) can be harvested from the solids and liquid streams recovered from the livestock waste stream and can be utilized as either high value fertilizer (organic and/or inorganic) and/or the basis for high protein animal feed and the nutrient rich effluent can potentially be utilized in integrated hydroponic agriculture and/or field applied as fertilizer. Bion believes that its large scale Projects (including Integrated Projects) will produce high quality, traceable animal protein which can address consumer food safety/security concerns at a lower cost than current industry practices while also maintaining a far lower net environmental footprint per unit of protein produced due to water recycling (possible due to the removal of nutrients, etc. from the water by Bion's technology applications), production of renewable energy from the waste stream (reducing the use of fossil fuels), and multiple levels of economies of scale, co-location and integration savings in transportation and other logistics. Projects may involve various degrees of integration which will limit the benefits described herein.

During 2008 the Company commenced actively pursuing the opportunity presented by environmental retrofit and remediation of the waste streams of existing CAFOs which effort has met with very limited success to date. The first commercial activity in this area is represented by our agreement with Kreider Farms ("KF"), pursuant to which the Kreider 1 system to treat KF's dairy waste streams to reduce nutrient releases to the environment while generating marketable nutrient credits and renewable energy was designed, constructed and entered full-scale operation during 2011. On January 26, 2009 the Board of the Pennsylvania Infrastructure Investment Authority ("Pennvest") approved a $7.75 million loan to Bion PA 1, LLC ("PA1"), a wholly-owned subsidiary of the Company, for the initial Kreider Farms project ("Kreider 1 System"). After substantial unanticipated delays, on August 12, 2010 PA1 received a permit for construction of the Kreider 1 system. Construction activities commenced during November 2010. The closing/settlement of the Pennvest Loan took place on November 3, 2010. PA1 finished the construction of the Kreider 1 System and entered a period of system 'operational shakedown' during May 2011. The Kreider 1 System reached full, stabilized operation by the end of the 2012 fiscal year. During 2011 the Pennsylvania Department of Environmental Protection ("PADEP") re-certified the nutrient credits for this project. The PADEP issued final permits for the Kreider 1 System (including the credit verification plan) on August 1, 2012 on which date the Company deemed that the Kreider System was 'placed in service'. As a result, PA1 commenced generating nutrient reduction credits for potential sale while continuing to utilize the Kreider 1 system to test improvements and add-ons. However, to date liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth, which limited liquidity/depth has negatively impacted Bion's business plans and has resulted in challenges to monetizing the nutrient reductions created by PA1's existing Kreider 1 project and Bion's other proposed projects. These difficulties have prevented PA1 from generating any material revenues from the Kreider 1 project to date and raise significant questions as to when, if ever, PA1 will be able to generate such revenues from the Kreider 1 system. PA1 has had sporadic discussions/negotiations with Pennvest related to forbearance and/or re-structuring its obligations pursuant to the Pennvest Loan for more than three years. In the context of such discussions/negotiations, PA1 elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of September 30, 2016. Due to the failure of the Pennsylvania nutrient reduction credit market to develop, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, PA1 and the Company recorded impairments related to the value of the Kreider 1 assets totaling $3,750,000 through June 30, 2015. During the 2016 fiscal year, effective June 30, 2016, PA1 and the Company recorded an impairment of $1,684,562 to the value of the Kreider 1 assets which reduced the value on the Company's books to $0. This impairment reflects management's judgment that the salvage value of the Kreider 1 assets roughly equals PA1's contractual obligations related to the Kreider 1 system, including expenses related to decommissioning of the Kreider 1 system, costs associated with needed capital upgrade expenses, and re-certification/ permitting amendments.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and accelerated the Pennvest Loan and demanded that PA1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA1 did not make the payment and does not have the resources to make the payments demanded by Pennvest. PA1 has commenced discussions and negotiations with Pennvest concerning this matter but Pennvest has rejected PA1's proposal made during the fall of 2014. No formal proposals are under consideration and only sporadic communication has taken place regarding the matters involved over the last 18 months. It is not possible at this date to predict the outcome of such this matter, but the Company believes that a loan modification agreement may be reached in the future if/when a more robust market for nutrient reductions develops in Pennsylvania, of which there is no assurance. PA1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the 'technology guaranty' standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan has been (and is now) solely an obligation of PA1 since that date.

The economics (potential revenues, profitability and continued operation) of the Kreider 1 System are based almost entirely on the long term sale of nutrient (nitrogen and/or phosphorus) reduction credits to meet the requirements of the Chesapeake Bay environmental clean-up.

On May 5, 2016, Bion PA2 LLC ("PA2") executed a stand-alone joint venture agreement with Kreider Farms covering all matters related to development and operation of a system to treat the waste streams from Kreider's poultry facilities ("Kreider 2").

The Kreider projects are owned and operated by Bion through separate subsidiaries, in which Kreider has the option to acquire a noncontrolling interest. Substantial capital (equity and/or debt) has been and will continue to be expended on these projects. Additional funds will be required for continuing operations and additional capital expenditures for upgrades at Kreider 1 until sufficient revenues can be generated, of which there is no assurance. The Company anticipates that the Kreider 1 project will generate revenue primarily from the sale of nutrient reduction (and/or other) environmental credits. A portion of Bion's research and development activities has taken place at the Kreider 1 facility.

Kreider 2 (not yet constructed) (and most future Projects) will be developed using Bion's 3G Tech to recover substantial marketable nutrients and renewable energy to supplement its revenue from nutrient reductions. The Company believes that the proceeds from multiple byproduct streams including i) fertilizer (organic and non-organic) and/or feed additives and ii) renewable energy (and related credits) can be reasonably projected to generate, in aggregate, revenue streams that, in certain circumstances, may exceed 50% of total revenues from such Project(s). To date the market for long-term nutrient reduction credits in Pennsylvania has been very slow to develop and the Company's activities have been negatively affected by the lack of such development.

Kreider 2 development work and technology evaluation, including execution of a stand-alone joint venture agreement, amended credit certification and discussions with potential joint venture partners, continues, which Project primarily relates to treatment of the wastes from Kreider's poultry operations. Assuming there are positive developments related to the market for nutrient reductions in Pennsylvania, the Company intends to pursue development, design and construction of the Kreider 2 poultry waste/renewable energy project with a goal of achieving operational status during calendar year 2017. However, as discussed above, this Project faces challenges related to the current limits of the existing nutrient reduction market and funding of technology-based, verifiable agricultural nutrient reductions which are anticipated to constitute the largest share of its revenues.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

A significant portion of Bion's activities concern efforts with private and public stakeholders (at local and state level) in Pennsylvania (and other Chesapeake Bay and Midwest and Great Lakes states) and at the federal level (the Environmental Protection Agency ("EPA") and the Department of Agriculture ("USDA") (and other executive departments) and Congress) to establish appropriate public policies which will create regulations and funding mechanisms that foster installation of the low cost environmental solutions that Bion (and others) can provide through clean-up of agricultural waste streams. The Company anticipates that such efforts will continue in Pennsylvania and other Chesapeake Bay watershed states throughout the next 12 months and in various additional states thereafter.

Going concern and management's plans:

The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has not generated significant revenues and has incurred net losses (including significant non-cash expenses) of approximately $4,522,000 and $5,642,000 during the years ended June 30, 2016 and 2015, respectively and a net loss of approximately $630,000 during the three months ended September 30, 2016. At September 30, 2016, the Company has a working capital deficit and a stockholders' deficit of approximately $11,044,000 and $14,412,000, respectively. These factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability or classification of assets or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. The following paragraphs describe management's plans with regard to these conditions.

The Company continues to explore sources of additional financing (including potential agreements with strategic partners –both financial and ag-industry) to satisfy its current and future operating and capital expenditure requirements as it is not currently generating any significant revenues.

During the year ended June 30, 2016 the Company received total proceeds of $760,604 from the sale of its debt and equity securities. Proceeds during the 2016 fiscal year have been lower than in earlier years which reduction has negatively impacted the Company's business development efforts.

During the three months ended September 30, 2016, the Company received $112,850 from the sale of its debt and equity securities.

During fiscal years 2016 and 2015 and through the three months ended September 30, 2016, the Company experienced greater difficulty in raising equity funding than in the prior years. As a result, the Company faced, and continues to face, significant cash flow management challenges due to working capital constraints. To partially mitigate these working capital constraints, the Company's core senior management and several key employees and consultants have been deferring (and continue to defer) all or part of their cash compensation and/or are accepting compensation in the form of securities of the Company (Notes 4 and 6) and members of the Company's senior management have made loans to the Company. Additionally, the Company made reductions in its personnel during the year ended June 30, 2014. The constraint on available resources has had, and continues to have, negative effects on the pace and scope of the Company's efforts to develop its business. The Company has had to delay payment of trade obligations and has had to economize in many ways that have potentially negative consequences. If the Company does not have greater success in its efforts to raise needed funds during the 2017 fiscal year (and subsequent periods), management will need to consider deeper cuts (including additional personnel cuts) and curtailment of operations (including possibly Kreider 1 operations) and/or research and development activities.

The Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Projects (including Integrated Projects) (including the Kreider 2 facility) and CAFO Retrofit waste remediation systems and to continue to operate the Kreider 1 facility. The Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more debt and/or equity through joint ventures, strategic partnerships and/or sale of its equity securities (common, preferred and/or hybrid) and/or debt (including convertible) securities, and/or through use of 'rights' and/or warrants (new and/or existing) during the next twelve months. However, as discussed above, there is no assurance, especially in light of the difficulties the Company has experienced in recent periods and the extremely unsettled capital markets that presently exist (especially for companies like us), that the Company will be able to obtain the funds that it needs to stay in business, complete its technology development or to successfully develop its business and Projects.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

There is no realistic likelihood that funds required during the next twelve months or in the periods immediately thereafter for the Company's basic operations and/or proposed Projects will be generated from operations. Therefore, the Company will need to raise sufficient funds from external sources such as debt or equity financings or other potential sources. The lack of sufficient additional capital resulting from the inability to generate cash flow from operations and/or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Further, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significantly dilutive effect on the Company's existing shareholders. All of these factors have been exacerbated by the extremely limited and unsettled credit and capital markets presently existing for small companies like Bion.

2. SIGNIFICANT ACCOUNTING POLICIES

Principles of consolidation:

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. ("Projects Group"), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA1, and PA2; and its 58.9% owned subsidiary, Centerpoint Corporation ("Centerpoint"). All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at September 30, 2016, and the results of operations and cash flows of the Company for the three months ended September 30, 2016 and 2015. Operating results for the three months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the year ending June 30, 2017.

Property and equipment:

Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years. The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects. The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations.

Warrants:

The Company has issued warrants to purchase common shares of the Company. Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Company's value as of the date of the issuance, consideration of the Company's limited liquid resources and business prospects, the market price of the Company's stock in its mostly inactive public market and the historical valuations and purchases of the Company's warrants. When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined.

Fair value measurements:

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2 – observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and

Level 3 – assets and liabilities whose significant value drivers are unobservable.

Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company's market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment.

The fair value of cash and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable approximates its carrying amount as it bears interest at rates commensurate with market rates. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of deferred compensation and convertible notes payable - affiliates are not practicable to estimate due to the related party nature of the underlying transactions.

Revenue Recognition:

Revenues are generated from the sale of nutrient reduction credits. The Company recognizes revenue from the sale of nutrient credits when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured.

The Company expects that technology license fees will be generated from the licensing of Bion's integrated system. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company's interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue.

Loss per share:

Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share. During three months ended September 30, 2016 and 2015, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive.

The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:

	September 30, 2016		September 30, 2015
Warrants		7,439,795		8,295,989
Options		4,260,537		4,413,870
Convertible debt		8,361,559		7,119,524
Convertible preferred stock		15,250		14,250

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

The following is a reconciliation of the denominators of the basic loss per share computations for the three months ended September 30, 2016 and 2015:

	Three months ended September 30, 2016			Three months ended September 30, 2015
Shares issued – beginning of period		23,573,057			22,089,650
Shares held by subsidiaries (Note 7)		(704,309	)		(704,309	)
Shares outstanding – beginning of period		22,868,748			21,385,341
Weighted average shares for fully vested stock bonuses		600,000			600,000
Weighted average shares issued during the period		75,374			303,736
Basic weighted average shares – end of period		23,544,122			22,289,077

Reclassifications:

Certain amounts in the prior year financial statements have been reclassified to conform to the current year presentation including the reclassification of accrued interest related to the Pennvest Loan from accounts payable and accrued expenses into loan payable and accrued interest.

Recent Accounting Pronouncements:

The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company's financial statements properly reflect the change.

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09 "Revenue from Contracts from Customers," which supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017 and earlier application is permitted only as of annual reporting periods beginning after December 15, 2016. The Company is currently evaluating the new standard and assessing the potential impact on its operations and financial statements.

In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements – Going Concern: Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern." The new standard requires management to perform interim and annual assessments of an entity's ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity's ability to continue as a going concern. The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted. The adoption of ASU No. 2014-15 did not have a material impact on the Company's financial statements.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

3. PROPERTY AND EQUIPMENT:

Property and equipment consists of the following:

	September 30, 2016			June 30, 2016
Machinery and equipment	$	2,222,670		$	2,222,670
Buildings and structures		401,470			401,470
Computers and office equipment		171,560			173,313
		2,795,700			2,797,453
Less accumulated depreciation		(2,791,943	)		(2,793,194	)
	$	3,757		$	4,259

Management reviewed property and equipment for impairment as of June 30, 2016 and determined that the carrying amount of property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and potentially needed capital expenditures and it was also determined that the salvage value of the system components will be offset by contractual decommissioning obligations. Kreider 1 was measured at estimated fair value on a non-recurring basis using level 3 inputs, which resulted in an impairment of $1,684,562 of the property and equipment for the year ended June 30, 2016. As of June 30, 2016, the net book value of Kreider 1 was zero. As of September 30, 2016, management believes that no additional impairment exists.

Depreciation expense was $502 and $75,879 for the three months ended September 30, 2016 and 2015, respectively.

4. DEFERRED COMPENSATION:

The Company owes deferred compensation to various employees, former employees and consultants totaling $1,657,541 as of September 30, 2016. Included in the deferred compensation balances as of September 30, 2016, are $672,753, $227,166 and $116,182 owed Dominic Bassani ("Bassani"), the Company's Chief Executive Officer ("CEO"), Mark A. Smith ("Smith"), the Company's President, and Edward Schafer ("Schafer"), the Company's Vice Chairman, respectively, pursuant to extension agreements effective January 1, 2015, whereby unpaid compensation earned after January 1, 2015, accrues interest at 4% per annum and can be converted into shares of the Company's common stock at the election of the employee during the first five calendar days of any month. The conversion price shall be the average closing price of the Company's common stock for the last 10 trading days of the immediately preceding month. The Company also owes various consultants, pursuant to various agreements, for deferred compensation of $399,956 as of September 30, 2016 with similar conversion terms as those described above for Bassani, Smith and Schafer, with the exception that the interest accrues at 3% per annum. The Company also owes a former employee and a current employee deferred compensation of $168,000 and $984, respectively, which is convertible into 226,168 and 1,172 shares, respectively, of the Company's common stock as of September 30, 2016 and, a former employee $72,500, which is not convertible and is non-interest bearing.

5. LOAN PAYABLE:

As of September 30, 2016, PA1, the Company's wholly-owned subsidiary, owes $8,621,827 under the terms of the Pennvest Loan related to the construction of the Kreider 1 System including accrued interest and late charges totaling $867,827. The terms of the Pennvest Loan provided for funding of up to $7,754,000 which was to be repaid by interest-only payments for three years, followed by an additional ten-year amortization of principal. The Pennvest Loan accrues interest at 2.547% per annum for years 1 through 5 and 3.184% per annum for years 6 through maturity. The Pennvest Loan required minimum annual principal payments of approximately $2,001,000 in fiscal years 2013 through 2016, and $741,000 in fiscal year 2017, $760,000 in fiscal year 2018, $771,000 in fiscal year 2019, $794,000 in fiscal year 2020, $819,000 in fiscal year 2021 and $1,867,000 thereafter. The Pennvest Loan is collateralized by the Kreider 1 System and by a pledge of all revenues generated from Kreider 1 including, but not limited to, revenues generated from nutrient reduction credit sales and by-product sales. In addition, in consideration for the excess credit risk associated with the project, Pennvest is entitled to participate in the profits from Kreider 1 calculated on a net cash flow basis, as defined. The Company has incurred interest expense related to the Pennvest Loan of $49,374 for both of the three months ended September 30, 2016 and 2015, respectively. Based on the limited development of the depth and breadth of the Pennsylvania nutrient reduction credit market to date, PA1 commenced negotiations with Pennvest related to forbearance and/or re-structuring the obligations under the Pennvest Loan. In the context of such negotiations, PA1 has elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of September 30, 2016.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. PA1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active. As of the date of this report, no formal proposals are under consideration and only sporadic communication has taken place regarding the matters involved over the past 18 months. It is not possible at this date to predict the outcome of this matter, but the Company believes it is possible that an agreement may yet be reached that will result in a viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

In connection with the Pennvest Loan financing documents, the Company provided a 'technology guaranty' regarding nutrient reduction performance of Kreider 1 which was structured to expire when Kreider 1's nutrient reduction performance had been demonstrated. During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 System had surpassed the requisite performance criteria and that the Company's 'technology guaranty' was met. As a result, the Pennvest Loan is solely an obligation of PA1.

6. CONVERTIBLE NOTES PAYABLE - AFFILIATES:

January 2015 Convertible Notes

The January 2015 Convertible Notes accrue interest at 4% per annum and are due and payable on December 31, 2017. The January 2015 Convertible Notes (including accrued interest, plus all future deferred compensation), are convertible, at the sole election of the noteholder, into Units consisting of one share of the Company's common stock and one quarter warrant to purchase a share of the Company's common stock, at a price of $0.50 per Unit until December 31, 2020. The warrant contained in the Unit shall be exercisable at $1.00 per share until December 31, 2020. The original conversion price of $0.50 per Unit approximated the fair value of the Units at the date of the agreements; therefore no beneficial conversion feature exists. Management evaluated the terms and conditions of the embedded conversion features based on the guidance of ASC 815-15 "Embedded Derivatives" to determine if there was an embedded derivative requiring bifurcation. An embedded derivative instrument (such as a conversion option embedded in the deferred compensation) must be bifurcated from its host instruments and accounted for separately as a derivative instrument only if the "risks and rewards" of the embedded derivative instrument are not "clearly and closely related" to the risks and rewards of the host instrument in which it is embedded. Management concluded that the embedded conversion feature of the deferred compensation was not required to be bifurcated because the conversion feature is clearly and closely related to the host instrument, and because of the Company's limited trading volume that indicates the feature is not readily convertible to cash in accordance with ASC 815-10, "Derivatives and Hedging".

As of September 30, 2016, the January 2015 Convertible Note balances, including accrued interest, owed Bassani, Smith and Schafer were $1,566,944, $813,692 and $404,739, respectively. During the three months ended September 30, 2016 and 2015, the Company recorded interest expense of $26,247 and $26,248, respectively, related to the January 2015 Convertible Notes.

September 2015 Convertible Notes

During the year ended June 30, 2016, the Company entered into September 2015 Convertible Notes with Bassani, Schafer and a Shareholder which replaced previously issued promissory notes. The initial principal balances of the September 2015 Convertible Notes were $405,831, $16,382 and $82,921, respectively. The September 2015 Convertible Notes bear interest at 4% per annum, have maturity dates of December 31, 2017 and may be converted at the sole election of the noteholders into restricted common shares of the Company at a conversion price of $0.60 per share. As the conversion price of $0.60 approximated the fair value of the common shares at the date of the September 2015 Convertible Notes, no beneficial conversion feature exists. The balances of the September 2015 Convertible Notes as of September 30, 2016, including accrued interest, are $423,087, $17,079 and $86,447, respectively. The Company recorded interest expense related to the 2015 Convertible Notes of $5,093 and $1,218 for the three months ended September 30, 2016 and 2015, respectively.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

7. STOCKHOLDERS' EQUITY:

Series B Preferred stock:

At July 1, 2014, the Company had 200 shares of Series B redeemable convertible Preferred stock outstanding with a par value of $0.01 per share, convertible at the option of the holder at $2.00 per share, with dividends accrued and payable at 2.5% per quarter. The Series B Preferred stock is mandatorily redeemable at $2.00 per share by the Company three years after issuance and accordingly was classified as a liability. The 200 shares have reached their maturity date, but due to the cash constraints of the Company have not been redeemed.

During the years ended June 30, 2016 and 2015, the Company declared dividends of $2,000 and $2,000 respectively. During the three months ended September 30, 2016, the Company declared dividends of $500. At September 30, 2016, accrued dividends payable are $10,500. The dividends are classified as a component of operations as the Series B Preferred stock is presented as a liability in these financial statements. For the three months ended September 30, 2015 these amounts were presented differently but the September 30, 2015 financial statements were revised even though such revision previously was and continues to be immaterial to the prior year financial statements.

Common stock:

Holders of common stock are entitled to one vote per share on all matters to be voted on by common stockholders. In the event of liquidation, dissolution or winding up of the Company, the holders of common stock are entitled to share in all assets remaining after liabilities have been paid in full or set aside and the rights of any outstanding preferred stock have been satisfied. Common stock has no preemptive, redemption or conversion rights. The rights of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of any outstanding series of preferred stock or any series of preferred stock the Company may designate in the future.

Centerpoint holds 704,309 shares of the Company's common stock. These shares of the Company's common stock held by Centerpoint are for the benefit of its shareholders without any beneficial interest. The Company accounts for these shares similar to treasury stock.

During the three months ended September 30, 2016, the Company issued 20,492 shares of the Company's common stock at prices ranging from $0.75 to $0.83 per share for services valued at $16,556, in the aggregate, to consultants and employees.

During the three months ended September 30, 2016, the Company issued 10,000 shares of the Company's restricted common stock upon receipt of its subscription receivable of $7,500 for the exercise of 10,000 warrants.

During the three months ended September 30, 2016, the Company entered into subscription agreements to sell units for $0.75 per unit, with each unit consisting of one share of the Company's restricted common stock and one warrant to purchase one half of a share of the Company's restricted common stock for $1.00 per share until December 31, 2017 and pursuant thereto, the Company issued 120,000 units for total proceeds of $90,000. The Company allocated the proceeds from the shares and the warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the warrants, which was determined to be $0.05 per warrant. As a result, $2,579 was allocated to the warrants and $87,421 was allocated to the shares, and both were recorded as additional paid in capital.

During the three months ended September 30, 2016, the Company sold 30,467 shares of the Company's common stock for $0.75 per share for total proceeds of $22,850.

During the three months ended September 30, 2016, a consultant elected to convert $6,008 of deferred compensation into 7,152 shares of the Company's common stock at a conversion rate of $0.84 per share.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

Warrants:

As of September 30, 2016, the Company had approximately 7.4 million warrants outstanding, with exercise prices from $0.75 to $3.00 and expiring on various dates through December 31, 2021.

The weighted-average exercise price for the outstanding warrants is $1.29, and the weighted-average remaining contractual life as of September 30, 2016 is 4.0 years.

During the three months ended September 30, 2016, warrants to purchase 722,319 shares of common stock of the Company at prices between $0.75 per share expired.

At June 30, 2016 the Company had a subscription agreement for the exercise of 10,000 warrants at an exercise price of $0.75, resulting in a subscription receivable of $7,500. During the three months ended September 30, 2016, the received the subscription receivable of $7,500 and the Company issued 10,000 shares of the Company's common stock in satisfaction of the warrant exercise.

Stock options:

The Company's 2006 Consolidated Incentive Plan, as amended (the "2006 Plan"), provides for the issuance of options (and/or other securities) to purchase up to 22,000,000 shares of the Company's common stock. Terms of exercise and expiration of options/securities granted under the 2006 Plan may be established at the discretion of the Board of Directors, but no option may be exercisable for more than ten years.

The Company recorded compensation expense related to employee stock options of $20,856 and $15,320 for the three months ended September 30, 2016 and 2015, respectively. The Company granted 35,000 and nil options during the three months ended September 30, 2016 and 2015, respectively.

The fair value of the options granted during the three months ended September 30, 2016 and 2015 were estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

	Weighted Average, September 30, 2016	Range, September 30, 2016	Weighted Average, September 30, 2015	Range, September 30, 2015
Volatility	81%	78%-86%	-	-
Dividend yield	-	-	-	-
Risk-free interest rate	0.93%	0.82%-0.97%	-	-
Expected term (years)	3.7	3-4	-	-

The expected volatility was based on the historical price volatility of the Company's common stock. The dividend yield represents the Company's anticipated cash dividend on common stock over the expected term of the stock options. The U.S. Treasury bill rate for the expected term of the stock options was utilized to determine the risk-free interest rate. The expected term of stock options represents the period of time the stock options granted are expected to be outstanding based upon management's estimates.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

A summary of option activity under the 2006 Plan for the three months ended September 30, 2016 is as follows:

	Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Aggregate Intrinsic Value
Outstanding at July 1, 2016		4,225,537		$1.79		4.1	$	158,675
Granted		35,000		1.00
Exercised		-		-
Forfeited		-		-
Expired		-		-
Outstanding at September 30, 2016		4,260,537		$1.78		3.4	$	124,375
Exercisable at September 30, 2016		4,210,537		$1.80		3.4	$	111,875

The following table presents information relating to nonvested stock options as of September 30, 2016:

	Options	Weighted Average Grant-Date Fair Value
Nonvested at July 1, 2016	50,000	$ 0.76
Granted	35,000	0.45
Vested	(35,000)	(0.45)
Nonvested at September 30, 2016	50,000	$ 0.76

The total fair value of stock options that vested during the three months ended September 30, 2016 and 2015 was $15,900 and nil, respectively. As of September 30, 2016, the Company had $4,957 of unrecognized compensation cost related to stock options.

Stock-based employee compensation charges in operating expenses in the Company's financial statements for the three months ended September 30, 2016 and 2015 are as follows:

	Three months ended September 30, 2016		Three months ended September 30, 2015
General and administrative:
Fair value of stock options expensed	$	16,495	$	1,838
Total	$	16,495	$	1,838

Research and development:
Fair value of stock options expensed	$	4,361	$	13,482
Total	$	4,361	$	13,482

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

8. COMMITMENTS AND CONTINGENCIES:

Employment and consulting agreements:

Smith has held the positions of Director, President and General Counsel of Company and its subsidiaries under various agreements and terms since March 2003. During September 2014, Smith agreed to continue his employment agreement through April 15, 2015 and also agreed to continue to defer his temporarily reduced salary of $14,000 per month until such date. On February 10, 2015, the Company executed an Extension Agreement with Smith pursuant to which Smith extended his employment with the Company to December 31, 2015 (with the Company having an option to extend his employment an additional six months). As part of the Extension Agreement, the balance of Smith's existing convertible note payable as of December 31, 2014, adjusted for conversions subsequent to that date, was replaced with a new convertible note with an initial principal amount of $760,520 with terms that i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increases the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017. Additionally, pursuant to the Extension Agreement, Smith: i) will continue to defer his cash compensation ($18,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation, ii) cancelled 150,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 150,000 new options which vested immediately and iv) outstanding options and warrants owned by Smith (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50). In October 2015, the Company executed an Extension Agreement ("FY2016 Extension Agreement") with Smith pursuant to which Smith extended his employment with the Company to June 30, 2016 (with Company having an option to extend his employment an additional six months). As part of the FY2016 Extension Agreement, Smith: i) will continue to defer his cash compensation ($19,000 per month) until the Board of Directors re-instates cash payments, ii) has been granted 100,000 new options which vested immediately, and iii) has been granted 75,000 shares of common stock as an extension bonus which are immediately vested and were issued on January 5, 2016. As of July 1, 2016, Smith is working under a month to month contract extension until a longer term agreement is reached.

Since March 31, 2005, the Company has had various agreements with Brightcap and/or Bassani, through which the services of Bassani are provided. The Board appointed Bassani as the Company's CEO effective May 13, 2011. During the fiscal years 2012 and 2013, Bassani entered into extension agreements whereby he was awarded fully vested stock grants totaling 600,000 shares, 500,000 shares of which are to be issued January 15, 2016 and 100,000 shares are to be issued January 15, 2017. The stock grants were expensed in the years they were awarded as they are fully vested. On February 10, 2015, the Company executed an Extension Agreement with Bassani pursuant to which Bassani extended the term of his service to the Company to December 31, 2017, (with the Company having an option to extend the term an additional six months.) As part of the agreement, the Company's then existing loan payable, deferred compensation and convertible note payable to Bassani, were restructured into two promissory notes as follows: a) The sum of the cash loaned by Bassani to the Company of $279,000 together with $116,277 of unreimbursed expenses through December 31, 2014, were placed into a new promissory note with initial principal of $395,277 which was due and payable on December 31, 2015 and now has been replaced with a September 2015 Convertible Note (Note 8). In connection with these sums and the new promissory note, Bassani was issued warrants to purchase 592,916 shares of the Company's common stock at a price of $1.00 until December 31, 2020; and b) the remaining balances of the Company's accrued obligations to Bassani ($1,464,545) were replaced with a new convertible promissory note with terms that compared with the largest prior convertible note obligation to Bassani: i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increase the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017 (Note 8). Additionally, pursuant to the Extension Agreement, Bassani i) will continue to defer his cash compensation ($31,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation, ii) cancelled 250,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 450,000 new options which vested immediately and iv) outstanding options and warrants owned by Bassani (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50).

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

On February 10, 2015, the Company entered into an agreement with Schafer pursuant to which Schafer will continue to provide services to the Company through December 31, 2015. Additionally, pursuant to the agreement, i) the exercise period of outstanding options and warrants owned by Schafer have been extended, and ii) 25,000 contingent stock bonuses previously granted to Schafer have been cancelled by the Company. In January 2016, Schafer agreed to extend his agreement with the Company through December 31, 2016. During June 2016, Schafer and the Company determined that due to other obligations Schafer's involvement with the Company during the 2016 fiscal year was less than anticipated and reduced his fiscal year 2016 compensation (all of which had been deferred) by $160,000 and future compensation will be determined periodically based on evaluation by the board of directors.

Contingent stock bonuses:

The Company has declared contingent deferred stock bonuses to its key employees and consultants at various times throughout the years. The stock bonuses are contingent upon the Company's stock price exceeding a certain target price per share, and the grantees still being employed by or providing services to the Company at the time the target prices are reached.

The Company's outstanding contingent stock bonuses as of September 30, 2016 are as follows:

Target Price per share		$5.00	$10.00		$20.00
Number of shares		50,000	40,000		27,500

Execution/exercise bonuses:

As part of agreements the Company entered into with Bassani and Smith effective May 15, 2013, they were each granted the following: a) a 50% execution/exercise bonus which shall be applied upon the effective date of the notice of intent to exercise (for options and warrants) or issuance event, as applicable, of any currently outstanding and/or subsequently acquired options, warrants and/or contingent stock bonuses owned by each (and/or their donees) as follows: i) in the case of exercise by payment of cash, the bonus shall take the form of reduction of the exercise price; ii) in the case of cashless exercise, the bonus shall be applied to reduce the exercise price prior to the cashless exercise calculations; and iii) with regard to contingent stock bonuses, issuance shall be triggered upon the Company's common stock reaching a closing price equal to 50% of currently specified price; and b) the right to extend the exercise period of all or part of the applicable options and warrants for up to five years (one year at a time) by annual payments of $.05 per option or warrant to the Company on or before a date during the three months prior to expiration of the exercise period at least three business days before the end of the expiration period. Effective January 1, 2016 such annual payments to extend warrant exercise periods have been reduced to $.01 per option or warrant.

During the year ended June 30, 2014, the Company extended execution/exercise bonuses with the same terms as described above to Schafer and to Jon Northrop, the Company's other board member.

As of September 30, 2016, the execution/exercise bonus was applicable to 3,070,000 of the Company's outstanding options and 6,753,219 of the Company's outstanding warrants.

Litigation:

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that PA1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the 'technology guaranty' standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA1. No litigation has commenced related to this matter but such litigation is likely if negotiations do not produce a resolution (Notes 1 and Note 5).

The Company currently is not involved in any other material litigation.

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2016

(UNAUDITED)

9. SUBSEQUENT EVENTS:

The Company has evaluated events that occurred subsequent to September 30, 2016 for recognition and disclosure in the financial statements and notes to the financial statements.

From October 1, 2016 through November 11, 2016, the Company has issued 2,137 shares of the Company's common shares to an employee for services valued at approximately $2,000.

On October 10, 2016, the Company:

a)	approved the cancellation the 117,500 outstanding contingent stock bonus shares and replaced the cancelled contingent stock bonuses with 109,500 fully vested options to purchase shares of the Company's common shares at an exercise price of $1.00 per share until December 31, 2020.

b)	approved the modification of certain stock options to certain employees and consultants which will reduce the exercise prices to such options to $1.50 per share.

c)	granted 125,000 bonus shares, in aggregate, to certain employees and consultants with various issuance dates from January 15, 2017 to January 15, 2020.

d)	granted 75,000 options to purchase shares of the Company's common shares at an exercise price of $1.00 per share with vesting occurring from December 31, 2016 through December 31, 2017.

approved a month to month contract extension with Smith which includes provisions for i) issuance of 25,000 bonus shares of the Company's common shares on January 15, 2017, ii) grant of 75,000 options to purchase shares of the Company's common shares at $0.90 per share with expiry date of December 31, 2020, which options are subject to the exercise/extension bonus, iii) a monthly deferred salary of $18,000 effective October 1, 2016, iv) the right to convert up to $125,000 of his deferred compensation, at his sole election, at $0.75 per share, until March 15, 2018, and v) the right to convert his deferred compensation in whole or in part, at his sole election, at any time in any amount at "market" or into securities sold in the Company's current/most recent private offering at the price of such offering to third parties.

f)	modified 60,000 outstanding warrants owned by Bassani to make them subject to the exercise/extension bonus applicable to his other warrants/options and granted Bassani the right to convert up to $125,000 of his deferred compensation, at his sole election, at $0.75 per share, until March 15, 2018.

g)	issued 25,000 warrants to purchase the Company's common shares at $0.90 per share, expiring on December 31, 2019 to a consultant for services.

Effective October 12, 2016, the Company agreed to cancel 650,000 bonus shares due to be issued to employees during January 2017, of which 600,000 were bonus shares due to Bassani and 25,000 bonus shares were due to Smith.

On November 9, 2016, the Company's Board of Directors ratified:

the sale to Smith, effective November 9, 2016, of warrants to purchase 40,000 shares of the Company's common stock exercisable at $1.00 per share until December 31, 2021 (which warrants are subject to an exercise bonus) at the purchase price of $.05 per warrant ($2,000, in aggregate) which was paid by reduction of Smith's accrued deferred compensation.

the sale to Bassani, effective November 9, 2016, of warrants to purchase 800,000 shares of the Company's common stock exercisable at a price of $1.00 per share until December 31, 2021 (which warrants are subject to an augmented exercise bonus), at a purchase price of $.05 per warrant ($40,000, in aggregate) which was paid by a note from Bassani due November 15, 2017.

the sale to an employee, effective November 9, 2016, of warrants to purchase 40,000 shares of the Company's common stock exercisable at $1.00 per share until December 31, 2021 (which warrants are subject to an exercise bonus) at the purchase price of $.05 per warrant ($2,000, in aggregate) which was paid by reduction of the employee's accrued deferred compensation.

PART I – FINANCIAL INFORMATION

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Statements made in this Form 10-Q that are not historical or current facts, which represent the Company's expectations or beliefs including, but not limited to, statements concerning the Company's operations, performance, financial condition, business strategies, and other information, involve substantial risks and uncertainties. The Company's actual results of operations, most of which are beyond the Company's control, could differ materially. These statements often can be identified by the use of terms such as "may," "will," "expect," "believe," anticipate," "estimate," or "continue" or the negative thereof. We wish to caution readers not to place undue reliance on any such forward looking statements, which speak only as of the date made. Any forward looking statements represent management's best judgment as to what may occur in the future. However, forward looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected.

These factors include adverse economic conditions, entry of new and stronger competitors, inadequate capital, unexpected costs, failure (or delay) to gain product or regulatory approvals in the United States (or particular states) or foreign countries and failure to capitalize upon access to new markets. Additional risks and uncertainties that may affect forward looking statements about Bion's business and prospects include the possibility that markets for nutrient reduction credits (discussed below) and/or other ways to monetize nutrient reductions will be slow to develop (or not develop at all), the existing default by PA1 on its loan secured by the Kreider 1 system, the possibility that a competitor will develop a more comprehensive or less expensive environmental solution, Bion's limited management team, delays in market awareness of Bion and our Systems, uncertainties and costs related to research and development efforts to update and improve Bion's technologies and applications thereof, and/or delays in Bion's development of Projects and failure of marketing strategies, each of which could have both immediate and long term material adverse effects by placing us behind our competitors and requiring expenditures of our limited resources. Bion disclaims any obligation subsequently to revise any forward looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

The following discussion and analysis should be read in conjunction with the unaudited Consolidated Financial Statements and Notes to Consolidated Financial Statements filed herein with the Company's Form 10-K for the year ended June 30, 2016.

BUSINESS OVERVIEW

During the 2014 and 2015 fiscal years, the Company increased its research and development activities toward development of our 3G Tech with focus on augmenting the basic 'separate and aggregate' approach of its technology platform to provide additional flexibility and to increase recovery of nutrient by-products (in organic and non-organic forms) and renewable energy production (either/both biogas and/or renewable electricity), thereby increasing potential related revenue streams and reducing dependence of its future projects on the monetization of nutrient reductions (which still remain a very important part of project revenue streams). This research and development effort also involves ongoing review of potential "add-ons" and applications to our technology platform for use in different regulatory and/or climate environments. These research and development activities continued through the 2016 fiscal year with increased focus on recovery of marketable 'byproducts' (including nutrients and renewable natural gas) and completion of development of Bion's 3G Tech and technology platform. We believe such activities will continue at least through the 2017 fiscal year, subject to availability of adequate financing for the Company's operations, of which there is no assurance.

Operational results from the initial commercial system (utilizing our 2G Tech) confirmed the ability of Bion's technologies to meet its nutrient reduction goals at commercial scale for an extended period of operation. Bion's current 2G Tech platform (and the new variations under development) center on its patented and proprietary processes that separate and aggregate the various assets in the CAFO waste stream so they become benign, stable and/or transportable. Bion systems can: a) remove up to 95% of the nutrients (primarily nitrogen and phosphorus) in the effluent, b) reduce greenhouse gases by 90% (or more) including elimination of virtually all ammonia emissions, c) while materially reducing pathogens, antibiotics and hormones in the livestock waste stream. In addition to capturing a portion of valuable nutrients for reuse (in organic and/or non-organic forms), Bion's 2^nd generation technology platform also recovers cellulosic biomass which can be used to generate renewable energy from the waste stream in a process more efficient than other technologies that seek to exploit this CAFO waste stream. Our core technology and its primary CAFO applications are now proven in commercial operations. It has been accepted by the Environmental Protection Agency ("EPA") and other regulatory agencies and it is protected by Bion's portfolio of U.S. and international patents (both issued and applied for). Currently, research and development activities are underway to improve, update and move toward completion and commercialization of our 3G Tech systems to meet the needs of CAFOs in various geographic and climate areas with nutrient release constraints and to increase the recovery and generation of valuable by-products while adding the capability to treat dry (poultry) waste streams in addition to wet manure streams.

During 2008 the Company commenced actively pursuing the opportunity presented by environmental retrofit and remediation of the waste streams of existing CAFOs which effort has met with very limited success to date. The first commercial activity in this area is represented by our agreement with Kreider Farms ("KF"), pursuant to which the Kreider 1 system to treat KF's dairy waste streams to reduce nutrient releases to the environment while generating marketable nutrient credits and renewable energy was designed, constructed and entered full-scale operation during 2011. On January 26, 2009 the Board of the Pennsylvania Infrastructure Investment Authority ("Pennvest") approved a $7.75 million loan to Bion PA 1, LLC ("PA1"), a wholly-owned subsidiary of the Company, for the initial Kreider Farms project ("Kreider 1 System"). After substantial unanticipated delays, on August 12, 2010 PA1 received a permit for construction of the Kreider 1 system. Construction activities commenced during November 2010. The closing/settlement of the Pennvest Loan took place on November 3, 2010. PA1 finished the construction of the Kreider 1 System and entered a period of system 'operational shakedown' during May 2011. The Kreider 1 System reached full, stabilized operation by the end of the 2012 fiscal year. During 2011 the PADEP re-certified the nutrient credits for this project. The PADEP issued final permits for the Kreider 1 System (including the credit verification plan) on August 1, 2012 on which date the Company deemed that the Kreider System was 'placed in service'. As a result, PA1 commenced generating nutrient reduction credits for potential sale while continuing to utilize the Kreider 1 system to test improvements and add-ons. However, to date liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth, which limited liquidity/depth has negatively impacted Bion's business plans and has resulted in challenges to monetizing the nutrient reductions created by PA1's existing Kreider 1 project and Bion's other proposed projects. These difficulties have prevented PA1 from generating any material revenues from the Kreider 1 project to date and raise significant questions as to when, if ever, PA1 will be able to generate such revenues from the Kreider 1 system. PA1 has had sporadic discussions/negotiations with Pennvest related to forbearance and/or re-structuring its obligations pursuant to the Pennvest Loan for more than three years. In the context of such discussions/negotiations, PA1 elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of September 30, 2016. Due to the failure of the PA nutrient reduction credit market to develop, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, PA1 and the Company recorded impairments related to the value of the Kreider 1 assets of $1,750,000 and $2,000,000 at June 30, 2015 and June 30, 2014, respectively. During the 2016 fiscal year, effective June 30, 2016, PA1 and the Company recorded an impairment of $1,684,562 to the value of the Kreider 1 assets which reduced the value on the Company's books to $0. This impairment reflects management's judgment that the salvage value of the Kreider 1 assets roughly equals PA1's contractual obligations related to the Kreider 1 system, including expenses related to decommissioning of the Kreider 1 system, costs associated with needed capital upgrade expenses, and re-certification/ permitting amendments. See "Impairment loss on property and equipment" below.

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and accelerated the Pennvest Loan and demanded that PA1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA1 did not make the payment and does not have the resources to make the payments demanded by Pennvest. PA1 has commenced discussions and negotiations with Pennvest concerning this matter but Pennvest has rejected PA1's proposal made during the fall of 2014. As of the date of this report, no formal proposals are under consideration and only sporadic communication has taken place regarding the matters involved over the last 18 months. It is not possible at this date to predict the outcome of this matter, but the Company believes that a loan modification agreement may be reached in the future if/when a more robust market for nutrient reductions develops in PA, of which there is no assurance. PA1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

The Company is currently operating the Kreider 1 System in a limited manner pending development of a more robust market for its nutrient reductions.

Bion continues its pre-develop work related to a waste treatment/renewable energy production facility to treat the waste from KF's approximately 5+ million chickens (planned to expand to approximately 9-10 million)(and potentially other poultry operations and/or other waste streams)('Kreider Renewable Energy Facility' or ' Kreider 2 Project'). On May 5, 2016, the Company executed a stand-alone joint venture agreement with Kreider Farms covering all matters related to development and operation of Kreider 2 system to treat the waste streams from Kreider's poultry facilities in Bion PA2 LLC ("PA2"). During May 2011 the PADEP certified a smaller version of the Kreider 2 Project for 559,457 nutrient credits under the old EPA's Chesapeake Bay model. The Company anticipates that the Kreider 2 Project will be re-certified for between 1.5-2 million nutrient reduction credits (for treatment of the waste stream from Kreider's poultry) pursuant to the Company's subsequent amended application during 2017 pursuant to the amended EPA Chesapeake Bay model and agreements between the EPA and PA. Note that this Project may be expanded in the future to treat wastes from other local and regional CAFOs (poultry and/or dairy) and/or additional Kreider poultry expansion (some of which may not qualify for nutrient reduction credits). The review process to clarify certain issues related to credit calculation and verification commenced during 2014 but has been largely placed on hold while certain matters are resolved between the EPA and PA and pending development of a robust market for nutrient reductions in PA. The Company anticipates it will submit an amended application once these matters are clear. Design and engineering work for this facility, which will probably be the first to utilize Bion's 3G Tech, have not commenced, and the Company does not yet have financing in place for the Kreider 2 Project. This opportunity is being pursued through PA2. If there are positive developments related to the market for nutrient reductions in PA, of which there is no assurance, the Company intends to pursue development, design and construction of the Kreider 2 Project with a goal of achieving operational status during the 2017 calendar year or early 2018, and hopes to enter into agreements related to sales of the nutrient reduction credits for future delivery (under long term contracts) during 2017 subject to verification by the PADEP based on operating data from the Kreider 2 Project. The economics (potential revenues and profitability) of the Kreider 2 Project, despite its use of Bion's 3G Tech for increased recovery of marketable by-products, are based in material part the long term sale of nutrient (nitrogen and/or phosphorus) reduction credits to meet the requirements of the Chesapeake Bay environmental clean-up. However, liquidity in the PA nutrient credit market has been slow to develop significant breadth and depth, which lack of liquidity has negatively impacted Bion's business plans and has resulted in challenges to monetizing the nutrient reduction credits generated by PA1's existing Kreider 1 project and will most likely delay PA2's Kreider 2 Project and other proposed projects in PA.

Note that while Bion believes that the Kreider 1 System, the Kreider 2 Project and/or subsequent Bion Projects will eventually generate revenue from the sale of: a) nutrient reductions (credits or in other form), b) renewable energy (and related credits), c) sales of fertilizer products, and/or d) potentially, in time, credits for the reduction of greenhouse gas emissions. We believe that the potential market is very large, but it is not possible to predict the exact timing and/or magnitude of these potential markets at this time.

A significant portion of Bion's current activities concern efforts with private and public stakeholders (at local and state level) in PA, (and other Chesapeake Bay, Midwest and Great Lakes states) and at the federal level (EPA and other executive departments and Congress) to establish appropriate public policies which will create regulations and funding mechanisms that foster installation of the low cost, technology-based environmental solutions that Bion (and others) can provide through clean-up of agricultural waste streams. In January 2013, the Pennsylvania Legislative Budget and Finance Committee issued a report stating that targeting upstream livestock would save Pennsylvania's taxpayers up to 80% of previously estimated costs (potential savings for PA in excess of a billion dollars per year over the next 20 years) which would be available for other needs (notably aging drinking water and sewer infrastructure) while creating large local benefits of an upstream treatment strategy including reduced freshwater compliance costs, future cost avoidance of treating drinking water from contaminated local aquifers and increased economic activity for agriculture, tourism and recreation. The Coalition for an Affordable Bay Solution ("Coalition") was formed to support the creation of a competitively-bid nitrogen trading program in Pennsylvania that will enable Pennsylvania to capture the economic benefits outlined in the legislative study. The Coalition supports legislation to establish a competitively-bid RFP program for nitrogen reductions, where bids will also be 'scored' to reflect the value of the benefits to PA's interior waterways and communities. Founding members of the Coalition represent both Chesapeake Bay and national industry participants, and include Bion, JBS, SA, Kreider Farms, and Fair Oaks Farms. The head of the Coalition is Ed Schafer, Bion's Vice Chairman. The Company believes that: i) the April 2015 release of a report from the Pennsylvania Auditor General titled "Special Report on the Importance of Meeting Pennsylvania's Chesapeake Bay Nutrient Reduction Targets" which highlighted the economic consequences of EPA-imposed sanctions if the state fails to meet the 2017 TMDL targets, as well as the need to support using low-cost solutions and technologies as alternatives to higher-cost public infrastructure projects, where possible, and ii) the April 2015 introduction of Senate Bill 724 (successor to prior SB 924) 'The Watershed Improvement Act', which, if adopted, would have established a program that will allow the Pennsylvania's tax- and rate-payers to meet their EPA-mandated Chesapeake Bay pollution reductions at significantly lower cost by purchasing verified reductions (by competitive bidding) from all sources, including those that Bion can produce through livestock waste treatment, represent visible evidence of progress being made on these matters in Pennsylvania. Such legislation, if passed and signed into law, will potentially enable Bion (and others) to compete for public funding on an equal basis with subsidized agricultural 'best management practices' and public works and storm water authorities. On May 6, 2015, the PA Senate Majority Policy Committee held a hearing on SB 724. Testifying in support of this legislation was Elliot Keller of JBS in Souderton PA, Phil Durgin – Executive Director of the PA Legislative Budget and Finance Committee, Ron Kreider of Kreider Farms, Ed Schafer representing the Coalition, and Mike McCloskey representing the National Milk Distributors Association. Bion's activity related to such legislation has intensified with increased stakeholder support and increasing attacks on the Company by those opposed to the legislation and Bion believes the primary provisions of such legislation will be incorporated into legislation that may be passed (in some version) by the Pennsylvania Legislature during 2016-2017, but cannot predict the exact final content of such legislation or guarantee such passage. Note, however, that there was vocal opposition to SB 724 from threatened stakeholders committed to the existing status quo approaches--- a significant portion of which was focused on attacking (in often inaccurate and/or vilifying ways) Bion in/through social media and internet articles, blogs, press releases, twitter posts and re-tweets, rather than engaging the substantive issues. The Company responded in a press release and postings on its website. As a result, Bion is exploring the use of social media including Facebook, twitter and other approaches to accurately communicate about the Company's business and positions. If legislation similar to SB 724 is passed and implemented (in something close to its current form), Bion expects that the policies and strategies being developed in PA will not only benefit the Company's existing and proposed PA projects, but will also subsequently provide the basis for a larger Chesapeake Bay watershed strategy and, thereafter, a national clean water strategy.

The Company believes that Pennsylvania is 'ground zero' in the long-standing clean water battle between agriculture and the further regulation of agriculture relative to nutrient impacts. The ability of Bion and other technology providers to achieve verified reductions from agricultural non-point sources can resolve the current stalemate and enable implementation of constructive solutions that benefit all stakeholders, providing a mechanism that ensures that taxpayer funds will be used to achieve the most beneficial result at the lowest cost, regardless of source. All sources, point and non-point, rural and urban, will be able to compete for tax payer-funded nitrogen reductions in a fair and transparent process; and since payment from the tax and rate payers would now be performance-based, these providers will be held financially accountable.

We believe that the overwhelming environmental, economic, quality of life and public health benefits to all stakeholders in the watershed, both within and outside of Pennsylvania, make the case for adoption of the strategies outlined in the Report less an issue of 'if', but of 'when and how'. The adoption of a competitive procurement program will have significant positive impact on technology providers that can deliver verified nitrogen reductions such as Bion, by allocating existing tax- and rate-payer clean water funding to low cost solutions based upon a voluntary and transparent procurement process. The Company believes that implementation of a competitively-bid nutrient reduction program to achieve the goals for the Chesapeake Bay watershed can also provide a working policy model and platform for other states to adopt that will enhance their efforts to comply with both current and future requirements for local and federal estuarine watersheds, including the Mississippi River/Gulf of Mexico, the Great Lakes Basin and other nutrient-impaired watersheds.

Bion will also pursue the opportunities related to development of Projects, including Integrated Projects. Integrated Projects will include large CAFOs (such as large dairies, beef cattle feed lots and/or hog farms) with Bion waste treatment system modules processing the aggregate CAFO waste stream from the equivalent of 20,000 to 80,000 (or more) beef or dairy cows (or the waste stream equivalent of other species) while recovering cellulosic biomass to be utilized for renewable energy production (and possibly high nutrient fine solids to be marketed as feed and/or fertilizer), integrated with CAFO end product users/processing facilities and/or a biofuel/ethanol plant capable of producing 40 million to 100 (or more) million gallons of ethanol per year. Such Integrated Projects will involve multiple CAFO modules of 10,000 or more beef or dairy cows (or waste stream equivalent of other species) with waste treatment modules on a single site and/or on sites within an approximately 30 mile radius. Bion believes its technology platform (2G Tech, 3G Tech and/or a hybrid in different situations) will allow integration of large-scale CAFO's with end product processors and/or ethanol production together with renewable energy production from cellulosic biomass recovered from the waste streams and on-site energy utilization in a 'closed loop' manner that will reduce the capital expenditures, operating costs and carbon footprint for the entire Integrated Project and each component facility. Some Projects may be developed from scratch while others may be developed in geographic proximity to (and in coordination with) existing participating CAFOs, ethanol plants and/or end product processors. Each Project is likely to have different degrees of integration, especially in the early development phases.

The Company currently anticipates that the Kreider 2 poultry waste treatment facility in PA will be its initial Project. Bion anticipates that it will select a site for the Kreider 2 Project and/or its initial Integrated Project (and possibly additional Projects) during calendar year 2017. Bion hopes to commence development of its initial Project by optioning land and beginning the permitting process during calendar year 2017, but delays are possible. It is not possible at this time to firmly predict where the initial Project will be developed or the order in which Projects will be developed. All potential Projects are in very early pre-development stages and may never progress to actual development or may be developed after other Projects not yet under active consideration.

Bion also hopes to be able to move forward on additional Projects through 2017-19 to create a pipeline of Projects. Management has a 5-year development target (through calendar year 2023) of approximately 10 or more Projects. Management hopes to have identified and begun development work related to 3-5 Projects over the next 2 years. At the end of the 5-year period, Bion projects that 3-8 of these Projects will be in full operation in 3-6 states (and possibly one or more foreign countries), and the balance would be in various stages ranging from partial operation to early development stage. It is possible that one or more Projects will be developed in joint ventures specifically targeted to meet the growing animal protein demand outside of the United States (including without limitation Asia, Europe and/or the Middle East). No Projects (including Integrated Projects) has been developed to date.

The Company's audited financial statements for the years ended June 30, 2016 and 2015 have been prepared assuming the Company will continue as a going concern. The Company has incurred net losses of approximately $4,522,000 and $5,642,000 during the years ended June 30, 2016 and 2015, respectively. The Report of the Independent Registered Public Accounting Firm on the Company's consolidated financial statements as of and for the year ended June 30, 2016 includes a "going concern" explanatory paragraph which means that the accounting firm has expressed substantial doubt about the Company's ability to continue as a going concern. The Company has incurred net losses of approximately $630,000 and $833,000 for the three months ended September 30, 2016 and 2015. At September 30, 2016, the Company had a working capital deficit and a stockholders' deficit of approximately $11,044,000 and $14,412,000, respectively. Management's plans with respect to these matters are described in this section and in our consolidated financial statements (and notes thereto), and this material does not include any adjustments that might result from the outcome of this uncertainty. However, there is no guarantee that we will be able to raise sufficient funds or further capital for the operations planned in the near future.

CRITICAL ACCOUNTING POLICIES

Revenue Recognition

While the Company has not recognized any significant operating revenues for the past two fiscal years, the Company has commenced generation of revenues during the year ended June 30, 2013. Revenues are generated from the sale of nutrient reduction credits, product sales, technology license fees, annual waste treatment fees and/or direct ownership interests in Integrated Projects. The Company recognizes revenue from the sale of nutrient credits and products when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured. The Company expects that technology license fees will be generated from the licensing of Bion's systems. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company's interest in Projects will be recognized when the entity in which the Project has been developed recognizes such revenue.

Stock-based compensation

The Company follows the provisions of Accounting Standards Codification ("ASC") 718, which generally requires that share-based compensation transactions be accounted and recognized in the statement of income based upon their grant date fair values.

Derivative Financial Instruments:

Pursuant to ASC Topic 815 "Derivatives and Hedging" ("Topic 815"), the Company reviews all financial instruments for the existence of features which may require fair value accounting and a related mark-to-market adjustment at each reporting period end. Once determined, the Company assesses these instruments as derivative liabilities. The fair value of these instruments is adjusted to reflect the fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.

Warrants:

Property and equipment:

Recent Accounting Pronouncements:

In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements – Going Concern: Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern." The new standard requires management to perform interim and annual assessments of an entity's ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity's ability to continue as a going concern. The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted. The Company believes the adoption of ASU No. 2014-15 will not have a material impact on its financial statements.

THREE MONTHS ENDED SEPTEMBER 30, 2016 COMPARED TO THE THREE MONTHS ENDED SEPTEMBER 30, 2015

Revenue

Total revenues were nil for both the three months ended September 30, 2016 and 2015, respectively.

General and Administrative

Total general and administrative expenses were $425,000 and $508,000 for the three months ended September 30, 2016 and 2015, respectively.

General and administrative expenses, excluding stock-based compensation charges of $16,000 and $2,000, were $409,000 and $506,000 for the three months ended September 30, 2016 and 2015, respectively, representing a $97,000 decrease. Salaries and related payroll tax expenses were $76,000 and $$78,000 for the three months ended September 30, 2016 and 2015, respectively. Consulting costs were $159,000 and $241,000 for the three months ended September 30, 2016 and 2015, respectively, representing a $82,000 decrease primarily due to decrease in the costs of services provided by Schafer during the three months ended September 30, 2016 and a shift in services provided by the Company's CEO to more research and development activities. Investor relation costs increased from $24,000 for the three months ended September 30, 2015 to $33,000 for the three months ended September 30, 2016 due to the Company's hiring of a new investor relations development firm during the three months ended September 30, 2016. Travel expenses were $10,000 and $20,000 for the three months ended September 30, 2016 and 2015, respectively, representing a $10,000 decrease.

General and administrative stock-based employee compensation for the three months ended September 30, 2016 and 2015 consists of the following:

	Three Months ended September 30, 2016		Three Months ended September 30, 2015
General and administrative:
Fair value of stock options expensed under ASC 718	$	16,000	$	2,000
Total	$	16,000	$	2,000

Stock-based compensation charges were $16,000 and $2,000 for the three months ended September 30, 2016 and 2015, respectively. The increase in the fair value of stock options expensed for the three months ended September 30, 2016 is due to the fact that 35,000 options were granted and vested during the three months ended September 30, 2016, while no options were granted during the same period in fiscal year 2016.

Depreciation

Total depreciation expense was $1,000 and $76,000 for the three months ended September 30, 2016 and 2015, respectively. Depreciation expense is lower for the three months ended September 30, 2016 due to the fiscal year 2016 $1,685,000 impairment of the Kreider 1 assets which reduced the net book value of those assets to zero.

Research and Development

Total research and development expenses were $112,000 and $134,000 for the three months ended September 30, 2016 and 2015, respectively.

Research and development expenses, excluding stock-based compensation expenses of $4,000 and $13,000 were $108,000 and $121,000 for the three months ended September 30, 2016 and 2015, respectively. The primary reason for the decrease is due to less expenses related to the pilot program testing to enhance the Company's technology during the three months ended September 30, 2016.

Research and development stock-based employee compensation for the three months ended September 30, 2016 and 2015 consists of the following:

	Three Months ended September 30, 2016		Three Months ended September 30, 2015
Research and development:
Fair value of stock options expensed under ASC 718	$	4,000	$	13,000
Total	$	4,000	$	13,000

Stock-based compensation expenses were $4,000 and $13,000 and for the three months ended September 30, 2016 and 2015, respectively. The decrease resulted from a reduced number of option vesting to an employee performing research and development during the three months ended September 30, 2016. No new options were granted in either three month period.

Loss from Operations

As a result of the factors described above, the loss from operations was $537,000 and $718,000 for the three months ended September 30, 2016 and 2015, respectively.

Other Expense (Income)

Other expense was $93,000 and $115,000 for the three months ended September 30, 2016 and 2015, respectively. Interest expense decreased $22,000 for the three months ended September 30, 2016 compared to the three months ended September 30, 2015 due to the restructuring of various notes during September 2015 which reduced the interest owed for the three months ended September 30, 2015. Interest expense related to the Pennvest loan was $49,000 for both periods.

Net Loss Attributable to the Noncontrolling Interest

The net loss attributable to the noncontrolling interest was $1,000 for both the three months ended September 30, 2016 and 2015, respectively.

Net Loss Attributable to Bion's Common Stockholders

As a result of the factors described above, the net loss attributable to Bion's stockholders was $630,000 and $832,000 for the three months ended September 30, 2016 and 2015, respectively, and the net loss per basic and diluted common share was $0.03 and $0.04 for the three months ended September 30, 2016 and 2015, respectively.

LIQUIDITY AND CAPITAL RESOURCES

The Company's consolidated financial statements for the three months ended September 30, 2016 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Report of our Independent Registered Public Accounting Firm on the Company's consolidated financial statements as of and for the year ended June 30, 2016 includes a "going concern" explanatory paragraph which means that the auditors stated that conditions exist that raise substantial doubt about the Company's ability to continue as a going concern.

Operating Activities

As of September 30, 2016, the Company had cash of approximately $64,000. During the three months ended September 30, 2016, net cash used in operating activities was $226,000, primarily consisting of cash operating expenses related to salaries and benefits, and other general and administrative costs such as insurance and legal and accounting expenses. As previously noted, the Company is currently not generating significant revenue and accordingly has not generated cash flows from operations. The Company does not anticipate generating sufficient revenues to offset operating and capital costs for a minimum of two to five years. While there are no assurances that the Company will be successful in its efforts to develop and construct its Projects and market its Systems, it is certain that the Company will require substantial funding from external sources. Given the unsettled state of the current credit and capital markets for companies such as Bion, there is no assurance the Company will be able to raise the funds it needs on reasonable terms.

Investing Activities

During the three months ended September 30, 2016, the Company did not have any investing activities.

Financing Activities

During the three months ended September 30, 2016, the Company received cash proceeds of $7,500 due to the receipt of a subscription receivable for the exercise of 10,000 warrants. The Company also received cash proceeds of $23,000 from the sale of 30,467 shares the Company's common stock at a price of $0.75 per share. The Company also received cash proceeds of $90,000 from the sale of 120,000 units which consisted of one share of the Company's restricted common stock and one warrant to purchase one half of a share of the Company's restricted common stock for $1.00 per share until December 30, 2017.

As of September 30, 2016 the Company has debt obligations consisting of: a) deferred compensation of $1,658,000, b) convertible notes payable – affiliates of $3,312,000, and, c) a loan payable of $7,754,000 (owed by PA1) (plus accrued interest of $868,000).

Plan of Operations and Outlook

As of September 30, 2016, the Company had cash of approximately $64,000.

The Company continues to explore sources of additional financing to satisfy its current operating requirements as it is not currently generating any significant revenues. During fiscal years 2014 through 2016, the Company experienced greater difficulty in raising equity and debt funding than in the prior years. During the years ended June 30, 2014 and through 2016, the Company had the greatest difficulty raising funds to date. As a result, the Company faced, and continues to face, significant cash flow management challenges due to material working capital constraints. These difficulties, challenges and constraints have continued during fiscal year 2017 and the Company anticipates that they may continue for the next twelve (12) months or longer. To partially mitigate these working capital constraints, the Company's core senior management and some key employees and consultants have been deferring all or part of their cash compensation and/or are accepting compensation in the form of securities of the Company (Notes 4 and 6 to Financial Statements) and members of the Company's senior management have made loans to the Company which have been converted into convertible promissory notes. As of September 30, 2016, such deferrals totaled approximately $4,970,000 (including accrued interest and deferred compensation converted into promissory notes but excluding conversions of deferred compensation into the Company's common stock by officers, employees and consultants that have already been completed). The extended constraints on available resources have had, and continue to have, negative effects on the pace and scope of the Company's effort to develop its business. The Company made reductions in its personnel during the year ended June 30, 2014. The Company has had to delay payments of trade obligations and economize in many ways that have potentially negative consequences. If the Company does not have greater success in its efforts to raise needed funds during the current year (and subsequent periods), we will need to consider deeper cuts (including additional personnel cuts) and curtailments of operations (including possibly Kreider 1 operations). The Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Projects (including Integrated Projects) and CAFO Retrofit waste remediation systems (including the Kreider 2 facility) and to continue to operate the Kreider 1 facility (subject to agreements being reached with Pennvest as discussed above). The Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more (debt and equity) during the next twelve months. However, as discussed above, there is no guarantee that we will be able to raise sufficient funds or further capital for the operations planned in the near future.

The Company is not currently generating any significant revenues. Further, the Company's anticipated revenues, if any, from existing projects and proposed Projects will not be sufficient to meet the Company's anticipated operational and capital expenditure needs for many years. During the three months ended September 30, 2016 the Company raised proceeds of approximately $113,000 through the sale of its securities (Note 7 to Financial Statements) and anticipates raising additional funds from such sales and transactions. However, there is no guarantee that we will be able to raise sufficient funds or further capital for the operations planned in the near future.

Because the Company is not currently generating significant revenues, the Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Projects and to sustain operations at the KF 1 facility.

The first commercial activity in the Retrofit segment is represented by our agreement with Kreider Farms ("KF"), pursuant to which the Kreider 1 system to treat KF's dairy waste streams to reduce nutrient releases to the environment while generating marketable nutrient credits and renewable energy was designed, constructed and entered full-scale operation during 2011. On January 26, 2009 the Board of the Pennsylvania Infrastructure Investment Authority ("Pennvest") approved a $7.75 million loan to Bion PA 1, LLC ("PA1"), a wholly-owned subsidiary of the Company, for the initial Kreider Farms project ("Kreider 1 System"). After substantial unanticipated delays, on August 12, 2010 PA1 received a permit for construction of the Kreider 1 system. Construction activities commenced during November 2010. The closing/settlement of the Pennvest Loan took place on November 3, 2010. PA1 finished the construction of the Kreider 1 System and entered a period of system 'operational shakedown' during May 2011. The Kreider 1 System reached full, stabilized operation by the end of the 2012 fiscal year. During 2011 the PADEP re-certified the nutrient credits for this project. The PADEP issued final permits for the Kreider 1 System (including the credit verification plan) on August 1, 2012 on which date the Company deemed that the Kreider System was 'placed in service'. As a result, PA1 commenced generating nutrient reduction credits for potential sale while continuing to utilize the Kreider 1 system to test improvements and add-ons. However, to date liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth, which limited liquidity/depth has negatively impacted Bion's business plans and has resulted in challenges to monetizing the nutrient reductions created by PA1's existing Kreider 1 project and Bion's other proposed projects. These difficulties have prevented PA1 from generating any material revenues from the Kreider 1 project to date and raise significant questions as to when, if ever, PA1 will be able to generate such revenues from the Kreider 1 system. PA1 has had sporadic discussions/negotiations with Pennvest related to forbearance and/or re-structuring its obligations pursuant to the Pennvest Loan for more than three years. In the context of such discussions/negotiations, PA1 elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of September 30, 2016. Due to the failure of the PA nutrient reduction credit market to develop, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, PA1 and the Company recorded impairments related to the value of the Kreider 1 assets of $1,750,000 and $2,000,000 at June 30, 2015 and June 30, 2014, respectively. During the 2016 fiscal year, effective June 30, 2016, PA1 and the Company recorded an impairment of $1,684,562 to the value of the Kreider 1 assets which reduced the value on the Company's books to $0. This impairment reflects management's judgment that the salvage value of the Kreider 1 assets roughly equals PA1's contractual obligations related to the Kreider 1 system, including expenses related to decommissioning of the Kreider 1 system, costs associated with needed capital upgrade expenses, and re-certification/ permitting amendments. See "Impairment loss on property and equipment" above.

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and accelerated the Pennvest Loan and demanded that PA1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA1 did not make the payment and does not have the resources to make the payments demanded by Pennvest. PA1 has commenced discussions and negotiations with Pennvest concerning this matter but Pennvest has rejected PA1's proposal made during the fall of 2014. As of the date of this report, no formal proposals are under consideration and only sporadic communication has taken place regarding the matters involved over the last 18 months. It is not possible at this date to predict the outcome of this matter, but the Company believes that a loan modification agreement may be reached in the future if/when a more robust market for nutrient reductions develops in PA, of which there is no assurance. PA1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

The Company is currently operating the Kreider 1 System in a limited manner pending development of a more robust market for its nutrient reductions.

As indicated above, the Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more (from debt, equity, joint venture, strategic partnering, etc.) during the next twelve months, some of which may be in the context of joint ventures for the development of one or more large scale projects. We reiterate that there is no assurance, especially in the extremely unsettled capital markets that presently exist for companies such as Bion, that the Company will be able to obtain the funds that it needs to stay in business, finance its Projects and other activities, continue its technology development and/or to successfully develop its business.

There is extremely limited likelihood that funds required during the next twelve months or in the periods immediately thereafter will be generated from operations and there is no assurance that those funds will be available from external sources such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from operations and/or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Further, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significantly dilutive effect on the Company's existing shareholders. All of these factors have been exacerbated by the extremely limited and unsettled credit and capital markets presently existing for companies such as Bion.

Currently, Bion is focused on using applications of its patented and proprietary waste management technologies and technology platform to pursue three main business opportunities: 1) installation of Bion systems ( some of which may generate verified nutrient credits and revenues from the production of renewable energy and byproducts) to retrofit and environmentally remediate existing CAFOs ("Retrofits") in selected markets where: a) government policy supports such efforts (such as the Chesapeake Bay watershed, Great Lakes Basin states, and/or other states and watersheds facing EPA 'total maximum daily load' ("TMDL") issues, and/or b) where CAFO's need our technology to obtain permits to expand or develop without negative environmental consequences; 2) development of new state-of-the-art large scale waste treatment facilities in strategic locations ("Projects") ( some of these may be Integrated Projects as described below) with multiple revenue streams, and 3) licensing and/or joint venturing of Bion's technology and applications (primarily) outside North America. The opportunities described at 1) and 2) above each require substantial political and regulatory (federal, state and local) efforts on the part of the Company and a substantial part of Bion's efforts are focused on such political and regulatory matters. Bion is currently pursuing the international opportunities primarily through the use of consultants with existing relationships in target. While the Company has commenced activities related to marketing and potential use of its technology in relation to expansion and/or development of CAFO's in the Northeast and Midwest (and elsewhere), we have met with extremely limited success to date. Bion considers these to be a large potential markets for the Company's growth over the next 36 months (and thereafter). Assuming that the Company can be successful in raising necessary funding and the development of a more robust market for nutrient reductions in Pennsylvania (and elsewhere), neither of which are assured at this date, the Company believes it will be able to succeed at such activities based on the operating results of its technologies and systems.

Additionally, the Kreider agreements provide for Bion to develop a waste treatment/renewable energy production facility to treat the waste from Kreider's approximately 5+ million chickens (planned to expand to approximately 9 million)(and potentially other poultry operations and/or other waste streams)('Kreider Renewable Energy Facility' or ' Kreider 2 Project'). On May 5, 2016, the Company executed a stand-alone joint venture agreement with Kreider Farms covering all matters related to development and operation of a system to treat the waste streams from Kreider's poultry facilities in Bion PA2 LLC ("PA2"). The Company continues its development work related to the details of the Kreider 2 Project. During May 2011 the PADEP certified Kreider 2 Project for 559,457 nutrient credits under the old EPA's Chesapeake Bay model. The Company anticipates that the Kreider 2 Project will be re-certified for between 1.5-2 million nutrient reduction credits (for treatment of the waste stream from Kreider's poultry) pursuant to the Company's pending reapplication (or subsequent amended application) during 2017 pursuant to the amended EPA Chesapeake Bay model and agreements between the EPA and PA. Note that this Project may be expanded in the future to treat wastes from other local and regional CAFOs (poultry and/or dairy) and/or Kreider poultry expansion (some of which may not qualify for nutrient reduction credits). The review process to clarify certain issues related to credit calculation and verification commenced during 2014 but has been largely placed on hold while certain matters are resolved between the EPA and PA and pending development of a robust market for nutrient reductions in PA. The Company anticipates it will submit an amended application once these matters are clear. Design and engineering work for this facility, which will probably be the first to utilize Bion's 3G Tech, have not commenced, and the Company does not yet have financing in place for the Kreider 2 Project. This opportunity is being pursued through PA2. If there are positive developments related to the market for nutrient reductions in PA, of which there is no assurance, the Company intends to pursue development, design and construction of the Kreider 2 Project with a goal of achieving operational status during the 2017 calendar year or early 2018, and hopes to enter into agreements related to sales of the nutrient reduction credits for future delivery (under long term contracts) during 2017 subject to verification by the PADEP based on operating data from the Kreider 2 Project. The economics (potential revenues and profitability) of the Kreider 2 Project, despite its use of Bion's 3G Tech for increased recovery of marketable by-products, are based in material part the long term sale of nutrient (nitrogen and/or phosphorus) reduction credits to meet the requirements of the Chesapeake Bay environmental clean-up. However, liquidity in the PA nutrient credit market has been slow to develop significant breadth and depth, which lack of liquidity has negatively impacted Bion's business plans and has resulted in challenges to monetizing the nutrient reduction credits generated by PA1's existing Kreider 1 project and will most likely delay PA2's Kreider 2 Project and other proposed projects in PA.

The Company anticipates that the Kreider 2 poultry waste treatment facility in PA will be its initial Project. Bion anticipates that it will select a site for the Kreider 2 Project and/or its initial Integrated Project (and possibly additional Projects) during calendar year 2017. Bion hopes to commence development of its initial Project by optioning land and beginning the permitting process during calendar year 2017, but delays are possible. It is not possible at this time to firmly predict where the initial Project will be developed or the order in which Projects will be developed. All potential Projects are in very early pre-development stages and may never progress to actual development or may be developed after other Projects not yet under active consideration.

CONTRACTUAL OBLIGATIONS

We have the following material contractual obligations (in addition to employment and consulting agreements with management and employees):

During 2008 the Company commenced actively pursuing the opportunity presented by environmental retrofit and remediation of the waste streams of existing CAFOs which effort has met with very limited success to date. The first commercial activity in this area is represented by our agreement with Kreider Farms ("KF"), pursuant to which the Kreider 1 system to treat KF's dairy waste streams to reduce nutrient releases to the environment while generating marketable nutrient credits and renewable energy was designed, constructed and entered full-scale operation during 2011. On January 26, 2009 the Board of the Pennsylvania Infrastructure Investment Authority ("Pennvest") approved a $7.75 million loan to Bion PA 1, LLC ("PA1"), a wholly-owned subsidiary of the Company, for the initial Kreider Farms project ("Kreider 1 System"). After substantial unanticipated delays, on August 12, 2010 PA1 received a permit for construction of the Kreider 1 system. Construction activities commenced during November 2010. The closing/settlement of the Pennvest Loan took place on November 3, 2010. PA1 finished the construction of the Kreider 1 System and entered a period of system 'operational shakedown' during May 2011. The Kreider 1System reached full, stabilized operation by the end of the 2012 fiscal year. During 2011 the PADEP re-certified the nutrient credits for this project. The PADEP issued final permits for the Kreider 1 System (including the credit verification plan) on August 1, 2012 on which date the Company deemed that the Kreider System was 'placed in service'. As a result, PA1 commenced generating nutrient reduction credits for potential sale while continuing to utilize the Kreider 1 system to test improvements and add-ons. However, to date liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth, which limited liquidity/depth has negatively impacted Bion's business plans and has resulted in challenges to monetizing the nutrient reductions created by PA1's existing Kreider 1 project and Bion's other proposed projects. These difficulties have prevented PA1 from generating any material revenues from the Kreider 1 project to date and raise significant questions as to when, if ever, PA1 will be able to generate such revenues from the Kreider 1 system. PA1 has had sporadic discussions/negotiations with Pennvest related to forbearance and/or re-structuring its obligations pursuant to the Pennvest Loan for more than three years. In the context of such discussions/negotiations, PA1 elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of September 30, 2016. Due to the failure of the PA nutrient reduction credit market to develop, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, PA1 and the Company recorded impairments related to the value of the Kreider 1 assets of $1,750,000 and $2,000,000 at June 30, 2015 and June 30, 2014, respectively. During the 2016 fiscal year, effective June 30, 2016, PA1 and the Company recorded an impairment of $1,684,562 to the value of the Kreider 1 assets which reduced the value on the Company's books to $0. This impairment reflects management's judgment that the salvage value of the Kreider 1 assets roughly equals PA1's contractual obligations related to the Kreider 1 system, including expenses related to decommissioning of the Kreider 1 system, costs associated with needed capital upgrade expenses, and re-certification/ permitting amendments. See "Impairment loss on property and equipment" above.

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and accelerated the Pennvest Loan and demanded that PA1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA1 did not make the payment and does not have the resources to make the payments demanded by Pennvest. PA1 has commenced discussions and negotiations with Pennvest concerning this matter but Pennvest has rejected PA1's proposal made during the fall of 2014. As of the date of this report, no formal proposals are under consideration and only sporadic communication has taken place regarding the matters involved over the last 18 months. It is not possible at this date to predict the outcome of this matter, but the Company believes that a loan modification agreement may be reached in the future if/when a more robust market for nutrient reductions develops in PA, of which there is no assurance. PA1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

The Company is currently operating the Kreider 1 System in a limited manner pending development of a more robust market for its nutrient reductions.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements (as that term is defined in Item 303 of Regulation S‑K) that are reasonably likely to have a current or future material effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

Item 4. Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures.

The term "disclosure controls and procedures" is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). This term refers to the controls and procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized, and reported within the required time periods. Our Chief Executive Officer and Principal Financial Officer has evaluated the effectiveness of the design and operations of our disclosure controls and procedures as of the end of the period covered by this quarterly report, and has concluded that, as of that date, our disclosure controls and procedures were not effective at ensuring that required information will be disclosed on a timely basis in our reports filed under the Exchange Act, as a result of the material weakness in internal control over financial reporting discussed in Item 9(A) of our Form 10-K for the year ended June 30, 2016.

(b) Changes in Internal Control over Financial Reporting.

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that our wholly-owned subsidiary Bion PA-1 LLC ('PA-1') pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. The Company anticipates that discussions and negotiations will take place between PA-1 and Pennvest concerning this matter over the next 90 days. No proposals are currently under consideration to resolve this matter. It is not possible at this date to predict the outcome of such negotiations, but the Company believes that it remains possible that negotiations will lead to a commercially reasonable loan modification agreement be reached between PA-1 and Pennvest. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion anticipate that it will be necessary for the Company to evaluate various options with regard to Kreider 1 over the coming months. Litigation has not commenced in this matter but has been threatened by Pennvest.

The Company currently is not involved in any other material litigation.

Item 1A. Risk Factors.

Not applicable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the quarter ended September 30, 2016, the Company sold the following restricted securities: a) 12,354 shares issued pursuant to our 2006 Consolidated Incentive Plan ('Plan'), valued at $10,453 in aggregate, to an employee and consultants for services, and b) 8138 shares were issued for conversion of debt totaling $6,103 and c) 120,000 units at $0.75 per unit were sold and the Company received proceeds of $90,000 (each unit consisted of one share of the Company's restricted common stock and one warrant to purchase half of a share of the Company's restricted common stock at $1.00 per share until December 31, 2017) and d) 30,467 shares of the Company's restricted common stock were sold at $0.75 per share for gross proceeds of $22,850. In all of these transactions the Company relied on the exemptions in Section 4(2) of the Securities Act of 1933, as amended, and/or under Rule 506 of Regulation D under the Securities Act of 1933, as amended. See Notes to Financial Statements (included herein) for additional details.

The proceeds were utilized for general corporate purposes.

Item 3. Defaults Upon Senior Securities.

Not applicable.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Not applicable.

Item 6. Exhibits.

(a) Exhibits required by Item 601 of Regulation S-K.

Exhibit		Description

31.1		Certification of CEO pursuant to Rule 13a-14(a) or Rule 15d-14(a) - Filed herewith electronically

31.2		Certification of Executive Chairman, President and CFO pursuant to Rule 13a-14(a) or Rule 15d-14(a) - Filed herewith electronically

32.1		Certification of CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - Filed herewith electronically

32.2		Certification of Executive Chairman, President and CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - Filed herewith electronically

101		XBRL Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		BION ENVIRONMENTAL TECHNOLOGIES, INC.


Date: November 14, 2016	By:	/s/ Mark A. Smith
		Mark A. Smith, President and Chief Financial Officer (Principal Financial and Accounting Officer)



Date: November 14, 2016	By:	/s/ Dominic Bassani
		Dominic Bassani, Chief Executive Officer

EX-31.1 2 ex31x1.htm EXHIBIT 31.1

Exhibit 31.1

SECTION 302 CERTIFICATION

I, Dominic Bassani, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Bion Environmental Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the of the registrant as of, and for, the periods presented in this report;

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

November 14, 2016	/s/ Dominic Bassani
	Dominic Bassani Chief Executive Officer

EX-31.2 3 ex31x2.htm EXHIBIT 31.2

Exhibit 31.2

SECTION 302 CERTIFICATION

I, Mark A. Smith, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Bion Environmental Technologies, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: November 14, 2016		/s/ Mark A. Smith
		Mark A. Smith Executive Chairman, President and Interim Chief Financial Officer

EX-32.1 4 ex32x1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION OF CEO PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Form 10-Q of Bion Environmental Technologies, Inc., a company duly formed under the laws of Colorado (the "Company"), for the period ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Dominic Bassani, Chief Executive Officer of the Company, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 14, 2016	/s/ Dominic Bassani
	Dominic Bassani Chief Executive Officer

This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been provided to Bion Environmental Technologies, Inc. and will be retained by Bion Environmental Technologies, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 ex32x2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION OF CFO PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Form 10-Q of Bion Environmental Technologies, Inc., a company duly formed under the laws of Colorado (the "Company"), for the period ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Mark A. Smith, President (Executive Chairman) and Interim Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: November 14, 2016		/s/ Mark A. Smith
		Mark A. Smith Executive Chairman, President and Interim Chief Financial Officer

EX-101.INS 6 bnet-20160930.xml XBRL INSTANCE DOCUMENT 867827 75 160000 650000 600000 25000 2000 40000 2000 10000 10000 25000 0.05 0.05 0.05 10000 10000 1 171560 173313 117500 0.5 0.50 0.60 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">6.     CONVERTIBLE NOTES PAYABLE - AFFILIATES:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 2015 Convertible Notes</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The January 2015 Convertible Notes accrue interest at 4% per annum and are due and payable on December 31, 2017. The January 2015 Convertible Notes (including accrued interest, plus all future deferred compensation), are convertible, at the sole election of the noteholder, into Units consisting of one share of the Company’s common stock and one quarter warrant to purchase a share of the Company’s common stock, at a price of $0.50 per Unit until December 31, 2020. The warrant contained in the Unit shall be exercisable at $1.00 per share until December 31, 2020. The original conversion price of $0.50 per Unit approximated the fair value of the Units at the date of the agreements; therefore no beneficial conversion feature exists. Management evaluated the terms and conditions of the embedded conversion features based on the guidance of ASC 815-15 “Embedded Derivatives” to determine if there was an embedded derivative requiring bifurcation. An embedded derivative instrument (such as a conversion option embedded in the deferred compensation) must be bifurcated from its host instruments and accounted for separately as a derivative instrument only if the “risks and rewards” of the embedded derivative instrument are not “clearly and closely related” to the risks and rewards of the host instrument in which it is embedded. Management concluded that the embedded conversion feature of the deferred compensation was not required to be bifurcated because the conversion feature is clearly and closely related to the host instrument, and because of the Company’s limited trading volume that indicates the feature is not readily convertible to cash in accordance with ASC 815-10, “Derivatives and Hedging”. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of September 30, 2016, the January 2015 Convertible Note balances, including accrued interest, owed Bassani, Smith and Schafer were $1,566,944, $813,692 and $404,739, respectively. During the three months ended September 30, 2016 and 2015, the Company recorded interest expense of $26,247 and $26,248, respectively, related to the January 2015 Convertible Notes.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">September 2015 Convertible Notes</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the year ended June 30, 2016, the Company entered into September 2015 Convertible Notes with Bassani, Schafer and a Shareholder which replaced previously issued promissory notes. The initial principal balances of the September 2015 Convertible Notes were $405,831, $16,382 and $82,921, respectively. The September 2015 Convertible Notes bear interest at 4% per annum, have maturity dates of December 31, 2017 and may be converted at the sole election of the noteholders into restricted common shares of the Company at a conversion price of $0.60 per share. As the conversion price of $0.60 approximated the fair value of the common shares at the date of the September 2015 Convertible Notes, no beneficial conversion feature exists. The balances of the September 2015 Convertible Notes as of September 30, 2016, including accrued interest, are $423,087, $17,079 and $86,447, respectively. The Company recorded interest expense related to the 2015 Convertible Notes of $5,093 and $1,218 for the three months ended September 30, 2016 and 2015, respectively.</div></div></div> P3Y 0.11 0.11 0.5 0.5 P10D P5D 6008 7152 125000 125000 226168 1172 0.75 0.75 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrants:</div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has issued warrants to purchase common shares of the Company. Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Company’s value as of the date of the issuance, consideration of the Company’s limited liquid resources and business prospects, the market price of the Company’s stock in its mostly inactive public market and the historical valuations and purchases of the Company’s warrants. When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined.</div></div></div></div></div></div></div></div></div></div> 0.5 0.05 0.01 P5Y 0.04 0.03 8621827 8563662 18000 19000 31000 14000 18000 1 1 1 1 1 1 1 1 0.25 1 0.75 90000 120000 120000 120000 0.75 90000 90000 90000 90000 704309 704309 704309 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 49%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Target Price per share</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">10.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">20.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Number of shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">50,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">40,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">27,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table></div> P3Y P10Y 116277 0.05 0.05 1.29 75374 303736 P4Y 600000 600000 -11044000 false --06-30 Q1 2017 2016-09-30 10-Q 0000875729 23058996 Yes Smaller Reporting Company BION ENVIRONMENTAL TECHNOLOGIES INC No No bnet

818133

768272

7500

2791943

2793194

102434634

102278364

87421

2579

20856

15320

16495

1838

16495

1838

4361

13482

4361

13482

7439795

8295989

4260537

4413870

8361559

7119524

15250

14250

85076

198193

81319

193934

401470

2500000

50000000

170194

339286

64418

180346

-105776

-158940

0.75

0.84

0.75

1.50

0.90

0.5

592916

40000

800000

40000

7400000

6753219

500000

100000

7500

100000000

23761168

23573057

22089650

23056859

22868748

21385341

7750000

8621827

1566944

813692

404739

405831

16382

82921

423087

17079

86447

3311988

3280647

760520

1464545

8137117

0.45

0.50

0.45

0.50

395277

0.02547

0.03184

0.04

0.08

0.04

0.08

0.04

1657541

672753

227166

116182

399956

168000

984

72500

1436595

502

75879

10500

2000

500

279000

-0.03

-0.04

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Loss per share:</div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share. During three months ended September 30, 2016 and 2015, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive.</div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,439,795</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,295,989</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,260,537</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,413,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible debt</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,361,559</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,119,524</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible preferred stock</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">15,250</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">14,250</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following is a reconciliation of the denominators of the basic loss per share computations for the three months ended September 30, 2016 and 2015: </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 7.5%; MARGIN-RIGHT: 7.5%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares issued – beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">23,573,057</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">22,089,650</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares held by subsidiaries (Note 7)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares outstanding – beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">22,868,748</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">21,385,341</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares for fully </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">vested stock bonuses </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">600,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">600,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares issued </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">during the period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">75,374</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">303,736</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic weighted average shares – </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">23,544,122</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">22,289,077</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div></div></div></div></div></div></div></div></div>

4957

0.589

424691

507905

3750000

1684562

49861

34429

215400

227400

661

3914

-7500

-13125

26247

26248

5093

1218

92764

114756

49374

14437389

14076576

85076

198193

11125401

10795929

7754000

1867000

741000

819000

794000

771000

760000

8137117

2222670

27900

27400

59212

59746

120350

187314

-3260

-226126

-342994

-534

-1295

-629666

-831734

-92764

-114756

537436

718273

-537436

-718273

101560

114969

1000

6008

171717

105000

3260

0.025

30500

30000

0.01

50000

10000

60000

200

15901

15240

7500

22850

760604

112850

174189

-4522000

-5642000

-630200

-833029

-629666

-534

2795700

2797453

3757

4259

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 7.5%; MARGIN-RIGHT: 7.5%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">June 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Machinery and equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,222,670</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,222,670</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Buildings and structures</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">401,470</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">401,470</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Computers and office equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">171,560</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">173,313</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">2,795,700</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">2,797,453</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Less accumulated depreciation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(2,791,943</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(2,793,194</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">3,757</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,259</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table></div>

P3Y

P20Y

2001000

112243

134489

-116846159

-116216493

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 7.5%; MARGIN-RIGHT: 7.5%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares issued – beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">23,573,057</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">22,089,650</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares held by subsidiaries (Note 7)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares outstanding – beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">22,868,748</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">21,385,341</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares for fully </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">vested stock bonuses </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">600,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">600,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares issued </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">during the period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">75,374</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">303,736</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic weighted average shares – </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">23,544,122</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">22,289,077</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">General and administrative:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock options expensed</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">16,495</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,838</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">16,495</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,838</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Research and development:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock options expensed</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,361</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">13,482</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,361</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">13,482</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-LEFT: 2.5%; MARGIN-RIGHT: 2.5%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted-</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Price</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted-</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Life</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at July 1, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,225,537</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.79</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4.1</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">158,675</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">35,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at September 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,260,537</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.78</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">3.4</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">124,375</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at September 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,210,537</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.80</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3.4</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">111,875</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom" width="937"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width="184" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width="236" colspan="4"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Range,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width="184" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width="184" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Range,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px" width="4"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="937"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">81</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">78%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">86%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="4" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="937"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="4" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="937"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">0.93</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">0.82%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">0.97%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="4" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="937"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected term (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">3.7</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73">3</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73">4</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="4" nowrap="nowrap"> </td> </tr> </table></div>

37412

41272

0.81

0.78

0.86

0.0093

0.0082

0.0097

22000000

4210537

1.80

722319

150000

250000

25000

35000

150000

100000

600000

450000

109500

75000

0.45

158675

124375

3070000

50000

40000

27500

4225537

4260537

1.50

1.79

1.78

0.90

0.75

0.83

0.75

P10Y

P3Y255D

P3Y

P4Y

111875

P3Y146D

50000

0.76

P4Y36D

P3Y146D

15900

109500

35000

0.45

23573057

23761168

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2.     SIGNIFICANT ACCOUNTING POLICIES</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Principles of consolidation:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (“Projects Group”), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA1, and PA2; and its 58.9% owned subsidiary, Centerpoint Corporation (“Centerpoint”). All significant intercompany accounts and transactions have been eliminated in consolidation.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at September 30, 2016, and the results of operations and cash flows of the Company for the three months ended September 30, 2016 and 2015. Operating results for the three months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the year ending June 30, 2017.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Property and equipment:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years. The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects. The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrants:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has issued warrants to purchase common shares of the Company. Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Company’s value as of the date of the issuance, consideration of the Company’s limited liquid resources and business prospects, the market price of the Company’s stock in its mostly inactive public market and the historical valuations and purchases of the Company’s warrants. When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Fair value measurements:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value. </div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities;</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 2 – observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 3 – assets and liabilities whose significant value drivers are unobservable.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of cash and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable approximates its carrying amount as it bears interest at rates commensurate with market rates. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of deferred compensation and convertible notes payable - affiliates are not practicable to estimate due to the related party nature of the underlying transactions.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Revenue Recognition:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Revenues are generated from the sale of nutrient reduction credits. The Company recognizes revenue from the sale of nutrient credits when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company expects that technology license fees will be generated from the licensing of Bion’s integrated system. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company’s interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Loss per share:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share. During three months ended September 30, 2016 and 2015, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,439,795</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,295,989</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,260,537</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,413,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible debt</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,361,559</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,119,524</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible preferred stock</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">15,250</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">14,250</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following is a reconciliation of the denominators of the basic loss per share computations for the three months ended September 30, 2016 and 2015: </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 7.5%; MARGIN-RIGHT: 7.5%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares issued – beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">23,573,057</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">22,089,650</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares held by subsidiaries (Note 7)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares outstanding – beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">22,868,748</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">21,385,341</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares for fully </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">vested stock bonuses </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">600,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">600,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares issued </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">during the period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">75,374</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">303,736</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic weighted average shares – </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">23,544,122</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">22,289,077</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Reclassifications:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certain amounts in the prior year financial statements have been reclassified to conform to the current year presentation including the reclassification of accrued interest related to the Pennvest Loan from accounts payable and accrued expenses into loan payable and accrued interest.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company’s financial statements properly reflect the change. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09 “Revenue from Contracts from Customers,” which supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605),” and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017 and earlier application is permitted only as of annual reporting periods beginning after December 15, 2016. The Company is currently evaluating the new standard and assessing the potential impact on its operations and financial statements. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern: Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted. The adoption of ASU No. 2014-15 did not have a material impact on the Company’s financial statements.</div></div></div>

7152

20492

75000

2137

20492

10000

30467

125000

25000

30467

6008

16556

2000

16556

7500

22850

20856

-14411525

-13938129

102278364

-116216493

59746

-13878383

102434634

-116846159

59212

-14352313

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">7.     STOCKHOLDERS' EQUITY:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Series B Preferred stock:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At July 1, 2014, the Company had 200 shares of Series B redeemable convertible Preferred stock outstanding with a par value of $0.01 per share, convertible at the option of the holder at $2.00 per share, with dividends accrued and payable at 2.5% per quarter. The Series B Preferred stock is mandatorily redeemable at $2.00 per share by the Company three years after issuance and accordingly was classified as a liability. The 200 shares have reached their maturity date, but due to the cash constraints of the Company have not been redeemed. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the years ended June 30, 2016 and 2015, the Company declared dividends of $2,000 and $2,000 respectively. During the three months ended September 30, 2016, the Company declared dividends of $500. At September 30, 2016, accrued dividends payable are $10,500. The dividends are classified as a component of operations as the Series B Preferred stock is presented as a liability in these financial statements. For the three months ended September 30, 2015 these amounts were presented differently but the September 30, 2015 financial statements were revised even though such revision previously was and continues to be immaterial to the prior year financial statements. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Common stock:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Holders of common stock are entitled to one vote per share on all matters to be voted on by common stockholders. In the event of liquidation, dissolution or winding up of the Company, the holders of common stock are entitled to share in all assets remaining after liabilities have been paid in full or set aside and the rights of any outstanding preferred stock have been satisfied. Common stock has no preemptive, redemption or conversion rights. The rights of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of any outstanding series of preferred stock or any series of preferred stock the Company may designate in the future. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Centerpoint holds 704,309 shares of the Company’s common stock. These shares of the Company’s common stock held by Centerpoint are for the benefit of its shareholders without any beneficial interest. The Company accounts for these shares similar to treasury stock.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three months ended September 30, 2016, the Company issued 20,492 shares of the Company’s common stock at prices ranging from $0.75 to $0.83 per share for services valued at $16,556, in the aggregate, to consultants and employees. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three months ended September 30, 2016, the Company issued 10,000 shares of the Company’s restricted common stock upon receipt of its subscription receivable of $7,500 for the exercise of 10,000 warrants.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three months ended September 30, 2016, the Company entered into subscription agreements to sell units for $0.75 per unit, with each unit consisting of one share of the Company’s restricted common stock and one warrant to purchase one half of a share of the Company’s restricted common stock for $1.00 per share until December 31, 2017 and pursuant thereto, the Company issued 120,000 units for total proceeds of $90,000. The Company allocated the proceeds from the shares and the warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the warrants, which was determined to be $0.05 per warrant. As a result, $2,579 was allocated to the warrants and $87,421 was allocated to the shares, and both were recorded as additional paid in capital. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three months ended September 30, 2016, the Company sold 30,467 shares of the Company’s common stock for $0.75 per share for total proceeds of $22,850.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three months ended September 30, 2016, a consultant elected to convert $6,008 of deferred compensation into 7,152 shares of the Company’s common stock at a conversion rate of $0.84 per share. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrants:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of September 30, 2016, the Company had approximately 7.4 million warrants outstanding, with exercise prices from $0.75 to $3.00 and expiring on various dates through December 31, 2021. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The weighted-average exercise price for the outstanding warrants is $1.29, and the weighted-average remaining contractual life as of September 30, 2016 is 4.0 years.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three months ended September 30, 2016, warrants to purchase 722,319 shares of common stock of the Company at prices between $0.75 per share expired.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At June 30, 2016 the Company had a subscription agreement for the exercise of 10,000 warrants at an exercise price of $0.75, resulting in a subscription receivable of $7,500. During the three months ended September 30, 2016, the received the subscription receivable of $7,500 and the Company issued 10,000 shares of the Company’s common stock in satisfaction of the warrant exercise. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three months ended September 30, 2016, the Company entered into subscription agreements to sell units for $0.75 per unit, with each unit consisting of one share of the Company’s restricted common stock and one warrant to purchase one half of a share of the Company’s restricted common stock for $1.00 per share until December 31, 2017 and pursuant thereto, the Company issued 120,000 units for total proceeds of $90,000. The Company allocated the proceeds from the shares and the warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the warrants, which was determined to be $0.05 per warrant. As a result, $2,579 was allocated to the warrants and $87,421 was allocated to the shares, and both were recorded as additional paid in capital. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Stock options: </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company’s 2006 Consolidated Incentive Plan, as amended (the “2006 Plan”), provides for the issuance of options (and/or other securities) to purchase up to 22,000,000 shares of the Company’s common stock. Terms of exercise and expiration of options/securities granted under the 2006 Plan may be established at the discretion of the Board of Directors, but no option may be exercisable for more than ten years.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company recorded compensation expense related to employee stock options of $20,856 and $15,320 for the three months ended September 30, 2016 and 2015, respectively. The Company granted 35,000 and nil options during the three months ended September 30, 2016 and 2015, respectively. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of the options granted during the three months ended September 30, 2016 and 2015 were estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom" width="937"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width="184" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width="236" colspan="4"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Range,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width="184" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" width="184" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Range,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px" width="4"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="937"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">81</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">78%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">86%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="4" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="937"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="4" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="937"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">0.93</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">0.82%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="73">0.97%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="4" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="937"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected term (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">3.7</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73">3</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="73">4</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="17" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="17"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="167">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="4" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The expected volatility was based on the historical price volatility of the Company’s common stock. The dividend yield represents the Company’s anticipated cash dividend on common stock over the expected term of the stock options. The U.S. Treasury bill rate for the expected term of the stock options was utilized to determine the risk-free interest rate. The expected term of stock options represents the period of time the stock options granted are expected to be outstanding based upon management’s estimates.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A summary of option activity under the 2006 Plan for the three months ended September 30, 2016 is as follows:</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-LEFT: 2.5%; MARGIN-RIGHT: 2.5%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted-</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Price</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted-</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Life</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at July 1, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,225,537</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.79</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4.1</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">158,675</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">35,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at September 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,260,537</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.78</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">3.4</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">124,375</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at September 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,210,537</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.80</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3.4</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">111,875</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table presents information relating to nonvested stock options as of September 30, 2016:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Grant-Date Fair</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nonvested at July 1, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">50,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.76</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">35,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.45</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(35,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(0.45</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nonvested at September 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">50,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.76</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The total fair value of stock options that vested during the three months ended September 30, 2016 and 2015 was $15,900 and nil, respectively. As of September 30, 2016, the Company had $4,957 of unrecognized compensation cost related to stock options.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock-based employee compensation charges in operating expenses in the Company’s financial statements for the three months ended September 30, 2016 and 2015 are as follows: </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">General and administrative:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock options expensed</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">16,495</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,838</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">16,495</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1,838</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Research and development:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock options expensed</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,361</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">13,482</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,361</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">13,482</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> </table> </div></div>

60000

23544122

22289077

23544122

22289077

xbrli:shares iso4217:USD thunderdome:item xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0000875729 bnet:ExtensionAgreementOneMember us-gaap:ChiefExecutiveOfficerMember 2012-01-01 2013-12-31 0000875729 bnet:PennvestLoanMember 2012-07-01 2016-09-30 0000875729 us-gaap:SeriesBPreferredStockMember 2014-07-01 2014-07-02 0000875729 2014-07-01 2015-06-30 0000875729 bnet:PropertyPlantAndEquipmentOfPA1Member 2014-07-01 2015-06-30 0000875729 us-gaap:SeriesBPreferredStockMember 2014-07-01 2015-06-30 0000875729 bnet:ExtensionAgreementOneMember us-gaap:PresidentMember 2014-09-01 2014-09-30 0000875729 bnet:PennvestLoanMember 2014-09-25 2014-09-25 0000875729 bnet:StockBonusMember bnet:ExecutiveViceChairmanMember 2015-02-10 2015-02-10 0000875729 bnet:StockBonusMember us-gaap:PresidentMember 2015-02-10 2015-02-10 0000875729 us-gaap:PresidentMember 2015-02-10 2015-02-10 0000875729 2015-07-01 2015-09-30 0000875729 us-gaap:ConvertibleDebtSecuritiesMember 2015-07-01 2015-09-30 0000875729 bnet:ConvertiblePreferredStockAntidilutiveSecuritiesMember 2015-07-01 2015-09-30 0000875729 us-gaap:EmployeeStockOptionMember 2015-07-01 2015-09-30 0000875729 us-gaap:WarrantMember 2015-07-01 2015-09-30 0000875729 us-gaap:EmployeeStockOptionMember 2015-07-01 2015-09-30 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2015-07-01 2015-09-30 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2015-07-01 2015-09-30 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2015-07-01 2015-09-30 0000875729 bnet:PennvestLoanMember 2015-07-01 2015-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2015-07-01 2015-09-30 0000875729 us-gaap:GeneralAndAdministrativeExpenseMember 2015-07-01 2015-09-30 0000875729 us-gaap:ResearchAndDevelopmentExpenseMember 2015-07-01 2015-09-30 0000875729 2015-07-01 2016-06-30 0000875729 bnet:PropertyPlantAndEquipmentOfPA1Member 2015-07-01 2016-06-30 0000875729 us-gaap:SeriesBPreferredStockMember 2015-07-01 2016-06-30 0000875729 bnet:ExecutiveViceChairmanMember 2015-07-01 2016-09-30 0000875729 bnet:Fy2016ExtensionAgreementMember us-gaap:PresidentMember 2015-10-01 2015-10-31 0000875729 bnet:ExerciseBonusMember bnet:CeoAndPresidentMember 2016-01-01 2016-09-30 0000875729 bnet:ExtensionBonusMember bnet:Fy2016ExtensionAgreementMember us-gaap:PresidentMember 2016-01-05 2016-01-05 0000875729 bnet:SubscriptionAgreementMember bnet:VariousWarrantHoldersMember 2016-06-30 2016-06-30 0000875729 2016-07-01 2016-09-30 0000875729 bnet:SubscriptionsReceivableMember us-gaap:RestrictedStockMember 2016-07-01 2016-09-30 0000875729 us-gaap:ConvertibleDebtSecuritiesMember 2016-07-01 2016-09-30 0000875729 bnet:ConvertiblePreferredStockAntidilutiveSecuritiesMember 2016-07-01 2016-09-30 0000875729 us-gaap:EmployeeStockOptionMember 2016-07-01 2016-09-30 0000875729 us-gaap:WarrantMember 2016-07-01 2016-09-30 0000875729 us-gaap:EmployeeStockOptionMember 2016-07-01 2016-09-30 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2016-07-01 2016-09-30 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2016-07-01 2016-09-30 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2016-07-01 2016-09-30 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2016-07-01 2016-09-30 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:WeightedAverageMember 2016-07-01 2016-09-30 0000875729 bnet:ExerciseBonusMember bnet:CeoAndPresidentMember 2016-07-01 2016-09-30 0000875729 bnet:StockBonusMember bnet:ExtensionAgreementTwoMember us-gaap:ChiefExecutiveOfficerMember 2016-07-01 2016-09-30 0000875729 bnet:StockBonusMember us-gaap:MaximumMember us-gaap:ChiefExecutiveOfficerMember 2016-07-01 2016-09-30 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2016-07-01 2016-09-30 0000875729 bnet:PennvestLoanMember 2016-07-01 2016-09-30 0000875729 bnet:PennvestLoanMember bnet:AmortizationOfPrincipalNumberOfYearsMember 2016-07-01 2016-09-30 0000875729 bnet:PennvestLoanMember bnet:InterestOnlyPaymentsNumberOfYearsMember 2016-07-01 2016-09-30 0000875729 bnet:PennvestLoanMember bnet:YearsOneThroughFiveMember 2016-07-01 2016-09-30 0000875729 bnet:PennvestLoanMember bnet:YearsSixThroughMaturityMember 2016-07-01 2016-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2016-07-01 2016-09-30 0000875729 us-gaap:GeneralAndAdministrativeExpenseMember 2016-07-01 2016-09-30 0000875729 us-gaap:ResearchAndDevelopmentExpenseMember 2016-07-01 2016-09-30 0000875729 us-gaap:MaximumMember 2016-07-01 2016-09-30 0000875729 us-gaap:MinimumMember 2016-07-01 2016-09-30 0000875729 us-gaap:SeriesBPreferredStockMember 2016-07-01 2016-09-30 0000875729 us-gaap:AdditionalPaidInCapitalMember 2016-07-01 2016-09-30 0000875729 us-gaap:CommonStockMember 2016-07-01 2016-09-30 0000875729 us-gaap:NoncontrollingInterestMember 2016-07-01 2016-09-30 0000875729 us-gaap:RetainedEarningsMember 2016-07-01 2016-09-30 0000875729 bnet:SubscriptionAgreementMember 2016-07-01 2016-09-30 0000875729 bnet:SubscriptionAgreementMember bnet:VariousWarrantHoldersMember 2016-07-01 2016-09-30 0000875729 bnet:SubscriptionAgreementTwoMember 2016-07-01 2016-09-30 0000875729 us-gaap:ChiefExecutiveOfficerMember 2016-07-01 2016-09-30 0000875729 bnet:ConsultantsMember 2016-07-01 2016-09-30 0000875729 bnet:FormerEmployee1Member 2016-07-01 2016-09-30 0000875729 bnet:IndividualEmployeeMember 2016-07-01 2016-09-30 0000875729 bnet:PropertyPlantAndEquipmentOfPA1Member 2016-09-30 2016-09-30 0000875729 us-gaap:SubsequentEventMember 2016-10-01 2016-11-11 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:SubsequentEventMember 2016-10-10 2016-10-10 0000875729 bnet:StockBonusMember us-gaap:SubsequentEventMember bnet:EmployeesAndConsultantsMember 2016-10-10 2016-10-10 0000875729 bnet:StockBonusMember us-gaap:SubsequentEventMember us-gaap:PresidentMember 2016-10-10 2016-10-10 0000875729 us-gaap:SubsequentEventMember 2016-10-10 2016-10-10 0000875729 us-gaap:SubsequentEventMember us-gaap:PresidentMember 2016-10-10 2016-10-10 0000875729 us-gaap:SubsequentEventMember bnet:AnEmployeeMember 2016-11-09 2016-11-09 0000875729 us-gaap:SubsequentEventMember us-gaap:ChiefExecutiveOfficerMember 2016-11-09 2016-11-09 0000875729 us-gaap:SubsequentEventMember us-gaap:PresidentMember 2016-11-09 2016-11-09 0000875729 2009-01-26 0000875729 bnet:StockBonusMember us-gaap:ChiefExecutiveOfficerMember 2013-05-15 0000875729 2013-12-31 0000875729 bnet:ExtensionAgreementOneMember us-gaap:ChiefExecutiveOfficerMember 2013-12-31 0000875729 us-gaap:SeriesBPreferredStockMember 2014-07-02 0000875729 bnet:PA1Member 2014-09-25 0000875729 bnet:MrBassaniMember us-gaap:ConvertibleDebtMember 2014-12-31 0000875729 bnet:MrBassaniMember us-gaap:ConvertibleDebtMember us-gaap:ChiefExecutiveOfficerMember 2014-12-31 0000875729 bnet:NewSmithNoteMember us-gaap:ConvertibleDebtMember us-gaap:PresidentMember 2014-12-31 0000875729 us-gaap:ChiefExecutiveOfficerMember 2014-12-31 0000875729 bnet:NewSmithNoteMember us-gaap:ConvertibleDebtMember us-gaap:PresidentMember 2015-02-10 0000875729 bnet:NewSmithNoteMember us-gaap:PresidentMember 2015-02-10 0000875729 us-gaap:PresidentMember 2015-02-10 0000875729 2015-06-30 0000875729 us-gaap:RestrictedStockMember bnet:SubscriptionAgreementMember 2015-06-30 0000875729 2015-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefExecutiveOfficerMember 2015-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefFinancialOfficerMember 2015-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ExecutiveVicePresidentMember 2015-09-30 0000875729 bnet:CashNoteMember us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000875729 2016-06-30 0000875729 bnet:PropertyPlantAndEquipmentOfPA1Member 2016-06-30 0000875729 us-gaap:SeriesAPreferredStockMember 2016-06-30 0000875729 us-gaap:SeriesBPreferredStockMember 2016-06-30 0000875729 us-gaap:SeriesCPreferredStockMember 2016-06-30 0000875729 us-gaap:AdditionalPaidInCapitalMember 2016-06-30 0000875729 us-gaap:CommonStockMember 2016-06-30 0000875729 us-gaap:NoncontrollingInterestMember 2016-06-30 0000875729 us-gaap:RetainedEarningsMember 2016-06-30 0000875729 bnet:SubscriptionAgreementMember bnet:VariousWarrantHoldersMember 2016-06-30 0000875729 2016-09-30 0000875729 us-gaap:EmployeeStockOptionMember 2016-09-30 0000875729 bnet:ExerciseBonusMember 2016-09-30 0000875729 us-gaap:RestrictedStockMember bnet:SubscriptionAgreementMember 2016-09-30 0000875729 us-gaap:RestrictedStockMember bnet:SubscriptionAgreementTwoMember 2016-09-30 0000875729 bnet:StockBonusMember bnet:StockBonusPayableUponStockPriceOf1000PerShareMember 2016-09-30 0000875729 bnet:StockBonusMember bnet:StockBonusPayableUponStockPriceOf2000PerShareMember 2016-09-30 0000875729 bnet:StockBonusMember bnet:StockBonusPayableUponStockPriceOf500PerShareMember 2016-09-30 0000875729 bnet:StockBonusMember us-gaap:ChiefExecutiveOfficerMember 2016-09-30 0000875729 bnet:CashNoteMember us-gaap:ChiefExecutiveOfficerMember 2016-09-30 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2016-09-30 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefExecutiveOfficerMember 2016-09-30 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefFinancialOfficerMember 2016-09-30 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember bnet:ExecutiveViceChairmanMember 2016-09-30 0000875729 bnet:MrBassaniMember 2016-09-30 0000875729 bnet:MrBassaniMember us-gaap:ConvertibleDebtMember 2016-09-30 0000875729 bnet:PennvestLoanMember 2016-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2016-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefExecutiveOfficerMember 2016-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefFinancialOfficerMember 2016-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ExecutiveVicePresidentMember 2016-09-30 0000875729 bnet:CenterpointMember 2016-09-30 0000875729 bnet:PropertyPlantAndEquipmentOfPA1Member 2016-09-30 0000875729 us-gaap:MaximumMember 2016-09-30 0000875729 us-gaap:MaximumMember bnet:EmployeesAndConsultantsMember 2016-09-30 0000875729 us-gaap:MinimumMember 2016-09-30 0000875729 us-gaap:MinimumMember bnet:EmployeesAndConsultantsMember 2016-09-30 0000875729 us-gaap:SeriesAPreferredStockMember 2016-09-30 0000875729 us-gaap:SeriesBPreferredStockMember 2016-09-30 0000875729 us-gaap:SeriesCPreferredStockMember 2016-09-30 0000875729 us-gaap:AdditionalPaidInCapitalMember 2016-09-30 0000875729 us-gaap:CommonStockMember 2016-09-30 0000875729 us-gaap:NoncontrollingInterestMember 2016-09-30 0000875729 us-gaap:RetainedEarningsMember 2016-09-30 0000875729 bnet:SubscriptionAgreementMember 2016-09-30 0000875729 bnet:SubscriptionAgreementTwoMember 2016-09-30 0000875729 us-gaap:ChiefExecutiveOfficerMember 2016-09-30 0000875729 bnet:ConsultantsMember 2016-09-30 0000875729 bnet:ExecutiveViceChairmanMember 2016-09-30 0000875729 bnet:FormerEmployee1Member 2016-09-30 0000875729 bnet:FormerEmployeeMember 2016-09-30 0000875729 bnet:IndividualEmployeeMember 2016-09-30 0000875729 us-gaap:PresidentMember 2016-09-30 0000875729 us-gaap:SubsequentEventMember 2016-10-10 0000875729 us-gaap:SubsequentEventMember us-gaap:ChiefExecutiveOfficerMember 2016-10-10 0000875729 us-gaap:SubsequentEventMember bnet:EmployeesAndConsultantsMember 2016-10-10 0000875729 us-gaap:SubsequentEventMember us-gaap:PresidentMember 2016-10-10 0000875729 us-gaap:SubsequentEventMember 2016-10-12 0000875729 us-gaap:SubsequentEventMember us-gaap:ChiefExecutiveOfficerMember 2016-10-12 0000875729 us-gaap:SubsequentEventMember us-gaap:PresidentMember 2016-10-12 0000875729 2016-11-03 0000875729 us-gaap:SubsequentEventMember bnet:AnEmployeeMember 2016-11-09 0000875729 us-gaap:SubsequentEventMember us-gaap:ChiefExecutiveOfficerMember 2016-11-09 0000875729 us-gaap:SubsequentEventMember us-gaap:PresidentMember 2016-11-09

EX-101.SCH 7 bnet-20160930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Changes in Equity (Deficit) (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Organization, Nature of Business, Going Concern and Management's Plans link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Property and Equipment link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Deferred Compensation link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Loan Payable link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Convertible Notes Payable - Affiliates link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 2 - Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 3 - Property and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 7 - Stockholders' Equity (Tables) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 8 - Commitments and Contingencies (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 1 - Organization, Nature of Business, Going Concern and Management's Plans (Details Textual) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 2 - Significant Accounting Policies - Antidilutive Securities (Details) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 3 - Property and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 3 - Property and Equipment - Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 4 - Deferred Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 5 - Loan Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 6 - Convertible Notes Payable - Affiliates (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 7 - Stockholders' Equity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 7 - Stockholders' Equity - Black-scholes Valuation Assumptions for Options (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 7 - Stockholders' Equity - Stock Options Activity (Details) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 7 - Stockholders' Equity - Allocation of Recognized Period Costs (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 8 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 8 - Commitments and Contingencies - Summary of Outstanding Contingent Stock Bonuses (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 9 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 bnet-20160930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 bnet-20160930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 bnet-20160930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Interest expense, net Interest Expense Note To Financial Statement Details Textual Property, Plant and Equipment Disclosure [Text Block] statementsignificantaccountingpoliciespolicies us-gaap_IncreaseDecreaseInDeferredCompensation Increase in deferred compensation and convertible notes Risk-free interest rate statementnote2significantaccountingpoliciestables Property, Plant and Equipment [Table Text Block] statementnote3propertyandequipmenttables statementnote7stockholdersequitytables statementnote8commitmentsandcontingenciestables us-gaap_InterestExpenseDebt Interest Expense, Debt statementnote2significantaccountingpoliciesantidilutivesecuritiesdetails statementnote2significantaccountingpoliciesearningspersharebasicanddiluteddetails Volatility Consolidation, Policy [Policy Text Block] statementnote3propertyandequipmentpropertyandequipmentdetails statementnote7stockholdersequityblackscholesvaluationassumptionsforoptionsdetails statementnote7stockholdersequitystockoptionsactivitydetails statementnote7stockholdersequitynonvestedshareactivitydetails Expected term (years) statementnote7stockholdersequityallocationofrecognizedperiodcostsdetails us-gaap_ConvertibleNotesPayable Convertible Notes Payable statementnote8commitmentsandcontingenciessummaryofoutstandingcontingentstockbonusesdetails bnet_MonthlyOfficersCompensation Monthly Officer's Compensation This item represents the amount of compensation paid monthly to Officers of the Company. Notes To Financial Statements Extension Agreement One [Member] This item represents the first extension agreement. Notes To Financial Statements [Abstract] Increase in accounts payable and accrued expenses Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $30,500 and $30,000, respectively (Note 7) Significant Accounting Policies [Text Block] us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Total deficit Balances Balances us-gaap_PolicyTextBlockAbstract Accounting Policies Accounting Policies [Abstract] Extension Agreement Two [Member] This item represents the second extension agreement. us-gaap_RepaymentsOfLongTermDebt Repayments of Long-term Debt us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Exercisable, aggregate intrinsic value us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Exercisable, weighted-average exercise price (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 Exercisable, weighted-average remaining contractual life us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Exercisable, options (in shares) Outstanding, aggregate intrinsic value Outstanding, aggregate intrinsic value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Granted, weighted-average grant-date fair value (in dollars per share) Operating expenses: General and Administrative Expense [Member] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 Outstanding, weighted-average remaining contractual life Revenue us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Nonvested, weighted-average grant-date fair value (in dollars per share) Nonvested, weighted-average grant-date fair value (in dollars per share) Deposits and other receivables Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Vested, weighted-average grant-date fair value (in dollars per share) us-gaap_SharesOutstanding Balances (in shares) Balances (in shares) Common stock, outstanding (in shares) us-gaap_ConstructionLoan Construction Loan us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Nonvested (in shares) Nonvested (in shares) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Vested (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding, weighted-average exercise price, beginning balance (in dollars per share) Outstanding, weighted-average exercise price, ending balance (in dollars per share) Receivable Type [Axis] Receivable [Domain] Cash Cash at beginning of period Cash at end of period Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Granted, weighted-average exercise price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Income Statement Location [Domain] Research and Development Expense [Member] Weighted Average [Member] Income Statement Location [Axis] Maximum [Member] Minimum [Member] Range [Axis] Range [Domain] us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Stock Bonus [Member] This item represent bonuses given in stock. us-gaap_DividendsPreferredStock Dividends, Preferred Stock us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Proceeds from sale of units This item represents the cash inflow related to the sale of units. us-gaap_AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued us-gaap_IncreaseDecreaseInPrepaidExpense Increase in prepaid expenses us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Loan payable and accrued interest (Note 5) Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer, including accrued interest and late charges. us-gaap_EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Equity Issuances Warrants Policy [Policy Text Block] Disclosure of accounting policy for its outstanding warrants. us-gaap_LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value Plan Name [Axis] Plan Name [Domain] Basic and diluted (in shares) us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive securities (in shares) us-gaap_SharePrice Share Price us-gaap_IncreaseDecreaseInReceivables Decrease in subscription receivable us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share) us-gaap_DebtDefaultLongtermDebtAmount Debt Instrument, Debt Default, Amount bnet_AccruedInterestAndLateChargesPayable Accrued Interest and Late Charges Payable The carrying amount of accrued interest and late charges payable to lender. Award Type [Axis] Equity Award [Domain] bnet_WorkingCapital Working Capital This item represents the capital available for operations for the Company. Subscriptions Receivable [Member] This item represents the subscriptions of shares that have not yet been fulfilled. bnet_ContingentStockBonusOutstandingSharesCanceledDuringPeriod Contingent Stock Bonus, Outstanding Shares, Canceled During Period The number of contingent stock bonus shares that have been canceled during the period. Subscription Agreement [Member] This item represents transactions occurring related to a subscription agreement. Contingent Consideration by Type [Axis] Conversion of debt (in shares) Contingent Consideration Type [Domain] Scenario, Unspecified [Domain] bnet_DeferredCompensationMaximumConvertibleAmount Deferred Compensation, Maximum Convertible Amount The maximum amount of deferred compensation that is deemed to be convertible. Basic weighted average shares – end of period (in shares) Conversion of debt Scenario [Axis] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Centerpoint [Member] This item represents the separate legal entity of Centerpoint. Disclosure of Compensation Related Costs, Share-based Payments [Text Block] bnet_DeferredCompensationStockConversionPricePerShare Deferred Compensation, Stock Conversion, Price Per Share The price per share in which an individual can convert their deferred compensation. Various Warrant Holders [Member] Represents various holders of the company's warrant. Vesting of options for services Convertible Preferred Stock Antidilutive Securities [Member] This item represents the convertible preferred stock securities that have been excluded from the computation of earnings per share. Fair Value Measurement, Policy [Policy Text Block] bnet_ClassOfWarrantOrRightIssuedDuringPeriod Class of Warrant or Right Issued During Period The number of warrants or rights issued during period. Statement [Table] Litigation Case [Domain] Litigation Case [Axis] Commitments and Contingencies Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Earnings Per Share, Policy [Policy Text Block] us-gaap_NetIncomeLossAttributableToNoncontrollingInterest Net loss attributable to the noncontrolling interest Granted, options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Income Statement [Abstract] Sale of Stock [Axis] bnet_AdjustmentForDeferredCompensationDuringThePeriod Adjustment for Deferred Compensation During the Period The adjustment for deferred compensation based on periodical evaluation. Sale of Stock [Domain] Issuance of common stock for services (in shares) Stock Issued During Period, Shares, Issued for Services us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used by investing activities CASH FLOWS FROM FINANCING ACTIVITIES Sale of common stock (in shares) Stock Issued During Period, Shares, New Issues Issuance of common stock for services Stock Issued During Period, Value, Issued for Services Sale of common stock Stock Issued During Period, Value, New Issues us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and deficit Accumulated deficit Chief Executive Officer [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Chief Financial Officer [Member] President [Member] Executive Vice President [Member] Convertible Debt [Member] Title of Individual [Axis] Relationship to Entity [Domain] Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Shares Outstanding under Contingent Stock Bonuses Plan by Target Price Per Share [Table Text Block] Tabular disclosure of Outstanding Contingent Stock Bonuses. Convertible notes payable - affiliates (Note 6) Convertible Notes Payable, Noncurrent us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights us-gaap_DividendsPayableCurrentAndNoncurrent Dividends Payable us-gaap_ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding Accrued interest on loan payable, deferred compensation and other us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Series B Preferred Stock [Member] Series C Preferred Stock [Member] Series A Preferred Stock [Member] Total current liabilities bnet_SharesHeldBySubsidiaries Shares Held by Subsidiaries Shares held by subsidiaries (Note 7) (in shares) Number of shares held by subsidiaries. us-gaap_DueToRelatedPartiesCurrent Due to Related Parties, Current Weighted average shares for fully vested stock bonuses (in shares) This item represents the weighted average shares outstanding for fully vested stock bonuses. Deficit: us-gaap_ProceedsFromCollectionOfNotesReceivable Proceeds from Collection of Notes Receivable bnet_ComputersAndOfficeEquipmentGross Computers and office equipment This item represents the gross amount computers and office equipment held by the Company. Class of Stock [Axis] Class of Stock [Domain] bnet_AccruedInterestOnDeferredCompensationAndOtherExpenses Accrued Interest on Deferred Compensation and Other Expenses This item represents the interest accrued on deferred compensation. bnet_InterestRateOnDeferredCompensation Interest Rate on Deferred Compensation This item represents the interest rate that is accrued on deferred compensation. Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Supplemental disclosure of cash flow information: us-gaap_ShareBasedCompensation Stock-based compensation Deferred compensation (Note 4) Deferred Compensation Liability, Current us-gaap_DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price Revenue Recognition, Policy [Policy Text Block] Common stock, no par value, 100,000,000 shares authorized, 23,761,168 and 23,573,057 shares issued, respectively; 23,056,859 and 22,868,748 shares outstanding, respectively us-gaap_TableTextBlock Notes Tables Common stock, issued (in shares) Common stock, authorized (in shares) Amendment Flag Depreciation Depreciation Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Common stock, par value (in dollars per share) Sale of units Sale of Units, Value Represents the equity impact of units issued during the period. us-gaap_CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance Sale of units (in shares) Sale of Units, Number Of Units Issued Number of units issued pursuant to a subscription agreement. Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] us-gaap_AssetsCurrent Total current assets us-gaap_DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period us-gaap_NonoperatingIncomeExpense Total other expense EX-101.PRE 11 bnet-20160930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Sep. 30, 2016	Nov. 03, 2016
Document Information [Line Items]
Entity Registrant Name	BION ENVIRONMENTAL TECHNOLOGIES INC
Entity Central Index Key	0000875729
Trading Symbol	bnet
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		23,058,996
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML 13 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2016	Jun. 30, 2016
Series B Preferred Stock [Member]
Current liabilities:
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $30,500 and $30,000, respectively (Note 7)	$ 27,900	$ 27,400
Series A Preferred Stock [Member]
Deficit:
Preferred stock, value	0	0
Series C Preferred Stock [Member]
Deficit:
Preferred stock, value	0	0
Cash	64,418	170,194
Prepaid expenses	15,901	15,240
Subscription receivable		7,500
Deposits and other receivables	1,000	1,000
Total current assets	81,319	193,934
Property and equipment, net (Note 3)	3,757	4,259
Total assets	85,076	198,193
Accounts payable and accrued expenses	818,133	768,272
Deferred compensation (Note 4)	1,657,541	1,436,595
Loan payable and accrued interest (Note 5)	8,621,827	8,563,662
Total current liabilities	11,125,401	10,795,929
Convertible notes payable - affiliates (Note 6)	3,311,988	3,280,647
Total liabilities	14,437,389	14,076,576
Common stock, no par value, 100,000,000 shares authorized, 23,761,168 and 23,573,057 shares issued, respectively; 23,056,859 and 22,868,748 shares outstanding, respectively	0	0
Additional paid-in capital	102,434,634	102,278,364
Accumulated deficit	(116,846,159)	(116,216,493)
Total Bion's stockholders’ deficit	(14,411,525)	(13,938,129)
Noncontrolling interest	59,212	59,746
Total deficit	(14,352,313)	(13,878,383)
Total liabilities and deficit	$ 85,076	$ 198,193

XML 14 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)	Sep. 30, 2016	Jun. 30, 2016
Series B Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	50,000	50,000
Preferred stock, issued (in shares)	200	200
Preferred stock, outstanding (in shares)	200	200
Preferred stock, liquidation preference	$ 30,500	$ 30,000
Series A Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	10,000	10,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Series C Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	60,000	60,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, authorized (in shares)	100,000,000	100,000,000
Common stock, issued (in shares)	23,761,168	23,573,057
Common stock, outstanding (in shares)	23,056,859	22,868,748

XML 15 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Revenue
Operating expenses:
General and administrative (including stock-based compensation (Note 7))	424,691	507,905
Depreciation	502	75,879
Research and development (including stock-based compensation (Note 7))	112,243	134,489
Total operating expenses	537,436	718,273
Loss from operations	(537,436)	(718,273)
Other expense:
Interest expense, net	92,764	114,756
Total other expense	92,764	114,756
Net loss	(630,200)	(833,029)
Net loss attributable to the noncontrolling interest	534	1,295
Net loss applicable to Bion's common stockholders	$ (629,666)	$ (831,734)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share)	$ (0.03)	$ (0.04)
Basic and diluted (in shares)	23,544,122	22,289,077

XML 16 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Changes in Equity (Deficit) (Unaudited) - 3 months ended Sep. 30, 2016 - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Balances (in shares) at Jun. 30, 2016	23,573,057
Balances at Jun. 30, 2016		$ 102,278,364	$ (116,216,493)	$ 59,746	$ (13,878,383)
Issuance of common stock for services (in shares)	20,492				20,492
Issuance of common stock for services		16,556			$ 16,556
Vesting of options for services		20,856			$ 20,856
Sale of common stock (in shares)	30,467				30,467
Sale of common stock		22,850			$ 22,850
Sale of units (in shares)	120,000
Sale of units		90,000			90,000
Warrants exercised for common stock (in shares)	10,000
Warrants exercised for common stock
Conversion of debt (in shares)	7,152
Conversion of debt		6,008			6,008
Net loss			(629,666)	(534)	(630,200)
Balances (in shares) at Sep. 30, 2016	23,761,168
Balances at Sep. 30, 2016		$ 102,434,634	$ (116,846,159)	$ 59,212	$ (14,352,313)

XML 17 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (630,200)	$ (833,029)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	502	75,879
Accrued interest on loan payable, deferred compensation and other	101,560	114,969
Stock-based compensation	37,412	41,272
Increase in prepaid expenses	(661)	(3,914)
Increase in accounts payable and accrued expenses	49,861	34,429
Increase in deferred compensation and convertible notes	215,400	227,400
Net cash used in operating activities	(226,126)	(342,994)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(3,260)
Net cash used by investing activities		(3,260)
CASH FLOWS FROM FINANCING ACTIVITIES
Decrease in subscription receivable	7,500	13,125
Proceeds from sale of common stock	22,850
Proceeds from sale of units	90,000
Proceeds from exercise of warrants		174,189
Net cash provided by financing activities	120,350	187,314
Net decrease in cash	(105,776)	(158,940)
Cash at beginning of period	170,194	339,286
Cash at end of period	64,418	180,346
Supplemental disclosure of cash flow information:
Cash paid for interest
Non-cash investing and financing transactions:
Issuance of common stock to satisfy deferred compensation	6,008	171,717
Exercise of warrants for promissory note receivable for shares		$ 105,000

XML 18 R7.htm IDEA: XBRL DOCUMENT

Note 1 - Organization, Nature of Business, Going Concern and Management's Plans	3 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENT’S PLANS: Organization and nature of business: Bion Environmental Technologies, Inc. (“Bion” or “We” or the “Company”) was incorporated in 1987 in the State of Colorado and has developed and continues to develop patented and proprietary technology and business models that provide comprehensive environmental solutions to a significant source of pollution in United States agriculture, large scale livestock facilities known as Confined Animal Feeding Operations (“CAFO’s”). Bion’s technologies (and applications related thereto) produce substantial reductions of nutrient releases (primarily nitrogen and phosphorus) to both water and air (including ammonia, which is subsequently re-deposited to the ground) from livestock waste streams based upon our operations and research to date (and third party peer review thereof). We are continually involved in research and development to upgrade and improve our technology and technology applications, including integration with third party technology. Bion provides comprehensive and cost-effective treatment of livestock waste onsite (and/or at nearby locations), while it is still concentrated and before it contaminates air, soil, groundwater aquifers and/or downstream waters, and, in certain configurations, can be optimized to maximize recovery of marketable nutrients for potential use as fertilizer (organic and/or inorganic) and/or feed additives plus renewable energy (and related environmental credits). During the 2014 to 2016 fiscal years, the Company increased its research and development focus on augmenting the basic ‘separate and aggregate’ approach of its technology platform to provide additional flexibility and to increase recovery of marketable nutrient by-products (in organic and non-organic forms) and renewable energy production (either/both biogas and/or renewable electricity), thereby increasing potential related revenue streams and reducing dependence of its future projects on the monetization of nutrient reductions (which still remain a very important part of project revenue streams). This research and development effort also involves ongoing review of potential “add-ons” and applications to our technology platform for use in different regulatory and/or climate environments. These research and development activities have targeted completion of development of the next generation of Bion’s technology and technology platform. We believe such activities will continue at least through the 2017 fiscal year, subject to availability of adequate financing for the Company’s operations, of which there is no assurance. Currently, Bion is focused on using applications of its patented and proprietary waste management technologies and technology platform to pursue three main business opportunities: 1) installation of Bion systems ( some of which may generate verified nutrient credits and revenues from the production of renewable energy and byproducts) to retrofit and environmentally remediate existing CAFOs (“Retrofits”) in selected markets where: a) government policy supports such efforts (such as the Chesapeake Bay watershed, some Great Lakes Basin states, and/or other states and watersheds facing EPA ‘total maximum daily load’ (“TMDL”) issues, and/or b) where CAFO’s need our technology to obtain permits to expand or develop without negative environmental consequences; 2) development of new state-of-the-art large scale waste treatment facilities in strategic locations (“Projects”) ( some of these may be Integrated Projects as described below) with multiple revenue streams, and 3) licensing and/or joint venturing of Bion’s technology and applications (primarily) outside North America. The opportunities described at 1) and 2) above each require substantial political and regulatory (federal, state and local) efforts on the part of the Company and a substantial part of Bion’s efforts are focused on such political and regulatory matters. Bion is currently pursuing the international opportunities primarily through the use of consultants with existing relationships in target locations. The most intense focus is currently on the requirements for the clean-up of the Chesapeake Bay faced by the Commonwealth of Pennsylvania and the potential use of Bion’s technology and technology platform on CAFOs as an alternative to what the Company believes is far more expensive nutrient removal downstream in storm water projects. Management believes that Bion’s technology platform (including utilization of various third party technologies to supplement the Company’s proprietary technologies), through the combination of remediation of the waste streams of large scale existing CAFOs with recovery of valuable marketable nutrients and renewable energy, can enable the integration of large-scale CAFO’s and their end-product users, renewable energy production from the CAFO waste stream, on site utilization of the renewable energy generated and biofuel/ethanol production in an environmentally and economically sustainable manner while reducing the aggregate capital expense, operating costs and environmental footprint for the entire integrated complex (“Integrated Projects”). In the context of Integrated Projects, Bion’s waste treatment process, in addition to mitigating polluting releases, enables generation of renewable energy from the CAFO waste stream, which renewable energy can be sold into renewable energy markets (with material economic incentives) and/or utilized by integrated facilities including ethanol plants, CAFO end-product processors (including cheese, ice cream and/or bottling plants in the case of dairy CAFO’s and/or slaughter and/or processing facilities in the context of beef and/or swine CAFO’s) and/or other users as a fossil fuel replacement. The nutrients (primarily nitrogen and phosphorus) can be harvested from the solids and liquid streams recovered from the livestock waste stream and can be utilized as either high value fertilizer (organic and/or inorganic) and/or the basis for high protein animal feed and the nutrient rich effluent can potentially be utilized in integrated hydroponic agriculture and/or field applied as fertilizer. Bion believes that its large scale Projects (including Integrated Projects) will produce high quality, traceable animal protein which can address consumer food safety/security concerns at a lower cost than current industry practices while also maintaining a far lower net environmental footprint per unit of protein produced due to water recycling (possible due to the removal of nutrients, etc. from the water by Bion’s technology applications), production of renewable energy from the waste stream (reducing the use of fossil fuels), and multiple levels of economies of scale, co-location and integration savings in transportation and other logistics. Projects may involve various degrees of integration which will limit the benefits described herein. During 2008 the Company commenced actively pursuing the opportunity presented by environmental retrofit and remediation of the waste streams of existing CAFOs which effort has met with very limited success to date. The first commercial activity in this area is represented by our agreement with Kreider Farms (“KF”), pursuant to which the Kreider 1 system to treat KF's dairy waste streams to reduce nutrient releases to the environment while generating marketable nutrient credits and renewable energy was designed, constructed and entered full-scale operation during 2011. On January 26, 2009 the Board of the Pennsylvania Infrastructure Investment Authority (“Pennvest”) approved a $7.75 million loan to Bion PA 1, LLC (“PA1”), a wholly-owned subsidiary of the Company, for the initial Kreider Farms project (“Kreider 1 System”). After substantial unanticipated delays, on August 12, 2010 PA1 received a permit for construction of the Kreider 1 system. Construction activities commenced during November 2010. The closing/settlement of the Pennvest Loan took place on November 3, 2010. PA1 finished the construction of the Kreider 1 System and entered a period of system ‘operational shakedown’ during May 2011. The Kreider 1 System reached full, stabilized operation by the end of the 2012 fiscal year. During 2011 the Pennsylvania Department of Environmental Protection (“PADEP”) re-certified the nutrient credits for this project. The PADEP issued final permits for the Kreider 1 System (including the credit verification plan) on August 1, 2012 on which date the Company deemed that the Kreider System was ‘placed in service’. As a result, PA1 commenced generating nutrient reduction credits for potential sale while continuing to utilize the Kreider 1 system to test improvements and add-ons. However, to date liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth, which limited liquidity/depth has negatively impacted Bion’s business plans and has resulted in challenges to monetizing the nutrient reductions created by PA1’s existing Kreider 1 project and Bion’s other proposed projects. These difficulties have prevented PA1 from generating any material revenues from the Kreider 1 project to date and raise significant questions as to when, if ever, PA1 will be able to generate such revenues from the Kreider 1 system. PA1 has had sporadic discussions/negotiations with Pennvest related to forbearance and/or re-structuring its obligations pursuant to the Pennvest Loan for more than three years. In the context of such discussions/negotiations, PA1 elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of September 30, 2016. Due to the failure of the Pennsylvania nutrient reduction credit market to develop, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, PA1 and the Company recorded impairments related to the value of the Kreider 1 assets totaling $3,750,000 through June 30, 2015. During the 2016 fiscal year, effective June 30, 2016, PA1 and the Company recorded an impairment of $1,684,562 to the value of the Kreider 1 assets which reduced the value on the Company’s books to $0. This impairment reflects management’s judgment that the salvage value of the Kreider 1 assets roughly equals PA1’s contractual obligations related to the Kreider 1 system, including expenses related to decommissioning of the Kreider 1 system, costs associated with needed capital upgrade expenses, and re-certification/ permitting amendments. On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and accelerated the Pennvest Loan and demanded that PA1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA1 did not make the payment and does not have the resources to make the payments demanded by Pennvest. PA1 has commenced discussions and negotiations with Pennvest concerning this matter but Pennvest has rejected PA1’s proposal made during the fall of 2014. No formal proposals are under consideration and only sporadic communication has taken place regarding the matters involved over the last 18 months. It is not possible at this date to predict the outcome of such this matter, but the Company believes that a loan modification agreement may be reached in the future if/when a more robust market for nutrient reductions develops in Pennsylvania, of which there is no assurance. PA1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days. During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the ‘technology guaranty’ standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan has been (and is now) solely an obligation of PA1 since that date. The economics (potential revenues, profitability and continued operation) of the Kreider 1 System are based almost entirely on the long term sale of nutrient (nitrogen and/or phosphorus) reduction credits to meet the requirements of the Chesapeake Bay environmental clean-up. On May 5, 2016, Bion PA2 LLC (“PA2”) executed a stand-alone joint venture agreement with Kreider Farms covering all matters related to development and operation of a system to treat the waste streams from Kreider’s poultry facilities (“Kreider 2”). The Kreider projects are owned and operated by Bion through separate subsidiaries, in which Kreider has the option to acquire a noncontrolling interest. S ubstantial capital (equity and/or debt) has been and will continue to be expended on these projects. Additional funds will be required for continuing operations and additional capital expenditures for upgrades at Kreider 1 until sufficient revenues can be generated, of which there is no assurance. The Company anticipates that the Kreider 1 project will generate revenue primarily from the sale of nutrient reduction (and/or other) environmental credits. A portion of Bion’s research and development activities has taken place at the Kreider 1 facility. Kreider 2 (not yet constructed) (and most future Projects) will be developed using Bion’s 3G Tech to recover substantial marketable nutrients and renewable energy to supplement its revenue from nutrient reductions. The Company believes that the proceeds from multiple byproduct streams including i) fertilizer (organic and non-organic) and/or feed additives and ii) renewable energy (and related credits) can be reasonably projected to generate, in aggregate, revenue streams that, in certain circumstances, may exceed 50% of total revenues from such Project(s). To date the market for long-term nutrient reduction credits in Pennsylvania has been very slow to develop and the Company’s activities have been negatively affected by the lack of such development. Kreider 2 development work and technology evaluation, including execution of a stand-alone joint venture agreement, amended credit certification and discussions with potential joint venture partners, continues, which Project primarily relates to treatment of the wastes from Kreider’s poultry operations. Assuming there are positive developments related to the market for nutrient reductions in Pennsylvania, the Company intends to pursue development, design and construction of the Kreider 2 poultry waste/renewable energy project with a goal of achieving operational status during calendar year 2017. However, as discussed above, this Project faces challenges related to the current limits of the existing nutrient reduction market and funding of technology-based, verifiable agricultural nutrient reductions which are anticipated to constitute the largest share of its revenues. A significant portion of Bion’s activities concern efforts with private and public stakeholders (at local and state level) in Pennsylvania (and other Chesapeake Bay and Midwest and Great Lakes states) and at the federal level (the Environmental Protection Agency (“EPA”) and the Department of Agriculture (“USDA”) (and other executive departments) and Congress) to establish appropriate public policies which will create regulations and funding mechanisms that foster installation of the low cost environmental solutions that Bion (and others) can provide through clean-up of agricultural waste streams. The Company anticipates that such efforts will continue in Pennsylvania and other Chesapeake Bay watershed states throughout the next 12 months and in various additional states thereafter. Going concern and management’s plans: The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has not generated significant revenues and has incurred net losses (including significant non-cash expenses) of approximately $4,522,000 and $5,642,000 during the years ended June 30, 2016 and 2015, respectively and a net loss of approximately $630,000 during the three months ended September 30, 2016. At September 30, 2016, the Company has a working capital deficit and a stockholders’ deficit of approximately $11,044,000 and $14,412,000, respectively. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability or classification of assets or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. The following paragraphs describe management’s plans with regard to these conditions. The Company continues to explore sources of additional financing (including potential agreements with strategic partners –both financial and ag-industry) to satisfy its current and future operating and capital expenditure requirements as it is not currently generating any significant revenues. During the year ended June 30, 2016 the Company received total proceeds of $760,604 from the sale of its debt and equity securities. Proceeds during the 2016 fiscal year have been lower than in earlier years which reduction has negatively impacted the Company’s business development efforts. During the three months ended September 30, 2016, the Company received $112,850 from the sale of its debt and equity securities. During fiscal years 2016 and 2015 and through the three months ended September 30, 2016, the Company experienced greater difficulty in raising equity funding than in the prior years. As a result, the Company faced, and continues to face, significant cash flow management challenges due to working capital constraints. To partially mitigate these working capital constraints, the Company’s core senior management and several key employees and consultants have been deferring (and continue to defer) all or part of their cash compensation and/or are accepting compensation in the form of securities of the Company (Notes 4 and 6) and members of the Company’s senior management have made loans to the Company. Additionally, the Company made reductions in its personnel during the year ended June 30, 2014. The constraint on available resources has had, and continues to have, negative effects on the pace and scope of the Company’s efforts to develop its business. The Company has had to delay payment of trade obligations and has had to economize in many ways that have potentially negative consequences. If the Company does not have greater success in its efforts to raise needed funds during the 2017 fiscal year (and subsequent periods), management will need to consider deeper cuts (including additional personnel cuts) and curtailment of operations (including possibly Kreider 1 operations) and/or research and development activities. The Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Projects (including Integrated Projects) (including the Kreider 2 facility) and CAFO Retrofit waste remediation systems and to continue to operate the Kreider 1 facility. The Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more debt and/or equity through joint ventures, strategic partnerships and/or sale of its equity securities (common, preferred and/or hybrid) and/or debt (including convertible) securities, and/or through use of ‘rights’ and/or warrants (new and/or existing) during the next twelve months. However, as discussed above, there is no assurance, especially in light of the difficulties the Company has experienced in recent periods and the extremely unsettled capital markets that presently exist (especially for companies like us), that the Company will be able to obtain the funds that it needs to stay in business, complete its technology development or to successfully develop its business and Projects. There is no realistic likelihood that funds required during the next twelve months or in the periods immediately thereafter for the Company’s basic operations and/or proposed Projects will be generated from operations. Therefore, the Company will need to raise sufficient funds from external sources such as debt or equity financings or other potential sources. The lack of sufficient additional capital resulting from the inability to generate cash flow from operations and/or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Further, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significantly dilutive effect on the Company’s existing shareholders. All of these factors have been exacerbated by the extremely limited and unsettled credit and capital markets presently existing for small companies like Bion.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Note 2 - Significant Accounting Policies

3 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Significant Accounting Policies [Text Block]

2. SIGNIFICANT ACCOUNTING POLICIES

Principles of consolidation:

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (“Projects Group”), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA1, and PA2; and its 58.9% owned subsidiary, Centerpoint Corporation (“Centerpoint”). All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at September 30, 2016, and the results of operations and cash flows of the Company for the three months ended September 30, 2016 and 2015. Operating results for the three months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the year ending June 30, 2017.

Property and equipment:

Warrants:

The Company has issued warrants to purchase common shares of the Company. Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Company’s value as of the date of the issuance, consideration of the Company’s limited liquid resources and business prospects, the market price of the Company’s stock in its mostly inactive public market and the historical valuations and purchases of the Company’s warrants. When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined.

Fair value measurements:

Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 3 – assets and liabilities whose significant value drivers are unobservable.

Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment.

Revenue Recognition:

The Company expects that technology license fees will be generated from the licensing of Bion’s integrated system. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company’s interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue.

Loss per share:

The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:

	September 30, 2016		September 30, 2015
Warrants		7,439,795		8,295,989
Options		4,260,537		4,413,870
Convertible debt		8,361,559		7,119,524
Convertible preferred stock		15,250		14,250

The following is a reconciliation of the denominators of the basic loss per share computations for the three months ended September 30, 2016 and 2015:

	Three months ended September 30, 2016			Three months ended September 30, 2015
Shares issued – beginning of period		23,573,057			22,089,650
Shares held by subsidiaries (Note 7)		(704,309	)		(704,309	)
Shares outstanding – beginning of period		22,868,748			21,385,341
Weighted average shares for fully vested stock bonuses		600,000			600,000
Weighted average shares issued during the period		75,374			303,736
Basic weighted average shares – end of period		23,544,122			22,289,077

Reclassifications:

Recent Accounting Pronouncements:

The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company’s financial statements properly reflect the change.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09 “Revenue from Contracts from Customers,” which supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605),” and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017 and earlier application is permitted only as of annual reporting periods beginning after December 15, 2016. The Company is currently evaluating the new standard and assessing the potential impact on its operations and financial statements.

In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern: Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted. The adoption of ASU No. 2014-15 did not have a material impact on the Company’s financial statements.

XML 20 R9.htm IDEA: XBRL DOCUMENT

Note 3 - Property and Equipment

3 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]

3. PROPERTY AND EQUIPMENT:

Property and equipment consists of the following:

	September 30, 2016			June 30, 2016
Machinery and equipment	$	2,222,670		$	2,222,670
Buildings and structures		401,470			401,470
Computers and office equipment		171,560			173,313
		2,795,700			2,797,453
Less accumulated depreciation		(2,791,943	)		(2,793,194	)
	$	3,757		$	4,259

Depreciation expense was $502 and $75,879 for the three months ended September 30, 2016 and 2015, respectively.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Deferred Compensation	3 Months Ended
Note 4 - Deferred Compensation	Sep. 30, 2016
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	4. DEFERRED COMPENSATION: The Company owes deferred compensation to various employees, former employees and consultants totaling $1,657,541 as of September 30, 2016. Included in the deferred compensation balances as of September 30, 2016, are $672,753, $227,166 and $116,182 owed Dominic Bassani (“Bassani”), the Company’s Chief Executive Officer (“CEO”), Mark A. Smith (“Smith”), the Company’s President, and Edward Schafer (“Schafer”), the Company’s Vice Chairman, respectively, pursuant to extension agreements effective January 1, 2015, whereby unpaid compensation earned after January 1, 2015, accrues interest at 4% per annum and can be converted into shares of the Company’s common stock at the election of the employee during the first five calendar days of any month. The conversion price shall be the average closing price of the Company’s common stock for the last 10 trading days of the immediately preceding month. The Company also owes various consultants, pursuant to various agreements, for deferred compensation of $399,956 as of September 30, 2016 with similar conversion terms as those described above for Bassani, Smith and Schafer, with the exception that the interest accrues at 3% per annum. The Company also owes a former employee and a current employee deferred compensation of $168,000 and $984, respectively, which is convertible into 226,168 and 1,172 shares, respectively, of the Company’s common stock as of September 30, 2016 and, a former employee $72,500, which is not convertible and is non-interest bearing.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 22 R11.htm IDEA: XBRL DOCUMENT

Note 5 - Loan Payable	3 Months Ended
Note 5 - Loan Payable	Sep. 30, 2016
Notes to Financial Statements
Debt Disclosure [Text Block]	5. LOAN PAYABLE: As of September 30, 2016, PA1, the Company’s wholly-owned subsidiary, owes $8,621,827 under the terms of the Pennvest Loan related to the construction of the Kreider 1 System including accrued interest and late charges totaling $867,827. The terms of the Pennvest Loan provided for funding of up to $7,754,000 which was to be repaid by interest-only payments for three years, followed by an additional ten-year amortization of principal. The Pennvest Loan accrues interest at 2.547% per annum for years 1 through 5 and 3.184% per annum for years 6 through maturity. The Pennvest Loan required minimum annual principal payments of approximately $2,001,000 in fiscal years 2013 through 2016, and $741,000 in fiscal year 2017, $760,000 in fiscal year 2018, $771,000 in fiscal year 2019, $794,000 in fiscal year 2020, $819,000 in fiscal year 2021 and $1,867,000 thereafter. The Pennvest Loan is collateralized by the Kreider 1 System and by a pledge of all revenues generated from Kreider 1 including, but not limited to, revenues generated from nutrient reduction credit sales and by-product sales. In addition, in consideration for the excess credit risk associated with the project, Pennvest is entitled to participate in the profits from Kreider 1 calculated on a net cash flow basis, as defined. The Company has incurred interest expense related to the Pennvest Loan of $49,374 for both of the three months ended September 30, 2016 and 2015, respectively. Based on the limited development of the depth and breadth of the Pennsylvania nutrient reduction credit market to date, PA1 commenced negotiations with Pennvest related to forbearance and/or re-structuring the obligations under the Pennvest Loan. In the context of such negotiations, PA1 has elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of September 30, 2016. On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. PA1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active. As of the date of this report, no formal proposals are under consideration and only sporadic communication has taken place regarding the matters involved over the past 18 months. It is not possible at this date to predict the outcome of this matter, but the Company believes it is possible that an agreement may yet be reached that will result in a viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days. In connection with the Pennvest Loan financing documents, the Company provided a ‘technology guaranty’ regarding nutrient reduction performance of Kreider 1 which was structured to expire when Kreider 1’s nutrient reduction performance had been demonstrated. During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 System had surpassed the requisite performance criteria and that the Company’s ‘technology guaranty’ was met. As a result, the Pennvest Loan is solely an obligation of PA1.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Note 6 - Convertible Notes Payable - Affiliates	3 Months Ended
Note 6 - Convertible Notes Payable - Affiliates	Sep. 30, 2016
Notes to Financial Statements
Convertible Debt [Text Block]	6. CONVERTIBLE NOTES PAYABLE - AFFILIATES: January 2015 Convertible Notes The January 2015 Convertible Notes accrue interest at 4% per annum and are due and payable on December 31, 2017. The January 2015 Convertible Notes (including accrued interest, plus all future deferred compensation), are convertible, at the sole election of the noteholder, into Units consisting of one share of the Company’s common stock and one quarter warrant to purchase a share of the Company’s common stock, at a price of $0.50 per Unit until December 31, 2020. The warrant contained in the Unit shall be exercisable at $1.00 per share until December 31, 2020. The original conversion price of $0.50 per Unit approximated the fair value of the Units at the date of the agreements; therefore no beneficial conversion feature exists. Management evaluated the terms and conditions of the embedded conversion features based on the guidance of ASC 815-15 “Embedded Derivatives” to determine if there was an embedded derivative requiring bifurcation. An embedded derivative instrument (such as a conversion option embedded in the deferred compensation) must be bifurcated from its host instruments and accounted for separately as a derivative instrument only if the “risks and rewards” of the embedded derivative instrument are not “clearly and closely related” to the risks and rewards of the host instrument in which it is embedded. Management concluded that the embedded conversion feature of the deferred compensation was not required to be bifurcated because the conversion feature is clearly and closely related to the host instrument, and because of the Company’s limited trading volume that indicates the feature is not readily convertible to cash in accordance with ASC 815-10, “Derivatives and Hedging”. As of September 30, 2016, the January 2015 Convertible Note balances, including accrued interest, owed Bassani, Smith and Schafer were $1,566,944, $813,692 and $404,739, respectively. During the three months ended September 30, 2016 and 2015, the Company recorded interest expense of $26,247 and $26,248, respectively, related to the January 2015 Convertible Notes. September 2015 Convertible Notes During the year ended June 30, 2016, the Company entered into September 2015 Convertible Notes with Bassani, Schafer and a Shareholder which replaced previously issued promissory notes. The initial principal balances of the September 2015 Convertible Notes were $405,831, $16,382 and $82,921, respectively. The September 2015 Convertible Notes bear interest at 4% per annum, have maturity dates of December 31, 2017 and may be converted at the sole election of the noteholders into restricted common shares of the Company at a conversion price of $0.60 per share. As the conversion price of $0.60 approximated the fair value of the common shares at the date of the September 2015 Convertible Notes, no beneficial conversion feature exists. The balances of the September 2015 Convertible Notes as of September 30, 2016, including accrued interest, are $423,087, $17,079 and $86,447, respectively. The Company recorded interest expense related to the 2015 Convertible Notes of $5,093 and $1,218 for the three months ended September 30, 2016 and 2015, respectively.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Note 7 - Stockholders' Equity

3 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

7. STOCKHOLDERS' EQUITY:

Series B Preferred stock:

Common stock:

Centerpoint holds 704,309 shares of the Company’s common stock. These shares of the Company’s common stock held by Centerpoint are for the benefit of its shareholders without any beneficial interest. The Company accounts for these shares similar to treasury stock.

During the three months ended September 30, 2016, the Company issued 20,492 shares of the Company’s common stock at prices ranging from $0.75 to $0.83 per share for services valued at $16,556, in the aggregate, to consultants and employees.

During the three months ended September 30, 2016, the Company issued 10,000 shares of the Company’s restricted common stock upon receipt of its subscription receivable of $7,500 for the exercise of 10,000 warrants.

During the three months ended September 30, 2016, the Company entered into subscription agreements to sell units for $0.75 per unit, with each unit consisting of one share of the Company’s restricted common stock and one warrant to purchase one half of a share of the Company’s restricted common stock for $1.00 per share until December 31, 2017 and pursuant thereto, the Company issued 120,000 units for total proceeds of $90,000. The Company allocated the proceeds from the shares and the warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the warrants, which was determined to be $0.05 per warrant. As a result, $2,579 was allocated to the warrants and $87,421 was allocated to the shares, and both were recorded as additional paid in capital.

During the three months ended September 30, 2016, the Company sold 30,467 shares of the Company’s common stock for $0.75 per share for total proceeds of $22,850.

During the three months ended September 30, 2016, a consultant elected to convert $6,008 of deferred compensation into 7,152 shares of the Company’s common stock at a conversion rate of $0.84 per share.

Warrants:

As of September 30, 2016, the Company had approximately 7.4 million warrants outstanding, with exercise prices from $0.75 to $3.00 and expiring on various dates through December 31, 2021.

The weighted-average exercise price for the outstanding warrants is $1.29, and the weighted-average remaining contractual life as of September 30, 2016 is 4.0 years.

During the three months ended September 30, 2016, warrants to purchase 722,319 shares of common stock of the Company at prices between $0.75 per share expired.

At June 30, 2016 the Company had a subscription agreement for the exercise of 10,000 warrants at an exercise price of $0.75, resulting in a subscription receivable of $7,500. During the three months ended September 30, 2016, the received the subscription receivable of $7,500 and the Company issued 10,000 shares of the Company’s common stock in satisfaction of the warrant exercise.

During the three months ended September 30, 2016, the Company entered into subscription agreements to sell units for $0.75 per unit, with each unit consisting of one share of the Company’s restricted common stock and one warrant to purchase one half of a share of the Company’s restricted common stock for $1.00 per share until December 31, 2017 and pursuant thereto, the Company issued 120,000 units for total proceeds of $90,000. The Company allocated the proceeds from the shares and the warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the warrants, which was determined to be $0.05 per warrant. As a result, $2,579 was allocated to the warrants and $87,421 was allocated to the shares, and both were recorded as additional paid in capital.

Stock options:

The Company’s 2006 Consolidated Incentive Plan, as amended (the “2006 Plan”), provides for the issuance of options (and/or other securities) to purchase up to 22,000,000 shares of the Company’s common stock. Terms of exercise and expiration of options/securities granted under the 2006 Plan may be established at the discretion of the Board of Directors, but no option may be exercisable for more than ten years.

	Weighted Average, September 30, 2016			Range, September 30, 2016				Weighted Average, September 30, 2015		Range, September 30, 2015
Volatility		81	%		78%	-	86%		-		-
Dividend yield		-				-			-		-
Risk-free interest rate		0.93	%		0.82%	-	0.97%		-		-
Expected term (years)		3.7			3	-	4		-		-

The expected volatility was based on the historical price volatility of the Company’s common stock. The dividend yield represents the Company’s anticipated cash dividend on common stock over the expected term of the stock options. The U.S. Treasury bill rate for the expected term of the stock options was utilized to determine the risk-free interest rate. The expected term of stock options represents the period of time the stock options granted are expected to be outstanding based upon management’s estimates.

A summary of option activity under the 2006 Plan for the three months ended September 30, 2016 is as follows:

	Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Aggregate Intrinsic Value
Outstanding at July 1, 2016		4,225,537	$	1.79		4.1	$	158,675
Granted		35,000		1.00
Exercised		-		-
Forfeited		-		-
Expired		-		-
Outstanding at September 30, 2016		4,260,537	$	1.78		3.4	$	124,375
Exercisable at September 30, 2016		4,210,537	$	1.80		3.4	$	111,875

The following table presents information relating to nonvested stock options as of September 30, 2016:

	Options			Weighted Average Grant-Date Fair Value
Nonvested at July 1, 2016		50,000		$	0.76
Granted		35,000			0.45
Vested		(35,000	)		(0.45	)
Nonvested at September 30, 2016		50,000		$	0.76

Stock-based employee compensation charges in operating expenses in the Company’s financial statements for the three months ended September 30, 2016 and 2015 are as follows:

	Three months ended September 30, 2016		Three months ended September 30, 2015
General and administrative:
Fair value of stock options expensed	$	16,495	$	1,838
Total	$	16,495	$	1,838

Research and development:
Fair value of stock options expensed	$	4,361	$	13,482
Total	$	4,361	$	13,482

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 25 R14.htm IDEA: XBRL DOCUMENT

Note 8 - Commitments and Contingencies

3 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

8. COMMITMENTS AND CONTINGENCIES:

Employment and consulting agreements:

Smith has held the positions of Director, President and General Counsel of Company and its subsidiaries under various agreements and terms since March 2003. During September 2014, Smith agreed to continue his employment agreement through April 15, 2015 and also agreed to continue to defer his temporarily reduced salary of $14,000 per month until such date. On February 10, 2015, the Company executed an Extension Agreement with Smith pursuant to which Smith extended his employment with the Company to December 31, 2015 (with the Company having an option to extend his employment an additional six months). As part of the Extension Agreement, the balance of Smith’s existing convertible note payable as of December 31, 2014, adjusted for conversions subsequent to that date, was replaced with a new convertible note with an initial principal amount of $760,520 with terms that i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increases the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017. Additionally, pursuant to the Extension Agreement, Smith: i) will continue to defer his cash compensation ($18,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation, ii) cancelled 150,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 150,000 new options which vested immediately and iv) outstanding options and warrants owned by Smith (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50). In October 2015, the Company executed an Extension Agreement (“FY2016 Extension Agreement”) with Smith pursuant to which Smith extended his employment with the Company to June 30, 2016 (with Company having an option to extend his employment an additional six months). As part of the FY2016 Extension Agreement, Smith: i) will continue to defer his cash compensation ($19,000 per month) until the Board of Directors re-instates cash payments, ii) has been granted 100,000 new options which vested immediately, and iii) has been granted 75,000 shares of common stock as an extension bonus which are immediately vested and were issued on January 5, 2016. As of July 1, 2016, Smith is working under a month to month contract extension until a longer term agreement is reached.

Since March 31, 2005, the Company has had various agreements with Brightcap and/or Bassani, through which the services of Bassani are provided. The Board appointed Bassani as the Company's CEO effective May 13, 2011. During the fiscal years 2012 and 2013, Bassani entered into extension agreements whereby he was awarded fully vested stock grants totaling 600,000 shares, 500,000 shares of which are to be issued January 15, 2016 and 100,000 shares are to be issued January 15, 2017. The stock grants were expensed in the years they were awarded as they are fully vested. On February 10, 2015, the Company executed an Extension Agreement with Bassani pursuant to which Bassani extended the term of his service to the Company to December 31, 2017, (with the Company having an option to extend the term an additional six months.) As part of the agreement, the Company’s then existing loan payable, deferred compensation and convertible note payable to Bassani, were restructured into two promissory notes as follows: a) The sum of the cash loaned by Bassani to the Company of $279,000 together with $116,277 of unreimbursed expenses through December 31, 2014, were placed into a new promissory note with initial principal of $395,277 which was due and payable on December 31, 2015 and now has been replaced with a September 2015 Convertible Note (Note 8). In connection with these sums and the new promissory note, Bassani was issued warrants to purchase 592,916 shares of the Company’s common stock at a price of $1.00 until December 31, 2020; and b) the remaining balances of the Company’s accrued obligations to Bassani ($1,464,545) were replaced with a new convertible promissory note with terms that compared with the largest prior convertible note obligation to Bassani: i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increase the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017 (Note 8). Additionally, pursuant to the Extension Agreement, Bassani i) will continue to defer his cash compensation ($31,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation, ii) cancelled 250,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 450,000 new options which vested immediately and iv) outstanding options and warrants owned by Bassani (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50).

On February 10, 2015, the Company entered into an agreement with Schafer pursuant to which Schafer will continue to provide services to the Company through December 31, 2015. Additionally, pursuant to the agreement, i) the exercise period of outstanding options and warrants owned by Schafer have been extended, and ii) 25,000 contingent stock bonuses previously granted to Schafer have been cancelled by the Company. In January 2016, Schafer agreed to extend his agreement with the Company through December 31, 2016. During June 2016, Schafer and the Company determined that due to other obligations Schafer’s involvement with the Company during the 2016 fiscal year was less than anticipated and reduced his fiscal year 2016 compensation (all of which had been deferred) by $160,000 and future compensation will be determined periodically based on evaluation by the board of directors.

Contingent stock bonuses:

The Company has declared contingent deferred stock bonuses to its key employees and consultants at various times throughout the years. The stock bonuses are contingent upon the Company’s stock price exceeding a certain target price per share, and the grantees still being employed by or providing services to the Company at the time the target prices are reached.

The Company’s outstanding contingent stock bonuses as of September 30, 2016 are as follows:

Target Price per share		$	5.00			$	10.00			$	20.00
Number of shares			50,000				40,000				27,500

Execution/exercise bonuses:

As part of agreements the Company entered into with Bassani and Smith effective May 15, 2013, they were each granted the following: a) a 50% execution/exercise bonus which shall be applied upon the effective date of the notice of intent to exercise (for options and warrants) or issuance event, as applicable, of any currently outstanding and/or subsequently acquired options, warrants and/or contingent stock bonuses owned by each (and/or their donees) as follows: i) in the case of exercise by payment of cash, the bonus shall take the form of reduction of the exercise price; ii) in the case of cashless exercise, the bonus shall be applied to reduce the exercise price prior to the cashless exercise calculations; and iii) with regard to contingent stock bonuses, issuance shall be triggered upon the Company’s common stock reaching a closing price equal to 50% of currently specified price; and b) the right to extend the exercise period of all or part of the applicable options and warrants for up to five years (one year at a time) by annual payments of $.05 per option or warrant to the Company on or before a date during the three months prior to expiration of the exercise period at least three business days before the end of the expiration period. Effective January 1, 2016 such annual payments to extend warrant exercise periods have been reduced to $.01 per option or warrant.

During the year ended June 30, 2014, the Company extended execution/exercise bonuses with the same terms as described above to Schafer and to Jon Northrop, the Company’s other board member.

As of September 30, 2016, the execution/exercise bonus was applicable to 3,070,000 of the Company’s outstanding options and 6,753,219 of the Company’s outstanding warrants.

Litigation:

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that PA1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the ‘technology guaranty’ standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA1. No litigation has commenced related to this matter but such litigation is likely if negotiations do not produce a resolution (Notes 1 and Note 5).

The Company currently is not involved in any other material litigation.

XML 26 R15.htm IDEA: XBRL DOCUMENT

Note 9 - Subsequent Events

3 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Subsequent Events [Text Block]

9. SUBSEQUENT EVENTS:

The Company has evaluated events that occurred subsequent to September 30, 2016 for recognition and disclosure in the financial statements and notes to the financial statements.

From October 1, 2016 through November 11, 2016, the Company has issued 2,137 shares of the Company’s common shares to an employee for services valued at approximately $2,000.

On October 10, 2016, the Company:

a) approved the cancellation the 117,500 outstanding contingent stock bonus shares and replaced the cancelled contingent stock bonuses with 109,500 fully vested options to purchase shares of the Company’s common shares at an exercise price of $1.00 per share until December 31, 2020.

b) approved the modification of certain stock options to certain employees and consultants which will reduce the exercise prices to such options to $1.50 per share.

c) granted 125,000 bonus shares, in aggregate, to certain employees and consultants with various issuance dates from January 15, 2017 to January 15, 2020.

d) granted 75,000 options to purchase shares of the Company’s common shares at an exercise price of $1.00 per share with vesting occurring from December 31, 2016 through December 31, 2017.

e) approved a month to month contract extension with Smith which includes provisions for i) issuance of 25,000 bonus shares of the Company’s common shares on January 15, 2017, ii) grant of 75,000 options to purchase shares of the Company’s common shares at $0.90 per share with expiry date of December 31, 2020, which options are subject to the exercise/extension bonus, iii) a monthly deferred salary of $18,000 effective October 1, 2016, iv) the right to convert up to $125,000 of his deferred compensation, at his sole election, at $0.75 per share, until March 15, 2018, and v) the right to convert his deferred compensation in whole or in part, at his sole election, at any time in any amount at “market” or into securities sold in the Company’s current/most recent private offering at the price of such offering to third parties.

f) modified 60,000 outstanding warrants owned by Bassani to make them subject to the exercise/extension bonus applicable to his other warrants/options and granted Bassani the right to convert up to $125,000 of his deferred compensation, at his sole election, at $0.75 per share, until March 15, 2018.

g) issued 25,000 warrants to purchase the Company’s common shares at $0.90 per share, expiring on December 31, 2019 to a consultant for services.

On November 9, 2016, the Company’s Board of Directors ratified:

	a)	the sale to Smith, effective November 9, 2016, of warrants to purchase 40,000 shares of the Company’s common stock exercisable at $1.00 per share until December 31, 2021 (which warrants are subject to an exercise bonus) at the purchase price of $.05 per warrant ($2,000, in aggregate) which was paid by reduction of Smith’s accrued deferred compensation.

	b)	the sale to Bassani, effective November 9, 2016, of warrants to purchase 800,000 shares of the Company’s common stock exercisable at a price of $1.00 per share until December 31, 2021 (which warrants are subject to an augmented exercise bonus), at a purchase price of $.05 per warrant ($40,000, in aggregate) which was paid by a note from Bassani due November 15, 2017.

	c)	the sale to an employee, effective November 9, 2016, of warrants to purchase 40,000 shares of the Company’s common stock exercisable at $1.00 per share until December 31, 2021 (which warrants are subject to an exercise bonus) at the purchase price of $.05 per warrant ($2,000, in aggregate) which was paid by reduction of the employee’s accrued deferred compensation.

XML 27 R16.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

3 Months Ended

Sep. 30, 2016

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

Principles of consolidation:

Property, Plant and Equipment, Policy [Policy Text Block]

Property and equipment:

Equity Issuances Warrants Policy [Policy Text Block]

Warrants:

The Company has issued warrants to purchase common shares of the Company. Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Company’s value as of the date of the issuance, consideration of the Company’s limited liquid resources and business prospects, the market price of the Company’s stock in its mostly inactive public market and the historical valuations and purchases of the Company’s warrants. When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined.

Fair Value Measurement, Policy [Policy Text Block]

Fair value measurements:

Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 3 – assets and liabilities whose significant value drivers are unobservable.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition:

Earnings Per Share, Policy [Policy Text Block]

Loss per share:

The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:

	September 30, 2016		September 30, 2015
Warrants		7,439,795		8,295,989
Options		4,260,537		4,413,870
Convertible debt		8,361,559		7,119,524
Convertible preferred stock		15,250		14,250

The following is a reconciliation of the denominators of the basic loss per share computations for the three months ended September 30, 2016 and 2015:

	Three months ended September 30, 2016			Three months ended September 30, 2015
Shares issued – beginning of period		23,573,057			22,089,650
Shares held by subsidiaries (Note 7)		(704,309	)		(704,309	)
Shares outstanding – beginning of period		22,868,748			21,385,341
Weighted average shares for fully vested stock bonuses		600,000			600,000
Weighted average shares issued during the period		75,374			303,736
Basic weighted average shares – end of period		23,544,122			22,289,077

Reclassification, Policy [Policy Text Block]

Reclassifications:

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements:

The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company’s financial statements properly reflect the change.

XML 28 R17.htm IDEA: XBRL DOCUMENT

Note 2 - Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2016

Notes Tables

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	September 30, 2016		September 30, 2015
Warrants		7,439,795		8,295,989
Options		4,260,537		4,413,870
Convertible debt		8,361,559		7,119,524
Convertible preferred stock		15,250		14,250

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three months ended September 30, 2016			Three months ended September 30, 2015
Shares issued – beginning of period		23,573,057			22,089,650
Shares held by subsidiaries (Note 7)		(704,309	)		(704,309	)
Shares outstanding – beginning of period		22,868,748			21,385,341
Weighted average shares for fully vested stock bonuses		600,000			600,000
Weighted average shares issued during the period		75,374			303,736
Basic weighted average shares – end of period		23,544,122			22,289,077

XML 29 R18.htm IDEA: XBRL DOCUMENT

Note 3 - Property and Equipment (Tables)

3 Months Ended

Sep. 30, 2016

Notes Tables

Property, Plant and Equipment [Table Text Block]

	September 30, 2016			June 30, 2016
Machinery and equipment	$	2,222,670		$	2,222,670
Buildings and structures		401,470			401,470
Computers and office equipment		171,560			173,313
		2,795,700			2,797,453
Less accumulated depreciation		(2,791,943	)		(2,793,194	)
	$	3,757		$	4,259

XML 30 R19.htm IDEA: XBRL DOCUMENT

Note 7 - Stockholders' Equity (Tables)

3 Months Ended

Sep. 30, 2016

Notes Tables

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Weighted Average, September 30, 2016			Range, September 30, 2016				Weighted Average, September 30, 2015		Range, September 30, 2015
Volatility		81	%		78%	-	86%		-		-
Dividend yield		-				-			-		-
Risk-free interest rate		0.93	%		0.82%	-	0.97%		-		-
Expected term (years)		3.7			3	-	4		-		-

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Aggregate Intrinsic Value
Outstanding at July 1, 2016		4,225,537	$	1.79		4.1	$	158,675
Granted		35,000		1.00
Exercised		-		-
Forfeited		-		-
Expired		-		-
Outstanding at September 30, 2016		4,260,537	$	1.78		3.4	$	124,375
Exercisable at September 30, 2016		4,210,537	$	1.80		3.4	$	111,875

Schedule of Nonvested Share Activity [Table Text Block]

	Options			Weighted Average Grant-Date Fair Value
Nonvested at July 1, 2016		50,000		$	0.76
Granted		35,000			0.45
Vested		(35,000	)		(0.45	)
Nonvested at September 30, 2016		50,000		$	0.76

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

	Three months ended September 30, 2016		Three months ended September 30, 2015
General and administrative:
Fair value of stock options expensed	$	16,495	$	1,838
Total	$	16,495	$	1,838

Research and development:
Fair value of stock options expensed	$	4,361	$	13,482
Total	$	4,361	$	13,482

XML 31 R20.htm IDEA: XBRL DOCUMENT

Note 8 - Commitments and Contingencies (Tables)

3 Months Ended

Sep. 30, 2016

Notes Tables

Shares Outstanding under Contingent Stock Bonuses Plan by Target Price Per Share [Table Text Block]

Target Price per share		$	5.00			$	10.00			$	20.00
Number of shares			50,000				40,000				27,500

XML 32 R21.htm IDEA: XBRL DOCUMENT

Note 1 - Organization, Nature of Business, Going Concern and Management's Plans (Details Textual) - USD ($)		3 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Sep. 25, 2014	Jan. 26, 2009
Property, Plant and Equipment of PA1 [Member]
Impairment of Long-Lived Assets Held-for-use	$ 0			$ 1,684,562	$ 3,750,000
Property, Plant and Equipment, Net	0	$ 0		0
PA-1 [Member]
Debt Instrument, Debt Default, Amount						$ 8,137,117
Minimum [Member]
Capital Required for Capital Adequacy	2,500,000	2,500,000
Maximum [Member]
Capital Required for Capital Adequacy	50,000,000	50,000,000
Construction Loan							$ 7,750,000
Impairment of Long-Lived Assets Held-for-use				1,684,562
Property, Plant and Equipment, Net	3,757	3,757		4,259
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		(630,200)	$ (833,029)	(4,522,000)	$ (5,642,000)
Working Capital	(11,044,000)	(11,044,000)
Stockholders' Equity Attributable to Parent	$ (14,411,525)	(14,411,525)		(13,938,129)
Proceeds from Issuance or Sale of Equity		$ 112,850		$ 760,604

XML 33 R22.htm IDEA: XBRL DOCUMENT

Note 2 - Significant Accounting Policies (Details Textual)	3 Months Ended
	Sep. 30, 2016
Centerpoint [Member]
Equity Method Investment, Ownership Percentage	58.90%
Minimum [Member]
Property, Plant and Equipment, Useful Life	3 years
Maximum [Member]
Property, Plant and Equipment, Useful Life	20 years

XML 34 R23.htm IDEA: XBRL DOCUMENT

Note 2 - Significant Accounting Policies - Antidilutive Securities (Details) - shares	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Warrant [Member]
Antidilutive securities (in shares)	7,439,795	8,295,989
Employee Stock Option [Member]
Antidilutive securities (in shares)	4,260,537	4,413,870
Convertible Debt Securities [Member]
Antidilutive securities (in shares)	8,361,559	7,119,524
Convertible Preferred Stock Antidilutive Securities [Member]
Antidilutive securities (in shares)	15,250	14,250

XML 35 R24.htm IDEA: XBRL DOCUMENT

Note 2 - Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details) - shares	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Common stock, issued (in shares)	23,761,168		23,573,057	22,089,650
Shares held by subsidiaries (Note 7) (in shares)	(704,309)	(704,309)
Common stock, outstanding (in shares)	23,056,859		22,868,748	21,385,341
Weighted average shares for fully vested stock bonuses (in shares)	600,000	600,000
Weighted average shares issued during the period (in shares)	75,374	303,736
Basic weighted average shares – end of period (in shares)	23,544,122	22,289,077

XML 36 R25.htm IDEA: XBRL DOCUMENT

Note 3 - Property and Equipment (Details Textual) - USD ($)		3 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Property, Plant and Equipment of PA1 [Member]
Impairment of Long-Lived Assets Held-for-use	$ 0			$ 1,684,562	$ 3,750,000
Property, Plant and Equipment, Net	0	$ 0		0
Impairment of Long-Lived Assets Held-for-use				1,684,562
Property, Plant and Equipment, Net	$ 3,757	3,757		$ 4,259
Depreciation		$ 502	$ 75,879

XML 37 R26.htm IDEA: XBRL DOCUMENT

Note 3 - Property and Equipment - Property and Equipment (Details) - USD ($)	Sep. 30, 2016	Jun. 30, 2016
Machinery and equipment	$ 2,222,670	$ 2,222,670
Buildings and structures	401,470	401,470
Computers and office equipment	171,560	173,313
Total	2,795,700	2,797,453
Less accumulated depreciation	(2,791,943)	(2,793,194)
Net	$ 3,757	$ 4,259

XML 38 R27.htm IDEA: XBRL DOCUMENT

Note 4 - Deferred Compensation (Details Textual) - USD ($)	3 Months Ended
	Sep. 30, 2016	Jun. 30, 2016
Chief Executive Officer [Member]
Deferred Compensation Liability, Current	$ 672,753
President [Member]
Deferred Compensation Liability, Current	227,166
Executive Vice Chairman [Member]
Deferred Compensation Liability, Current	116,182
Consultants [Member]
Deferred Compensation Liability, Current	$ 399,956
Interest Rate on Deferred Compensation	3.00%
Former Employee 1 [Member]
Deferred Compensation Liability, Current	$ 168,000
Deferred Compensation Shares Issued upon Conversion	226,168
Individual Employee [Member]
Deferred Compensation Liability, Current	$ 984
Deferred Compensation Shares Issued upon Conversion	1,172
Former Employee [Member]
Deferred Compensation Liability, Current	$ 72,500
Deferred Compensation Liability, Current	$ 1,657,541	$ 1,436,595
Interest Rate on Deferred Compensation	4.00%
Deferred Compensation Conversion Days	5 days
Deferred Compensation Consecutive Trading Days	10 days

XML 39 R28.htm IDEA: XBRL DOCUMENT

Note 5 - Loan Payable (Details Textual) - USD ($)	3 Months Ended		51 Months Ended
Note 5 - Loan Payable (Details Textual) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 25, 2014	Jan. 26, 2009
Pennvest Loan [Member] \| Amortization of Principal Number of Years [Member]
Term Loan Payment Term	3 years
Pennvest Loan [Member] \| Interest Only Payments Number of Years [Member]
Term Loan Payment Term	10 years
Pennvest Loan [Member] \| Years One Through Five [Member]
Debt Instrument, Interest Rate During Period	2.547%
Pennvest Loan [Member] \| Years Six Through Maturity [Member]
Debt Instrument, Interest Rate During Period	3.184%
Pennvest Loan [Member]
Interest Expense, Debt	$ 49,374	$ 49,374
Construction Loan	8,621,827		$ 8,621,827
Accrued Interest and Late Charges Payable	867,827		867,827
Line of Credit Facility, Maximum Borrowing Capacity	7,754,000		7,754,000
Repayments of Long-term Debt			2,001,000
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months	741,000		741,000
Long-term Debt, Maturities, Repayments of Principal in Year Two	760,000		760,000
Long-term Debt, Maturities, Repayments of Principal in Year Three	771,000		771,000
Long-term Debt, Maturities, Repayments of Principal in Year Four	794,000		794,000
Long-term Debt, Maturities, Repayments of Principal in Year Five	819,000		819,000
Long-term Debt, Maturities, Repayments of Principal after Year Five	$ 1,867,000		$ 1,867,000
PA-1 [Member]
Debt Instrument, Debt Default, Amount				$ 8,137,117
Construction Loan					$ 7,750,000

XML 40 R29.htm IDEA: XBRL DOCUMENT

Note 6 - Convertible Notes Payable - Affiliates (Details Textual)	3 Months Ended
	Sep. 30, 2016 USD ($) $ / shares	Sep. 30, 2015 USD ($)	Jun. 30, 2016 USD ($)
January 2015 Convertible Notes [Member] \| Convertible Debt [Member] \| Chief Executive Officer [Member]
Convertible Notes Payable, Noncurrent	$ 1,566,944
January 2015 Convertible Notes [Member] \| Convertible Debt [Member] \| Chief Financial Officer [Member]
Convertible Notes Payable, Noncurrent	813,692
January 2015 Convertible Notes [Member] \| Convertible Debt [Member] \| Executive Vice Chairman [Member]
Convertible Notes Payable, Noncurrent	$ 404,739
January 2015 Convertible Notes [Member] \| Convertible Debt [Member]
Debt Instrument, Interest Rate, Stated Percentage	4.00%
Number of Share Per Unit	1
Number of Warrants Per Unit	1
Conversion Price Per Unit \| $ / shares	$ 0.50
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 1
Interest Expense	$ 26,247	$ 26,248
September 2015 Convertible Notes [Member] \| Convertible Debt [Member] \| Chief Executive Officer [Member]
Convertible Notes Payable, Noncurrent	423,087	405,831
September 2015 Convertible Notes [Member] \| Convertible Debt [Member] \| Chief Financial Officer [Member]
Convertible Notes Payable, Noncurrent	17,079	16,382
September 2015 Convertible Notes [Member] \| Convertible Debt [Member] \| Executive Vice President [Member]
Convertible Notes Payable, Noncurrent	$ 86,447	82,921
September 2015 Convertible Notes [Member] \| Convertible Debt [Member]
Debt Instrument, Interest Rate, Stated Percentage	4.00%
Conversion Price Per Unit \| $ / shares	$ 0.60
Interest Expense	$ 5,093	1,218
Chief Executive Officer [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 1.50
Convertible Notes Payable, Noncurrent	$ 3,311,988		$ 3,280,647
Interest Expense	$ 92,764	$ 114,756

XML 41 R30.htm IDEA: XBRL DOCUMENT

Note 7 - Stockholders' Equity (Details Textual)				3 Months Ended		12 Months Ended
Note 7 - Stockholders' Equity (Details Textual)	Jun. 30, 2016 USD ($) $ / shares shares	Feb. 10, 2015 $ / shares shares	Jul. 02, 2014 $ / shares shares	Sep. 30, 2016 USD ($) $ / shares $ / item shares	Sep. 30, 2015 USD ($) shares	Jun. 30, 2016 USD ($) $ / shares shares	Jun. 30, 2015 USD ($) $ / shares
Series B Preferred Stock [Member]
Preferred Stock, Shares Outstanding \| shares	200		200	200		200
Preferred Stock, Par or Stated Value Per Share \| $ / shares	$ 0.01		$ 0.01	$ 0.01		$ 0.01
Preferred Stock, Redemption Price Per Share \| $ / shares			$ 2
Preferred Stock, Dividend Rate, Percentage			2.50%
Convertible Preferred Stock Redemption Period			3 years
Dividends, Preferred Stock				$ 500		$ 2,000	$ 2,000
Dividends Payable				$ 10,500
Centerpoint [Member]
Shares Held by Subsidiaries \| shares				704,309
Employees and Consultants [Member] \| Minimum [Member]
Share Price \| $ / shares				$ 0.75
Employees and Consultants [Member] \| Maximum [Member]
Share Price \| $ / shares				0.83
President [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross \| shares		150,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares		$ 1.50		$ 0.75
Number of Share Per Unit				1
Number of Warrants Per Unit				1
Consultants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares				$ 0.84
Deferred Compensation Converted to Common Stock Amount				$ 6,008
Deferred Compensation Converted to Common Stock Shares \| shares				7,152
Various Warrant Holders [Member] \| Subscription Agreement [Member]
Class of Warrant or Right Exercised During Period \| shares	10,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 0.75					$ 0.75
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable	$ 7,500					$ 7,500
Proceeds from Collection of Notes Receivable				$ 7,500
Common Stock Shares Issued upon Exercise of Warrants \| shares				10,000
Maximum [Member] \| Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period				10 years
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares				$ 3
Restricted Stock [Member] \| Subscriptions Receivable [Member]
Stock Issued During Period, Shares, New Issues \| shares				10,000
Stock Issued During Period, Value, New Issues				$ 7,500
Class of Warrant or Right Exercised During Period \| shares				10,000
Restricted Stock [Member] \| Subscription Agreement [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares				$ 0.75			$ 0.75
Restricted Stock [Member] \| Subscription Agreement Two [Member]
Number of Share Per Unit				1
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized \| shares				22,000,000
Allocated Share-based Compensation Expense				$ 20,856	$ 15,320
Subscription Agreement [Member]
Share Price \| $ / shares				$ 1
Number of Share Per Unit				1
Sale of Units, Number Of Units Issued \| shares				120,000
Sale of Units, Value				$ 90,000
Warrant Fair Value Price Per Share \| $ / shares				$ 0.05
Adjustments to Additional Paid in Capital, Warrant Issued				$ 2,579
Adjustments to Additional Paid in Capital, Other				$ 87,421
Subscription Agreement Two [Member]
Share Price \| $ / shares				$ 1
Number of Warrants Per Unit				1
Sale of Units, Number Of Units Issued \| shares				120,000
Sale of Units, Value				$ 90,000
Adjustments to Additional Paid in Capital, Warrant Issued				2,579
Adjustments to Additional Paid in Capital, Other				$ 87,421
Sale Of Units Price Per Unit Issued \| $ / item				0.75
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares				0.5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross \| shares				35,000	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value				$ 15,900	$ 0
Common Stock Voting Rights Votes Per Share				1
Shares Held by Subsidiaries \| shares				704,309	704,309
Stock Issued During Period, Shares, Issued for Services \| shares				20,492
Share Price \| $ / shares	$ 0.75					$ 0.75
Stock Issued During Period, Value, Issued for Services				$ 16,556
Stock Issued During Period, Shares, New Issues \| shares				30,467
Stock Issued During Period, Value, New Issues				$ 22,850
Sale of Units, Value				$ 90,000
Warrant Fair Value Price Per Share \| $ / shares				$ 0.05
Proceeds from Issuance of Common Stock				$ 22,850
Class of Warrant or Right, Outstanding \| shares				7,400,000
Weighted Average Exercise Price for Outstanding Warrants \| $ / shares				$ 1.29
Weighted Average Remaining Contractual Life for Outstanding Warrants				4 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period \| shares				722,319
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options				$ 4,957

XML 42 R31.htm IDEA: XBRL DOCUMENT

Note 7 - Stockholders' Equity - Black-scholes Valuation Assumptions for Options (Details) - Employee Stock Option [Member]	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Weighted Average [Member]
Volatility	81.00%
Risk-free interest rate	0.93%
Expected term (years)	3 years 255 days
Minimum [Member]
Volatility	78.00%
Dividend yield
Risk-free interest rate	0.82%
Expected term (years)	3 years
Maximum [Member]
Volatility	86.00%
Dividend yield
Risk-free interest rate	0.97%
Expected term (years)	4 years
Volatility
Dividend yield
Risk-free interest rate
Expected term (years)

XML 43 R32.htm IDEA: XBRL DOCUMENT

Note 7 - Stockholders' Equity - Stock Options Activity (Details) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2016	Sep. 30, 2016
Outstanding, beginning balance (in shares)	4,225,537
Outstanding, weighted-average exercise price, beginning balance (in dollars per share)	$ 1.79
Outstanding, weighted-average remaining contractual life	3 years 146 days		4 years 36 days
Outstanding, aggregate intrinsic value	$ 158,675
Granted, options (in shares)	35,000	0
Granted, weighted-average exercise price (in dollars per share)	$ 1
Outstanding, ending balance (in shares)	4,260,537		4,225,537
Outstanding, weighted-average exercise price, ending balance (in dollars per share)	$ 1.78		$ 1.79
Outstanding, aggregate intrinsic value	$ 158,675		$ 158,675	$ 124,375
Exercisable, options (in shares)				4,210,537
Exercisable, weighted-average exercise price (in dollars per share)				$ 1.80
Exercisable, weighted-average remaining contractual life	3 years 146 days
Exercisable, aggregate intrinsic value				$ 111,875

XML 44 R33.htm IDEA: XBRL DOCUMENT

Note 7 - Stockholders' Equity - Nonvested Share Activity (Details) - $ / shares	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Nonvested (in shares)	50,000
Nonvested, weighted-average grant-date fair value (in dollars per share)	$ 0.76
Granted, options (in shares)	35,000	0
Granted, weighted-average grant-date fair value (in dollars per share)	$ 0.45
Vested (in shares)	(35,000)
Vested, weighted-average grant-date fair value (in dollars per share)	$ (0.45)
Nonvested (in shares)	50,000
Nonvested, weighted-average grant-date fair value (in dollars per share)	$ 0.76

XML 45 R34.htm IDEA: XBRL DOCUMENT

Note 7 - Stockholders' Equity - Allocation of Recognized Period Costs (Details) - USD ($)	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Employee Stock Option [Member] \| General and Administrative Expense [Member]
Allocated Share-based Compensation Expense	$ 16,495	$ 1,838
Employee Stock Option [Member] \| Research and Development Expense [Member]
Allocated Share-based Compensation Expense	4,361	13,482
Employee Stock Option [Member]
Allocated Share-based Compensation Expense	20,856	15,320
General and Administrative Expense [Member]
Allocated Share-based Compensation Expense	16,495	1,838
Research and Development Expense [Member]
Allocated Share-based Compensation Expense	$ 4,361	$ 13,482

XML 46 R35.htm IDEA: XBRL DOCUMENT

Note 8 - Commitments and Contingencies (Details Textual)				1 Months Ended		3 Months Ended		9 Months Ended	15 Months Ended	24 Months Ended
	Jan. 05, 2016 shares	Feb. 10, 2015 USD ($) $ / shares shares	Sep. 25, 2014 USD ($)	Oct. 31, 2015 USD ($) shares	Sep. 30, 2014 USD ($)	Sep. 30, 2016 USD ($) $ / shares shares	Sep. 30, 2015 shares	Sep. 30, 2016 USD ($) $ / shares shares	Sep. 30, 2016 USD ($) $ / shares shares	Dec. 31, 2013 shares	Jun. 30, 2016 shares	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($) $ / shares	May 15, 2013
Extension Agreement One [Member] \| President [Member]
Monthly Officer's Compensation \| $					$ 14,000
Extension Agreement One [Member] \| Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross										600,000
Common Stock, Capital Shares Reserved for Future Issuance										500,000
FY2016 Extension Agreement [Member] \| President [Member] \| Extension Bonus [Member]
Stock Issued During Period, Shares, Issued for Services	75,000
FY2016 Extension Agreement [Member] \| President [Member]
Monthly Officers' Cash Compensation \| $				$ 19,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				100,000
Extension Agreement Two [Member] \| Chief Executive Officer [Member] \| Stock Bonus [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period						250,000
President [Member] \| New Smith Note [Member] \| Convertible Debt [Member]
Debt Instrument, Interest Rate Reduction, Percentage		50.00%
Debt Instrument, Interest Rate, Stated Percentage		4.00%											8.00%
Debt Instrument, Convertible Conversion Price, Incease, Percentage		11.00%
Debt Instrument, Convertible, Conversion Price \| $ / shares		$ 0.50											$ 0.45
Accrued Interest on Deferred Compensation and Other Expenses \| $		$ 75
Number of Warrants Per Unit		0.25											1
President [Member] \| New Smith Note [Member]
Convertible Notes Payable \| $		$ 760,520
President [Member] \| Stock Bonus [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period		150,000
President [Member]
Number of Warrants Per Unit						1		1	1
Monthly Officers' Cash Compensation \| $		$ 18,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		150,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares		$ 1.50				$ 0.75		$ 0.75	$ 0.75
Chief Executive Officer [Member] \| Cash Note [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares						$ 1		$ 1	$ 1
Debt Instrument, Face Amount \| $												$ 395,277
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						592,916		592,916	592,916
Chief Executive Officer [Member] \| Mr. Bassani [Member] \| Convertible Debt [Member]
Number of Warrants Per Unit													1
Chief Executive Officer [Member] \| Stock Bonus [Member] \| Maximum [Member]
ExtensionOfExercisePeriod						5 years
Chief Executive Officer [Member] \| Stock Bonus [Member]
Execution Bonus as Percentage of Exercised Options and Warrants														50.00%
ContingentStockBonusPercentageThresholdForIssuance						50.00%		50.00%	50.00%
Chief Executive Officer [Member]
Monthly Officers' Cash Compensation \| $						$ 31,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross						450,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares						$ 1.50		$ 1.50	$ 1.50
Due to Related Parties, Current \| $													$ 279,000
Unreimbursed Expenses \| $													$ 116,277
Executive Vice Chairman [Member] \| Stock Bonus [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period		25,000
Executive Vice Chairman [Member]
Adjustment for Deferred Compensation During the Period \| $									$ 160,000
CEO and President [Member] \| Exercise Bonus [Member]
Extension of Exercise Period Annual Payment per Option or Warrant \| $ / shares						$ 0.05		$ 0.01
Mr. Bassani [Member] \| Convertible Debt [Member]
Debt Instrument, Interest Rate Reduction, Percentage						50.00%		50.00%	50.00%
Debt Instrument, Interest Rate, Stated Percentage						4.00%		4.00%	4.00%				8.00%
Debt Instrument, Convertible Conversion Price, Incease, Percentage						11.00%		11.00%	11.00%
Debt Instrument, Convertible, Conversion Price \| $ / shares						$ 0.50		$ 0.50	$ 0.50				$ 0.45
Number of Warrants Per Unit Reduction Percentage						75.00%		75.00%	75.00%
Mr. Bassani [Member]
Convertible Notes Payable \| $						$ 1,464,545		$ 1,464,545	$ 1,464,545
Exercise Bonus [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number						3,070,000		3,070,000	3,070,000
Class of Warrant or Right, Outstanding						6,753,219		6,753,219	6,753,219
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares						$ 3		$ 3	$ 3
Pennvest Loan [Member]
Loss Contingency, Damages Sought, Value \| $			$ 8,137,117
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross						35,000	0
Stock Issued During Period, Shares, Issued for Services						20,492
Common Stock, Capital Shares Reserved for Future Issuance										100,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number						4,260,537		4,260,537	4,260,537		4,225,537
Class of Warrant or Right, Outstanding						7,400,000		7,400,000	7,400,000

XML 47 R36.htm IDEA: XBRL DOCUMENT

Note 8 - Commitments and Contingencies - Summary of Outstanding Contingent Stock Bonuses (Details) - $ / shares	Sep. 30, 2016	Jun. 30, 2016
Stock Bonus Payable Upon Stock Price of $5.00 per Share [Member] \| Stock Bonus [Member]
Share Price	$ 5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	50,000
Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] \| Stock Bonus [Member]
Share Price	$ 10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	40,000
Stock Bonus Payable Upon Stock Price of $20.00 per Share [Member] \| Stock Bonus [Member]
Share Price	$ 20
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	27,500
Share Price		$ 0.75
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	4,260,537	4,225,537

XML 48 R37.htm IDEA: XBRL DOCUMENT

Note 9 - Subsequent Events (Details Textual) - USD ($)				1 Months Ended	3 Months Ended
Note 9 - Subsequent Events (Details Textual) - USD ($)	Nov. 09, 2016	Oct. 10, 2016	Feb. 10, 2015	Nov. 11, 2016	Sep. 30, 2016	Sep. 30, 2015	Oct. 12, 2016	Jun. 30, 2016
Subsequent Event [Member] \| Employees and Consultants [Member] \| Stock Bonus [Member]
Stock Issued During Period, Shares, New Issues		125,000
Subsequent Event [Member] \| Employees and Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 1.50
Subsequent Event [Member] \| President [Member] \| Stock Bonus [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		75,000
Stock Issued During Period, Shares, New Issues		25,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price		$ 0.90
Subsequent Event [Member] \| President [Member]
Monthly Officer's Compensation		$ 18,000
Deferred Compensation, Maximum Convertible Amount		$ 125,000
Deferred Compensation, Stock Conversion, Price Per Share		$ 0.75
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1
Bonus Shares, Previously Due to Be Issued to Employees, Agreed to Cancel							25,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	40,000
Class of Warrant or Right, Purchase Price of Warrants or Rights, Per Share	$ 0.05
Class of Warrant or Right, Aggregate Purchase Price of Warrants or Rights	$ 2,000
Subsequent Event [Member] \| Chief Executive Officer [Member]
Deferred Compensation, Maximum Convertible Amount		$ 125,000
Warrants and Rights Outstanding		$ 60,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1
Bonus Shares, Previously Due to Be Issued to Employees, Agreed to Cancel							600,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	800,000
Class of Warrant or Right, Purchase Price of Warrants or Rights, Per Share	$ 0.05
Class of Warrant or Right, Aggregate Purchase Price of Warrants or Rights	$ 40,000
Subsequent Event [Member] \| An Employee [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	40,000
Class of Warrant or Right, Purchase Price of Warrants or Rights, Per Share	$ 0.05
Class of Warrant or Right, Aggregate Purchase Price of Warrants or Rights	$ 2,000
Subsequent Event [Member] \| Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		75,000
Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares		109,500
Stock Issued During Period, Shares, Issued for Services				2,137
Stock Issued During Period, Value, Issued for Services				$ 2,000
Contingent Stock Bonus, Outstanding Shares, Canceled During Period		117,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		109,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 1
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price		1
Deferred Compensation, Stock Conversion, Price Per Share		$ 0.75
Class of Warrant or Right Issued During Period		25,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.90
Bonus Shares, Previously Due to Be Issued to Employees, Agreed to Cancel							650,000
President [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			150,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 1.50		$ 0.75
Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					450,000
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 1.50
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares					35,000
Stock Issued During Period, Shares, Issued for Services					20,492
Stock Issued During Period, Value, Issued for Services					$ 16,556
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					35,000	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price					$ 1.78			$ 1.79
Stock Issued During Period, Shares, New Issues					30,467
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price					$ 1

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�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